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 Clinicians have made practical efforts for over 100 years in replacing damaged 
tissues and organs.  However, organ shortage and rejection still remain major 
challenges.  Rapidly emerging tissue engineering, which is interdisciplinary medical 
science and technology, has gained attention to resolve the challenges.  The grand 
aim of tissue engineering is to develop implantable tissue constructs via in vitro 
culture of cells seeded in three-dimensional (3-D) scaffolds formed in biomaterials.  
Microengineering and microfluidic techniques have demonstrated promising proof-of-
concept in developing potentially valuable in vitro culture systems.  However, in 
conventional microfluidic systems, the culture environment is confined to channels.  
Moreover, most of currently existing cell culture systems do not allow for the creation 
of fully functional tissues.  This limitation is also due to a lack of understanding 
principles of tissue function and growth.  Tissue-scale biology, combined with 
molecular and cell biology, would allow for better understandings of the principles, 
and can be complementarily interconnected to tissue engineering.  Therefore, we 
must develop in vitro tools to overcome the challenges and to enable tissue 
engineering and tissue-scale biology.  The development of the enabling tools could 
lead to exploitation of detailed principles and mechanisms in the study of 
physiological and pathological processes in a quantitative manner. 
 First, we present the development of microfluidic scaffolds that are formed by 
 embedding microfluidic networks directly within biomaterials.  Experiments with 
chondrocytes in calcium alginate demonstrated that these embedded microchannels 
enable the maintenance of a uniform metabolic environment within the bulk of the 
scaffold and the creation of distinct soluble environments experienced by cells in their 
3-D environment.  The generalization of the process into type I collagen allows for 
the embedded microchannels to serve as a template for microvascular 
endothelialization within a matrix that can support cellular remodeling. 
 In the new experimental context offered by these microfluidic scaffolds, we 
present detailed mass transport considerations in microfluidic biomaterials.  Such 
considerations include quantitative measurements of 1) diffusion of non-reactive 
solutes and 2) metabolic activity of reactive solutes such as oxygen, which should be 
also used in designing and operating microfluidic biomaterials. 
 Finally, we present the development of oxygen-sensing particles that are 
dispersible in aqueous environment and biocompatible.  Experiments show that the 
oxygen-sensing particles also allow monitoring oxygen concentration in a both 
spatially and temporally resolved manner.  We can use this tool for the direct 
visualization and optical measurement of oxygen-depletion lengths within cell-seeded 
3-D scaffolds in vitro, and the measurement of oxygen levels in animal blood streams 
in vivo. 
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CHAPTER 1 
INTRODUCTION 
 
 Some have probably dreamed that tissues or organs in our body, when they no 
longer function properly due to physical damage or diseases, could be healed or 
replaced with replacements that would be virtually the same as one’s original tissues 
or organs in the future.  Although this idea may be still a naive dream, humankind has 
been continuously seeking ways towards realizing it.  Since Watson and Crick 
discovered the double-helix structure of DNA in 1953, biologists have done extensive 
molecular biology, leading to the completion of the U.S. human genome project (HGP) 
in 2003 with the hope that all the identified genes in human DNA could help diagnose, 
treat, and even prevent diseases and disorders.  In parallel with the genetic perspective, 
clinicians have also made practical efforts for over 100 years in replacing damaged 
tissues and organs.  Clinically successful examples include transplantations of skin, 
cornea, kidney, liver, pancreas, and heart1-5.  Although the transplantation is a key life-
saving therapeutic strategy, there is a significant shortage of tissues and organs 
available for transplantation largely due to the difficulty to find immunologically 
matching tissues and organs between a donor and recipient.  The shortage also seems 
to be attributed to aging societies now in many countries.  In addition, almost all 
transplantations are performed with suppression of the immune system, an 
unavoidable complication that threatens the transplanted patients with serious side 
effects, including fatal kidney failure and increased risks of cancer and sepsis.  This 
organ shortage and rejection still remain major challenges. 
 Regenerative medicine is a rapidly emerging field that can provide alternative 
solutions to overcome the challenges described above and improve human health.  It 
covers primarily the creation of functional living tissues or organs to repair or replace 
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damaged ones (also see Fig. 1.1A).  A core sub-field is tissue engineering which aims 
at in vivo implantation of grown engineered tissues, obtained by culturing three-
dimensional (3-D) scaffold biomaterials seeded with cells of interest, in vitro6 (Fig. 
1.1B).  Until recently, the term “tissue engineering” has been used interchangeably 
with regenerative medicine.  Another sub-field is cell therapy which refers to 
therapeutic approaches of the use of cells, including stem cells for helping damaged 
tissues and organs regenerate in vivo.  Tissue engineering / regenerative medicine is 
multidisciplinary medical science and technology that include molecular and cell 
biology, materials science and engineering, chemical engineering, and bio/biomedical 
engineering.  Specifically, tissue engineering requires 1) the appropriate choice of 
scaffold biomaterials that serve as structural support and allow for cell proliferation, 
permeation of oxygen and other nutrients, and extracellular matrix (ECM) synthesis, 
and 2) in vitro culture of the scaffolds towards formation of functional tissues. 
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Figure 1.1 Regenerative medicine and tissue engineering.  A. Schematic illustration 
showing tissues and organs to create, and required components for regenerative 
medicine.  Image was obtained from 
http://www.jpte.co.jp/english/technologies/index.html.  B. Schematic diagram 
showing general approaches in tissue engineering.  Image was obtained from Langer, 
R. & Vacanti, J.P., Tissue Engineering. Science 260 (5110), 920-926 (1993). 
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What is tissue? 
 A tissue, an intermediate level between a cell and an organ (Fig. 1.2A), is 
composed of a large number of cells (e.g., ~ 104 10× cell/adipose tissue7) of a single or 
more often multiple cell types.  In other words, a tissue does not consist of mixture of 
cells differentiated from endoderm (internal layer), mesoderm (middle layer), and 
ectoderm (external layer) in a germ layer.  This is the formal definition, but in the 
context of tissue engineering, we sometimes (more often in the future) aim at 
developing composite tissues (e.g., liver with endothelia).  Tissues have their specific 
functions; for example, articular cartilage between knee joints allows smooth 
movement of the joints by absorbing load.  Tissue size can vary from ~10 micrometers 
to a few centimeters.  Tissues are categorized into 4 groups; 1) connective tissues 
holding other tissues together, 2) muscle tissues producing force and motion, 3) 
nervous tissues, and 4) epithelial tissues covering organ surfaces.  As we can expect, 
tissues are spatially heterogeneous in 3-D; for example, the articular cartilage can be 
divided into superficial, middle, deep, and calcified zones in each of which cell shape 
and the organization of ECM are different (also see Fig. 1.2B-E).  These complexity 
and characteristics of tissues are reflected in engineering functional ones as excellent 
challenges.  Therefore, strategic approaches from various fields of medicine, science, 
and engineering are required. 
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Figure 1.2 Various levels consisting of the body and human articular cartilage.  A. 
Illustration showing various levels of an organism: protein-cell-tissue-organ-organism.  
Image was obtained from 
http://www.sites.duq.edu/sepa/regmed/regmedbasics/CellsTissuesandOrgans.shtml.  B. 
3-D view of human articular cartialge.  C-E. 2-D virtual sections from image in B. 
Images were obtained from Sah, et al., 48th  Annual Meeting of the Orthopaedic 
Research Society Transactions 27, 0363 (2002). 
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Scaffold biomaterials 
 Researchers have been using a variety of biomaterials as tissue scaffolds, 
typically synthetic polymers, naturally derived hydrogels, or composite materials of 
the two.  Widely used biodegradable synthetic polymers include poly(glycolic acid) 
(PGA), poly(lactic acid) (PLA), and poly(lactic-co-glycolic acid) (PLGA).  These 
polymers can be extruded and molded into 3-D fibrous meshes to host cells, and 
cultured in vitro and in vivo8-10.  Although the biodegradable polymers allow for 
relatively precise control over scaffold properties (e.g., surface to volume ratio, 
degrade rate), high concentrations of degradation products, when they are not removed 
efficiently, show toxicity in some cases11. 
 Most commonly used naturally derived hydrogels are alginate and collagen.  
Alginate is a poly(saccharide) polymer, extracted from algae and composed of D-
mannuronate and L-guluronate subunits.  It is easy to seed cells uniformly in its pre-
gel form (i.e., viscous liquid), and divalent ions such as calcium can solidify the gel 
via cross-linking between guluronate subunits with the calcium ions.  This aspect 
allows for the creation of desired 3-D structural shapes via injection molding12-13 or 
computer-aided direct deposit14.  Alginate can be also chemically modified relatively 
easily to induce integrin-mediated interactions, involved during cell attachment and 
migration, by covalently attaching oligopeptide adhesion ligands (i.e., RGD motif)15.  
Collagen is a fibrous triple-helix protein and the most abundant ECM component in 
our body, implying that it could provide better biological recognition as a scaffold 
material.  While commercially available collagen is still very expensive, relatively 
large quantities for experiments in a laboratory can be obtained by harvesting animal 
tissues (e.g., rat tendons) and purifying collagen via ultracentrifugation.  It can be 
gelled simply by increasing pH and temperature to form 3-D structure despite its 
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substantially lower stiffness (i.e., Young’s modulus) compared with alginate.  Both 
alginate and collagen are permeable to small and macromolecules. 
 
In vitro tissue culture systems 
 Appropriately chosen scaffold biomaterials seeded with cells in bulk need to be 
cultured in vitro to allow for tissue development, which could take weeks and months.  
The most important aspect is to nourish cell-seeded scaffolds well enough throughout 
culture periods such that undesired heterogeneity (i.e., distribution of viable cells and 
deposition of ECM) within the scaffolds, caused by oxygen and nutrient depletion or 
accumulation of waste products, does not arise.  Designing in vitro tissue culture 
systems is, in fact, an excellent chemical engineering problem associated with mass 
transport to and within the cell-seeded scaffolds.  More specifically, oxygen supply in 
engineered tissue constructs is a key to successful development of functional tissues, 
because viable cells should maintain their metabolic activity and phenotypic behavior 
for ECM synthesis.  This issue was considered even before the field of tissue 
engineering was born.  In 1919, Krogh first conceptualized and modeled oxygen 
transport from a cylindrical capillary to a muscle tissue with a Danish mathematician, 
Erlang’s help16 (Fig. 1.3).  For simplicity, the Krogh model is based on a couple of 
major assumptions; convectively delivered oxygen from the vascular capillary only 
diffuses and is consumed by cells in the tissue with zeroth order kinetics (i.e., constant 
consumption rate).  The Krogh length can be then defined as a characteristic length 
over which oxygen is depleted.  Therefore, another vascular capillary should be 
located within a Krogh length of its neighbor.  Despite the assumptions used to 
simplify the mathematical model, the Krogh cylinder still has broad relevance to the 
fields of physiology, biomedical engineering, and clinical practice as a core 
consideration.  Colton is also one of early pioneers who was concerned about oxygen 
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supply to implantable artificial organs and stated that oxygen transport should be taken 
into account in designing devices17-18. 
 Generally speaking, static culture of engineered tissue constructs can cause cell 
death and less deposition of ECM towards the middle of the constructs19-20 (also see 
Fig. 1.5A).  Note that Ballyns et al. have recently observed that static culture of 
relatively large engineered meniscus constructs resulted in more deposition of ECM 
within the constructs, with maintaining cellularity for 8 weeks12.  They have been 
further investigating to characterize the heterogeneous ECM deposition.  In the case of 
cartilage-meniscus engineering, it seems controversial whether depletion of oxygen is 
detrimental.  Others have also argued that low oxygen increased ECM synthesis for 
articular cartilage21.  This may indicate that oxygen concentration has to be more 
finely controlled in a physiologically relevant way through in vitro culture periods 
rather than maintained at 17 ~ 18 % O2 in an incubator. 
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Figure 1.3 The Krogh model.  A. Optical micrograph showing vascular capillaries on 
abdominal muscle wall of the guinea pig.  Image was obtained from Krogh, A., The 
number and distribution of capillaries in muscles with calculations of the oxygen 
pressure head necessary for supplying the tissue. J. Physiol.-London 52 (6), 409-415 
(1919).  B. Schematic representation of the Krogh cylinder model.  Image was 
obtained from 
http://www.owlnet.rice.edu/~chbe402/proj04/seli/CENG402_Project_Files/Blank%20
Page%202.htm. 
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 Researchers have utilized bioreactors to enhance mass transport both outside 
and inside cell-seeded scaffolds.  Such bioreactors include stirred flasks, rotating wall 
vessel bioreactors, hollow fiber bioreactors, and direct perfusion bioreactors22 (Fig. 
1.4).  The stirred bioreactor allows for continuous agitation of culture media such that 
concentration boundary layers of oxygen and other growth factors are negligibly thin 
on surfaces of tissue constructs.  Enhanced mass transfer has resulted in slightly more 
deposition of glycosaminoglycan (GAG), an extracellular component in cartilage, 
towards central zones within bovine chondrocyte-seeded scaffolds22-23 (also see Fig. 
1.5B).  However, it may be practically difficult to precisely control the extent of the 
enhanced mass transport in the stirred bioreactor because increase of mass transfer 
could also cause the extraction of synthesized ECM components from cell-seeded 
scaffolds to well-agitated media.  The rotating wall vessel bioreactor could serve as an 
alternative method to resolve this issue.  Enhanced interfacial mass transfer and 
tolerable ECM extraction, probably attributed to relatively low shear, have 
demonstrated that ECM was uniformly deposited within scaffolds (Fig. 1.5C).  The 
hollow fiber and direct perfusion bioreactors have been also used to enhance mass 
transport through permeable cell-seeded fibers and cell-seeded scaffolds respectively.  
These bioreactors could be slightly more useful for high metabolic cells (e.g., liver and 
muscle cells), but other cell types can be cultured as well.  The hollow fiber reactor 
has a limitation of growing tissue size because cells or cell-seeded scaffolds are 
confined within small permeable fibers.  The direct perfusion bioreactor has a similar 
issue that can be caused in the stirred bioreactor; perfusion rate through cell-seeded 
scaffolds, if it is too high or the scaffolds are not mechanically stiff enough to sustain 
the direct perfusion, can lead to loss of synthesized ECM and possibly cells as well. 
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Figure 1.4 Schematic representations of bioreactors used to enhance mass 
transport for tissue engineering applications.  A. Stirred flask.  B. Rotating wall 
vessel bioreactor.  C. Hollow fiber bioreactor.  D. Direct perfusion bioreactor.  Image 
was obtained from Martin, I. et al., The role of bioreactors in tissue engineering. 
Trends Biotechnol. 22 (2), 80-86 (2004). 
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Figure 1.5 Histological cross-sections of engineered cartilage tissues after six 
weeks of culture in different bioreactors.  Red is Safranin-O-stained 
glycosaminoglycan (GAG).  Engineered tissue constructs cultured statically (A), in 
stirred flask (B), and in rotating wall vessel bioreactor (C).  Scale bars, 1 mm.  Image 
was obtained from Martin, I. et al., The role of bioreactors in tissue engineering. 
Trends Biotechnol. 22 (2), 80-86 (2004). 
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 Atala et al. have recently reported that they were able to implant tissue 
engineered bladders in human patients, obtained by culturing collagen or collagen-
PGA scaffolds seeded with urothelial and muscle cells for 7-8 weeks in vitro24.  Both 
this achievement, seen as the first clinically implanted engineered organ in human, and 
the significant advances in developing bioreactors have enlightened the field of tissue 
engineering and regenerative medicine with the hope that much more complex tissues 
could be also engineered and translated to the clinic in the near future.  Nevertheless, 
mass transport limitations are still the biggest challenge towards growing clinically 
relevant size of engineered tissues because most tissues, with the exception of mature 
cartilage, are vascularized.  The centrally networked vasculature is responsible for 
delivering oxygen, nutrients, and signaling molecules to the tissues in our body.  As 
Krogh observed in muscle tissues, spacing between vascular capillaries is 50 ~ 200 
µm (also see Fig. 1.3A), indicating that oxygen reaches up to the length scale due to 
metabolism (i.e., diffusion-reaction)16,25.  Therefore, vascularization of engineered 
tissue constructs has been considered as a necessary approach in not only overcoming 
the mass transport limitations but also ultimately better integrating the constructs into 
the body after in vivo implantation.  Strategies to vascularize tissue constructs include 
scaffold functionalization, cell-based techniques, and microengineering techniques26.  
Incorporation of angiogenic factors such as vascular endothelial growth factor (VEGF), 
basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF) 
within scaffold biomaterials can allow promoting vascularization by the host release of 
the factors over culture periods27-28.  The functionalization of scaffold biomaterials 
such as PGA, alginate, and collagen can be done by either simple loading of the 
soluble factors or chemical modification of a scaffold.  For instance, collagen 
decorated with heparin which enhances VEGF binding has shown increase of 
endothelial tube formation29.  Co-cultures with endothelial cells30 and incorporation of 
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VEGF-transfected cells (i.e., VEGF-producing cells)31 have also shown enhanced 
vascularization.  As Micro-Electro-Mechanical Systems (MEMS) techniques have 
been advancing and merging into biological applications, they can also allow the 
development of promising microfluidic tools in pre-vascularizing scaffolds.  The 
creation of fluidic networks on a biodegradable polymer, poly(glycerol sebacate) 
(PGS)32 or silk fibroin33 has demonstrated proof-of-concept that cells could be 
cultured within microfluidic channels.  Other research groups have also demonstrated 
that cells can be seeded within microfluidic hydrogels such as agarose34 (Fig. 1.6A), 
collagen, and fibrin35 (Fig. 1.6B).  Similarly, we have shown the development of 
microfluidic biomaterials with calcium alginate seeded with cells36-37.  Our work 
represents one of the leading efforts in this direction. 
 An underlying challenge is micrometer-scale control of the soluble chemical 
environment in the bulk of 3-D cell cultures; such control is necessary not only to 
maintain metabolic activity – which is also achievable with simple perfusion – but to 
deliver metabolites and signals with spatial and temporal control.  Another excellent 
challenge is to develop in vitro systems allowing for both the micrometer scale control 
and cellular remodeling of ECM; such remodeling is always occurring in our body and 
also essential towards building in vivo-like tissues. 
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Figure 1.6 Pre-vascularized scaffolds using microfluidics / microengineering 
techniques.  A. Fluorescence micrographs showing live (green) and dead (red) AML-
12 murine hepatocytes in agarose with a pre-defined microchannel, at 0 (left) and 72 
(right) hr.  Image was obtained from Ling, Y. et al., A cell-laden microfluidic 
hydrogel. Lab Chip 7 (6), 756-762 (2007).  B. Optical micrograph showing fibroblasts 
in collagen with pre-defined microchannels.  Image was obtained from Golden, A.P. 
& Tien, J., Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial 
element. Lab Chip 7 (6), 720-725 (2007). 
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Tissue-scale biology 
 As stated in the previous section, the current bottle neck point in the field of 
tissue engineering is to develop functional tissues in vitro for clinical use.  The 
approaches described above are mainly focused on developing methodology towards 
growing engineered tissue constructs better, for example by enhancing mass transport 
and promoting vascularization within the constructs.  However, a seemingly missing 
aspect from a slightly different perspective is to better understand principles of tissue 
function and growth.  Note that living tissues present a 3-D complexity where cells, 
ECM, and signaling molecules interplay both biochemically and mechanically.  
Although molecular biology, which overlaps with genetics and biochemistry, and cell 
biology have provided with tremendous amount of fundamental knowledge and 
mechanisms about how living systems are regulated, there is still a relatively big gap 
in the understanding of biological processes and the recapitulation of physiology on 
tissue scale for the creation of functional tissues.  Therefore, tissue-scale biology can 
serve as a complementary field that would be interconnected to tissue engineering 
applications in an iterative manner (also see Fig. 1.7).  Tissue-scale biology inevitably 
demands new tools, “enabling tools” that can be also used for tissue engineering. 
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Figure 1.7 Schematic illustration of tissue-scale biology interconnected with tissue 
engineering and regenerative medicine. 
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Tissue-scale tumor biology 
 One may argue that studies of tumor may have nothing to do with tissue 
engineering.  However, elucidating how tumor grows and metastasizes can help 
develop functional tissues in vitro because a key process in tumor progression is 
angiogenesis (i.e., the formation of new blood vessels from existing ones), which is 
also a main process in wound healing.  Note that both tumor progression and wound 
healing occur in the body (i.e., a host), but the main distinction between the two is that 
tumor grows in an uncontrolled manner that does not produce functional tissues.  
Improved understandings of tumor angiogenesis on tissue scale (or pathologically 
relevant scale) may also be potentially more useful in improving current anti-
angiogenic treatment and cancer therapies more generally. 
 In order for avascular solid tumor to grow and metastasize, it secrets 
angiogenic factors such as VEGF and recruits new blood vessels to become 
vascularized tumor38.  Oxygen concentration within tumor tissues is a driving factor; 
specifically, depletion of oxygen or hypoxia created deep in tumor tissues is known to 
cause angiogenic signaling between tumor tissues and blood vessels39-41 (also see Fig. 
1.8).  Although hypoxia-driven up-regulation of VEGF has been considered as the 
major player to initiate and promote tumor angiogesis, other microenvironmental cues 
may also play an important role42.  Fischbach et al. have recently shown that cell-cell 
and cell-ECM interactions in 3-D environment regulate the expression of other 
angiogenic factors such as bFGF and interleukin-8 (IL-8)43-44.  IL-8 is generally 
known as a chemoattractant recruiting neutrophils to inflammation sites, but it has also 
shown angiogenic effects45.  One of its receptors, CXCR2 (or IL8RB) mediates both 
the inflammatory response and angiogenic effects46-47. 
 Traditionally, tumor cell response to hypoxia has been studied in either 2-D 
cell culture or animal in vivo models.  As briefly stated in the previous section, petri-
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dish culture is a poor mimic of the in vivo microenvironment48, and can promote 
fundamentally different cellular behavior42-43, particularly related to spatiotemporally 
varing oxygen levels.  In animal in vivo models, it is practically difficult to control 
experimental parameters.  In addition, the animal models often do not recapitulate 
human tumor behavior.  A third category of experimental system, 3-D tumor models, 
has recently emerged to provide both precise control over experimental conditions and 
in-vivo-like microenvironments to recapitulate human tumor behavior43-44,49-50.  Yet, it 
remains a general challenge to separate out oxygen-related effects from other 
microenvironmental cues in elucidating angiogenic signaling and direct angiogenesis 
in 3-D.  Our work described in this dissertation represents the development of 
technologies towards addressing the challenge. 
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Figure 1.8 Schematic illustration of tumor angiogenesis. 
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Conclusions and motivations of research 
 Despite some clinically successful transplantation of tissues and organs, 
practical challenges remain due to organ shortage and rejection.  Rapidly emerging 
regenerative medicine, which is interdisciplinary medical science and technology, has 
gained attention to resolve the challenges.  The grand aim of a core sub-field, tissue 
engineering is to 1) choose appropriate scaffold biomaterials, 2) culture cell-seeded 3-
D tissue scaffolds in vitro, and 3) implant engineered tissues to the body.  Researchers 
have made significant advances towards overcoming mass transport limitations of 
oxygen and nutrients, and ultimately growing functional tissues in vitro.  Bioreactors 
and vacularization of engineered tissue constructs are useful in resolving the 
limitations.  Specifically, microengineering and microfluidic techniques have 
demonstrated promising proof-of-concept in developing potentially more valuable in 
vitro culture systems.  Nevertheless, most of currently existing such systems do not 
allow for the creation of fully functional tissues.  Tissue-scale biology would allow 
better understanding principles of tissue function and growth, and can be 
complementarily interconnected to tissue engineering and regenerative medicine.  
Tissue-scale tumor biology, where angiogenesis is involved, would allow not only for 
better understandings of the process, which could help develop vascularized functional 
tissues in the context of tissue engineering, but also for improvement of current anti-
angiogenic treatment.  Therefore, we must develop in vitro tools to enable tissue 
engineering and tissue-scale biology.  These tools should allow for both micrometer 
scale control of 3-D cellular microenvironment and cellular remodeling of ECM.  
Quantitative mass transport (e.g., metabolic activity) should be considered in 
designing such tools.  The development of the enabling tools could lead to exploitation 
of detailed principles and mechanisms in the study of physiological and pathological 
processes in a quantitative manner. 
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Summary of dissertation 
 In Chapter 2, we present the technology development of microfluidic 
biomaterials based on the embedding of fluidic networks directly within alginate and 
collagen.  Successful microfluidic biomaterials should meet the following conditions: 
1) fabrication processes are cell-friendly, and the materials are 2) appropriate for the 
replication of microstructure, 3) formable into sealed fluidic structures, and 4) 
diffusively permeable to small and large solutes.  We describe considerations related 
to the choice of biomaterials, fabrication, and qualitative characterization of 
microfluidic alginate scaffolds that can be utilized for tissue engineering and tissue-
scale biology.  Then, we characterize microfluidic collagen scaffolds as a structural 
template for endothelialization. 
 In Chapter 3, we present details about mass transport considerations in the 
microfluidic biomaterials.  The mass transport considerations are essential in 
designing microfluidic biomaterials.  The details include 1) desirable mode of 
operation, 2) the development of a technique to measure diffusion of solutes, 3) 
temporal and spatial control, and 4) quantitative measurements of metabolic activity 
using a model metabolite and oxygen. 
 In Chapter 4, we present the development of oxygen-sensing particles as an 
additional tool.  Combining with microfluidic biomaterials, oxygen concentration must 
not only be controlled but also monitored in a spatiotemporally resolved manner.  We 
describe 1) synthesis of oxygen-sensing micro- and nanoparticles, 2) characterization 
and calibration of the particles, and 3) biocompatibility.  Then, we demonstrate 1) 
visualization and optical measurement of oxygen-depletion lengths within 
microfluidic biomaterials, and 2) in vivo oxygen imaging. 
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 In Chapter 5, we conclude this dissertation with ideas of future directions that 
could aid towards developing functional tissues in vitro and allow further investigating 
detailed mechanisms of angiogenic signaling and direct angiogenesis. 
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CHAPTER 2 
MICROFLUIDIC BIOMATERIALS AS ENABLING TOOLS FOR TISSUE 
ENGINEERING AND TISSUE-SCALE BIOLOGY, IN VITRO 
 
I. Introduction 
 Living tissues in our body - composed of cells and their extracellular matrix 
(ECM) - are three-dimensional (3-D) and allowed to maintain their functions by the 
vascular system that provides the tissues with oxygen and nutrients.  Although 
conventional two-dimensional (2-D) cultures, such as monolayer cultures on solid or 
porous substrates, have provided enormous information in understanding cellular 
functions within the tissues, the 2-D cultures lack the capability of creating 
physiologically relevant 3-D microenvironments, including cell-cell and cell-extra 
cellular matrix (ECM) interactions, and gradients of soluble factors.  Recent studies 
have reported that 3-D cultures show significantly different patterns of cell shape, 
gene expression, growth, morphogenesis, motility, and differentiation1-3.  The dearth 
of in vitro tools, biomaterials, and techniques to process the materials has limited our 
ability to mimic physiological and pathological processes.  In addition to in vivo 
animal models, in vitro 3-D culture systems to create of realistic tissues in vitro are 
desirable for their potential use as replacements for full animal models in basic 
biological studies4-5 and pharmacological and toxicological screens6, and as 
replacement tissues for clinical applications7.  The generation of such tissues, where 
sophisticated interactions between living cells and host materials, requires tools to 
control the biological, chemical, and mechanical environment experienced by cells in 
culture.  Significant advances have been made towards this goal: scaffold biomaterials 
have been developed to host cells in well-defined, 3-D geometries8-9 and present 
biospecific extracellular ligands10-11; bioreactors have been designed to control global 
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mass transfer to the surface of cell-seeded scaffolds12 and to perfuse their bulk13-14; 
and microengineering techniques have been used to tailor extracellular chemistry15-16, 
co-cultures17, templates for endothelialization18-19, and to create microfluidic networks 
in hydrogels20 and cell-seeded hydrogels21-22.  An underlying challenge is micrometer-
scale control of the soluble chemical environment in the bulk of 3-D cell cultures; 
such control is necessary not only to maintain metabolic activity – which is also 
achievable with simple perfusion – but also to deliver metabolites and signals with 
spatial and temporal control.  Another important challenge is to develop in vitro 
systems allowing for both the micrometer scale control and cellular remodeling of 
ECM; such remodeling is always occurring in our body and also essential towards 
building in vivo-like tissues.  We address these challenges by embedding microfluidic 
networks directly within biomaterials - microfluidic biomaterials - to use convective 
mass transfer for control of the distributions and fluxes of solutes in the bulk of the 3-
D culture.  Successful microfluidic biomaterials should meet the following conditions: 
1) fabrication processes are cell-friendly, and the materials are 2) appropriate for the 
replication of microstructure, 3) formable into sealed fluidic structures, and 4) 
diffusively permeable to small and large solutes.  
 Microfluidic biomaterials define microchannels through which externally 
controlled, pressure-driven flows deliver solutes to the bulk of the material.  We 
consider two classes of solutes: reactive solutes such as metabolites and waste 
products and non-reactive solutes such as signaling molecules and buffers.  Figure 
2.1A schematically shows a steady-state distribution of a reactive solute delivered via 
the channels (the pink square) and consumed by cells in the bulk to a certain length 
scale (the pink shading).  For non-reactive solutes, the embedded microchannels can 
serve as sources and sinks to generate controlled gradients at steady-state (Fig. 2.1B).  
Persistent gradients are useful for the study of basic biological phenomena such as 
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chemotaxis23, morphogenesis24, axonogenesis25, and angiogenesis4.  The use of 
patterns of channels acting as sources and sinks within microfluidic biomaterials could 
extend these studies into 3-D cultures.  In addition, such gradients could be used as a 
tool to direct development of spatially heterogeneous tissues in the context of 
regenerative medicine26-27 and tissue-scale tumor biology28-29.  Figure 2.1C shows our 
strategy towards developing remodelable microfluidic biomaterials by endothelial 
cells: lithographically pre-defined microchannels in biomaterials are used as an 
endothelialization template.  As briefly mentioned above, multi-cellular dynamics in 
3-D, specifically by endothelial cells, are key steps in the development of vasculature 
at embryonic stages30, wound healing31, and tumor angiogenesis and metastasis4,31.  
Such remodelable microfluidic biomaterials could aid to find detailed mechanistic 
clues of these phenomena.  Figure 2.1D shows the three architectures of single-level 
microfluidic networks that we used.  In this chapter, we present considerations related 
to the choice of material, fabrication, and qualitative characterization of microfluidic 
biomaterials.  Details of mass transport in the microfluidic biomaterials are presented 
in Chapter 2. 
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Figure 2.1 Schematic representations of microfluidic biomaterials.  A and B. 
Cross-sectional views of microfluidic biomaterials.  Dispersed cells are shown as 
double circles.  Microchannels are shown as squares.  The pink shading represents 
steady-state distributions of solutes: in A, reactive solute is delivered via the channels 
and is consumed by cells as it diffuses into the matrix; in B, non-reactive solute is 
delivered via the two channels on the left and extracted by the channels on the right.  
C. Cross-sectional view of endothelialized microfluidic biomaterial.  Green objects 
represent endothelial cells on pre-defined microchannel walls.  D. Architectures of 
single-layer microfluidic networks used here: a single network (i), two independent 
networks (ii), a single network with variably spaced microchannels (iii). 
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Materials and methods 
A. Primary chondrocyte isolation and seeding 
 Bovine articular cartilage was sterilely harvested from the stifle joints of 1-3-
day-old calves (Gold Medal Packing, Syracuse, NY) and digested for 19 h in a 0.3 % 
[w/v] collagenase solution at 37 °C and 5 % CO2.  Following digestion, cells were 
isolated following standard protocols32 and suspended in 4 % [w/v] of charcoal-
filtered Protanal LF 10/60 (FMC Biopolymer, Drammen, Norway), a low- viscosity, 
high-guluronate-content alginate in a pH- and osmotically adjusted buffer solution (pH 
~ 7 and 300 mOsm) containing 15 mM N-(2-hydroxyethyl)-piperazine-N'-2-
ethanesulfonic acid (HEPES) and 42 mM NaCl at a desired seeding density. 
 
B. HepG2/C3A and L2 cell isolation and seeding 
 HepG2/C3A (human hepatocytes) cells were purchased from the American 
Type Culture Collection (ATCC).  HepG2/C3A cell lines were cultured in Eagle’s 
Modified Essential Medium (MEM) (Invitrogen Co., Carlsbad, California) 
supplemented with 10 % fetal bovine serum (FBS) (Invitrogen) and 1 mM sodium 
pyruvate (Sigma-Aldrich), at 37 °C and 5 % CO2. 
 L2 (rat lung epithelial) cells were purchased from the ATCC.  L2 cell lines 
were cultured in 50 % [v/v] Dulbecco’s Modified Eagle’s Medium and 50 % [v/v] 
Ham’s F-12 medium  (DMEM/F-12) (Invitrogen) supplemented with 10 % FBS, at 37 
°C and 5 % CO2. 
 Cells were harvested using 0.25 % trypsin / ethylenediaminetetraacetic acid 
(EDTA) (Invitrogen) and quenched with MEM to re-suspend the cells.  Cells were fed 
every 3-4 days and passed every 6-7 days. 
 MEM with a 2 mM GlutaMAX-I supplement (Sigma-Aldrich) or DMEM/F-12 
was added to charcoal-filtered Protanal LF 10/60, a low viscosity alginate with a mean 
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G/M ratio of 70 %, to yield a 4 % [w/v] solution.  The alginate solution was allowed to 
incubate at 37 °C for 12-24 h.  The alginate solution was then added to a HepG2/C3A 
or L2 cell pellet to achieve a desired seeding density.  Cells were re-suspended in the 
alginate by slow stirring with a sterile spatula. 
 
C. Fabrication of microfluidic alginate scaffold 
 Two jigs were assembled (Fig. 2.3A and Fig. A1.1):  one for forming a 
microstructured slab of calcium alginate (top layer) and one for forming an 
unstructured slab of gel (bottom layer, with fluidic connections).  The acrylic glass 
slide with tubing provided support to the assembled alginate structure and facilitated 
fluidic connections between the embedded microfluidic network and the external 
tubing.  The aluminum stencils and acrylic glass slide with tubing were pre-coated 
with 0.1 % [v/v] poly(ethylenimine) (PEI).  The aluminum stencils defined the 
thickness, size and shape of molded microfluidic scaffold.  Each mold had an exit port 
that allowed evacuation of air from the closed mold during injection. 
 Once the molding jigs were assembled, cell-seeded alginate was injected with 
a syringe into the molds.  Then, a pH-adjusted buffer solution containing 60 mM 
CaCl2, 15 mM HEPES, and 52.5 mM NaCl was applied in the upper reservoir of the 
jigs.  Calcium ions penetrated through the porous membrane (Nuclepore track-etched 
poly(carbonate) membrane, Whatman, Florham Park, NJ) to crosslink the cell-seeded 
alginate.  The injected cell-seeded alginate was allowed to cross-link for 1 h. 
 Two components of microfluidic scaffold - the flat slab on the slide-tubing 
assembly and the microstructured slab - were assembled and sealed by mechanical 
pressure within a cartridge.  This cartridge was formed directly from components of 
the molding jigs.  The precision of the interlocking of the jigs ensured alignment of the 
tubing with the inlets of the microfluidic network.  Functionality of microfluidic 
35 
collagen was examined by delivering fluorescein (MW 376.27 Da) via microchannels 
(Fig. 2.5A). 
 
D. Live/dead assay for process viability 
 Cell-seeded microfluidic alginate scaffolds were used to characterize cell 
viability after the fabrication process. After the cross-linking step, the two layers of the 
scaffold were submerged in a live/dead staining solution (5 μM calcein-AM-green and 
0.5 μM ethidium homodimer-1; Invitrogen) in the pH-adjusted buffer. The submerged 
layers were allowed to incubate for 1 h at 37 °C and 5 % CO2. Fluorescence images 
were acquired using an inverted microscope (Model ECLIPSE TE 2000-S, Nikon 
Instruments Inc., Melville, NY) and a CCD camera (Model SPOT RT-KE, Diagnostic 
Instruments Inc., Sterling Heights, MI). ImageJ (http://rsbweb.nih.gov/ij/) enabled the 
merging of green and red fluorescence images. 
 
E. Delivery of small molecules in cell-seeded microfluidic alginate scaffolds 
 Microfluidic alginate scaffolds seeded with chondrocytes (1×107 cell/mL) were 
stained with two different stains (5 μM calcein-AM-green and 2 μM calcein-AM-red 
in the pH-adjusted buffere solution; Invitrogen) via the embedded microchannels (Fig. 
2.1D, 2.7).  Microfluidic delivery of the staining solutions was carried out for ~ 160 
min, and then the pH-adjusted buffer was delivered for 60 min to extract non-
enzymatically cleaved (autohydrolyzed) dyes within the scaffold.  The flow rate was 
50 and 75 μL/min for the single-network and double-network respectively.  
Fluorescence images were acquired at regular intervals using a stereomicroscope (MZ 
FLIII, Leica), a CCD (charge-coupled device) camera (Retiga 1300, QImaging), and 
QCapture Pro 5.1 (QImaging). 
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F. OSCC-3 cell isolation and seeding 
 Oral squamous cell carcinoma (OSCC-3) cells (gift from Peter Polverini, 
University of Michigan) were cultured with DMEM, 10% [v/v] FBS, and 1% [v/v] 
penicillin/streptomycin (PS; 120 U/mL; Gibco, Grand Island, NY).  Cells were 
harvested using 0.05 % trypsin / EDTA and quenched with DMEM to re-suspend the 
cells.  Cells were fed and passed every 2-3 days. 
 Phenol red free DMEM was added to lyopholized Protanal LF 20/40 to yield 4 % 
[w/v] alginate solution.  The alginate was allowed to be fully dissolved in an incubator 
at 37 °C for 12-24 h.  The alginate solution was then applied to a OSCC-3 cell pellet.  
Cells were re-suspended in the alginate by slow stirring with a sterile spatula. 
 
G. Culture of microfluidic alginate scaffolds seeded with OSCC-3s 
 Microfluidic alginate scaffolds seeded with OSCC-3s were fabricated as 
described above, using autoclaved, plasma-sterilized, and ethanol-sterilized jig parts.  
The scaffolds were then cultured in an incubator (37 °C, 17 % O2, and 5 % CO2) for 
desired culture periods (Fig. 2.2).  Phenol red free DMEM was delivered to the tumor 
cell-seeded scaffold via microchannels, using a syringe pump.  The media was 
collected in an outlet reservoir for quantitative measurements of proteins secreted by 
the seeded cells. 
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Figure 2.2 Culture of microfluidic alginate scaffolds seeded with OSCC-3s.  
Dispersed cells are shown as double circles.  Microchannels are shown as squares. 
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H. Histological analysis  
 Prior to harvesting, the microfluidic alginate scaffolds seeded with OSCC-3s 
were incubated with hypoxyprobe (HPI, Inc., Burlington, MA) for 90 min.  The 
hypoxyprobe was delivered via microchannels.  Then, the alginate scaffolds were 
rinsed with a buffer solution and fixed with 3.7% [w/v] formaldehyde (Polysciences, 
Warrington, PA).  Histological cross-sections were then imaged with hematoxylin and 
eosin (H&E) stain to determine cellularity, and hypoxyprobe stain with mouse IgG1 
anti-pimonidazole MAb (primary antibody) and rabbit anti-mouse conjugated with 
Alexa Fluor® 488 (secondary antibody) to locate regions of hypoxia.  Images were 
taken on an inverted microscope (Axio Observer; Carl Zeiss, Inc., Thornwood, NY), 
in bright field. 
 
I. Analysis of angiogenic factor secretion 
 To quantify soluble VEGF and IL-8 in the collected media, enzyme-linked 
immunosorbent assay (ELISA; R&D Systems, Minneapolis, MN) was used.  The 
alginate scaffolds were dissolved in 50 mM EDTA, released cells were rinsed, and 
then lysed in Caron’s buffer.  DNA content was measured using Quant-iT™ 
PicoGreen® dsDNA reagent (Invitrogen Co., Carlabad, CA ), and cell number 
calculated using a measured value of 15.1 pg DNA/OSCC-3 cell.  Calculated cell 
numbers were then used to normalize VEGF and IL-8 secretions.  
 
J. Fabrication of microfluidic collagen scaffold 
 Prior to fabricating microfluidic collagen scaffolds, collagen (1 or 2 % [w/v]) 
was first prepared by mixing concentrated (2 or 3 % [w/v]) rat-tail collagen dissolved 
in 0.1 % [v/v] acetic acid with 1 N NaOH (~2% [v/v] of a stock volume, Vs), 10× 
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BioWhittaker® medium 199 (M199, Lonza, Walkersville, MD; 10 % [v/v] of a final 
volume, Vf), and an amount of 1× M199. 
 Microfluidic collagen was fabricated similarly as described above (Fig. 2.3B): 
1) uncross-linked rat-tail collagen was injected into a closed mold where a 
micropatterned PDMS stamp was inserted, and 2) cross-linked collagen with an 
imprinted microfluidic network was then pressure-sealed against a 1.2 mm-thick glass 
slide (Ted Pella, Inc., Redding, California).  Functionality of microfluidic collagen 
was examined by delivering green-fluorescent latex microbeads (FluoresbriteTM 
Carboxylate YG 1.0 micron Microspheres; Polyscience, Inc., Warrington, 
Pennsylvania) suspended in phosphate-buffered silane (PBS) (Invitrogen) and 
rhodamine B isothiocyanate-dextran (RITC-dextran, MW 70 kDa, Sigma-Aldrich) via 
microchannels (Fig. 2.5B). 
 
K. Endothelial cell isolation 
 Human umbilical vein endothelial cells (HUVECs) were purchased from 
Lonza Inc. (Walkersville, MD) and were used in passages 3-10.  HUVECs were 
cultured in M199 (Lonza) containing 20 % [v/v] FBS, 30 µg/mL endothelial cell 
growth supplement (ECGS, Millipore Co., Billerica, MA), 5 U/mL heparin solution 
(Invitrogen), 200 mM L-glutamine, and 120 U/mL penicillin/streptomycin (PS).  This 
growth media was changed every 2-3 days. 
 HUVECs at 75-95 % confluency were washed with PBS or HEPES buffered 
saline solution, removed from culture flasks with trypsin-EDTA, neutralized with 
growth media, centrifuged, and re-suspended at ~1×106 cell/mL. 
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L. Endothelialization of microfluidic collagen scaffold 
 Isolated HUVECs were seeded into microchannels by applying HUVEC-
suspended media in the inlet reservoir (Fig. 2.3B).  After confirming that endothelial 
cells were seeded uniformly within microchannels, the outlet reservoir was filled with 
growth media to balance the height difference between the in- and outlet reservoir.  
Endothelial cells were then allowed for attachment at 37 °C for ~30 min.  Non-
attached cells were rinsed away by applying growth media in the inlet reservoir. 
 HUVEC-attached microfluidic collagen scaffolds were cultured in an incubator 
(37 °C and 5 % CO2) for up to 21 days.  Growth media was used for 2-3 days and 
vasculogenesis media (M199 with ECGS, 20 % [v/v] FBS, 1 % [v/v] PS, 1 % [v/v] L-
ascorbic acid (50 µg/mL, Acros Organics, Morris Plains, NJ), and 0.16 % [v/v] 
tetradecanoyl phorbol acetate (TPA, 50 ng/mL, Cell Signaling Technology Inc., 
Danvers, MA)) for the rest culture period.  Media was changed every day. 
 
M. Confocal imaging 
 Confocal microscopy (LSM 700, Carl Zeiss Inc., Thornwood, NY) was used to 
obtain z-stacks of endothelia formed in collagen microchannels.  After fixing cells 
with 3.7 % [w/v] formaldehyde in situ, endothelial cell nuclei were stained with either 
YOYO®-1 iodide or 4’, 6-diamidino-2-phenylindole, dilactate (DAPI, dilactate), and 
actin stained with Alexa Fluor® either 568 or 488 phalloidin (Invitrogen).  Images 
were viewed and analyzed with ImageJ and LSM Image Browser (www.zeiss.com). 
 
N. Morphometric analysis of endothelial cells 
 For endothelia formed on various substrates, cell density was calculated by 
counting cell nuclei with the cell counter plug-in embedded in ImageJ.  In order to 
assess the extent of elongation, cell shape index ( 2cell cellCSI 4 /A Pπ≡ ) was calculated 
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by estimating cell area (Acell) and perimeter (Pcell) in ImageJ.  CSI varies from 0 (a 
straight line) to 1 (a perfect circle). 
 
O. Statistical analysis 
 Plots represent mean±standard deviations (SD).  Analysis of variance 
(ANOVA) with Tukey post-test was used for statistical analysis (GraphPad Prism, La 
Jolla, CA) and significance denoted as *P<0.05; **P<0.01; ***P<0.001. 
 
Results and discussion 
A. Choice of biomaterials 
 In the formation of a microfluidic scaffold, the host material must satisfy 
constraints imposed by the need to form both an appropriate cellular environment and 
a functional microfluidic structure.  Specific constraints on the material include: (1) 
biocompatibility, (2) mechanical stability to enable replication of microstructure and 
definition of discrete convective paths, (3) high diffusive permeability to small and 
large molecules, and (4) processability under physiological conditions (for example, 
pH, temperature, osmolarity and mechanical stress). 
 Our work9,20,32-36 and that of others37 point to calcium alginate hydrogels as a 
promising candidate material for this application.  Studies of calcium alginate as a 
tissue scaffold have shown that it is appropriate for long-term culture and formation of 
functional tissue9,34, compatible with macroscale molding to form cell-seeded 
structures with physiological geometries35,38 and chemically modifiable to enable the 
presentation of biospecific extracellular ligands36-37.  Our recent work demonstrated 
that laminated alginate hydrogels, the format used here to fabricate microfluidic 
structures, had shear moduli (3-25 kPa) that were similar to those reported for  
monolithic alginate hydrogels39-40 and supported long-term (10 weeks) culture of 
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primary chondrocytes with deposition of an ECM32.  We have also shown that calcium 
alginate gels are compatible with fabrication of functional, acellular microfluidic 
systems20. 
 In addition to calcium alginate hydrogels, collagen is another good host 
material for the study of dynamic cellular processes due to its specificity for 
extracellular adhesion and remodelability by a large number of tissue cells, including 
endothelial cells (ECs) and tumor cells.  Collagen gels are generally more difficult to 
handle and to form functional microfluidic structures compared with calcium alginate 
due to their low elastic modulus (0.04-2 kPa; 0.3-2 % [w/v]).  However, we have made 
progress towards overcoming these challenges with processing higher mass fraction 
up to 2 % [w/v].  Collagen-based microfluidic scaffolds can be valuable tools for 
studies of vasculogenesis, angiogenesis, and organogenesis of lymph node (LN), all of 
which involve cellular remodeling of ECM.  We can also endothelialize pre-defined 
microchannels in microfluidic collagen scaffolds with ECs, which is an essential step 
towards developing perfusable microvascular structure in parallel with tissue cells 
growing in the bulk of the scaffolds.  In the following, we will further demonstrate that 
fabrication can be carried out with living cells present. 
 
B. Fabrication of microfluidic biomaterials 
 Figure 2.3A shows a lithographic process that enables the incorporation of 
living cells within a microfluidic scaffold formed in 4 % [w/v] calcium alginate.  The 
key steps in the process are (see Materials and methods section and Appendix 1 for 
details):  (1) definition via soft lithography of a silicone stamp as a master on which to 
mold a hydrogel with microstructure, (2) injection and crosslinking of cell-seeded 
alginate within aluminum molding jigs (Fig. A1.1) and 3) sealing of hydrogel layers to 
form a sealed fluidic structure with application of pressure within an aluminum jig.  
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The aluminum jig was used to create an enclosed scaffold within which the exchange 
of solutes is mediated entirely by the flow of solutions through the microchannels 
embedded within 4 % [w/v] calcium alginate (Fig. 2.4A) , and to simplify the sealing 
process relative to the formation of a chemical seal, as in our previous work20,32.  We 
note that chemical sealing can be also used in the current process and that the main 
points of this article are still valid with either method.  Sealed microfluidic alginate 
scaffolds seeded with cells maintained functionality and sterility in an incubator for up 
to 1 week (data not shown). 
 We have also successfully fabricated single-layered microfluidic collagen in a 
similar way (Fig. 2.3B).  The glutaraldehyde-coated plexiglass jig provided enough 
mechanical support such that functional fluidic networks formed with 1 % [w/v] 
collagen (lower limit) as shown in Fig. 2.4B and C.  We note that the fabrication of 
microfluidic collagen with higher concentrations up to 3 % [w/v] was indeed 
achievable and that microfluidic 0.6 % [w/v] collagen failed sustaining pressure-
driven flows (~ 1 µL/min) mainly due to the low modulus of the gel (< 200 Pa) even 
though microstructure was successfully molded (data not shown).  All other 
microfluidic biomaterials made with > 1 % [w/v] collagen sustained pressure-driven 
flows (1-10 µL/min).  Microfluidic collagen scaffolds can be used as templates for 
microvascular endothelialization to investigate remodeling dynamics of ECs such as 
tube formation, vasculogenesis, and (tumor) angiogenesis in a more controlled manner.  
As shown in Fig. 2.3B, we endothelialize the pre-defined microchannels by delivering 
EC-suspended media via the channels.  A cell density of ~ 1×106 cell/mL and gravity-
driven flows by applying 100-200 µL of the cell suspension in the inlet allowed for 
relatively uniform initial seeding.  Too high cell densities can cause clogging, and too 
high pressures to resolve the clogging is highly likely to burst devices and may deform 
collagen permanently.  In addition, too large volumes of EC suspension can cause an 
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unnecessarily large number of cells left in external reservoirs which will eventually 
proliferate and deprive endothelialized cells in microchannels of nutrients. 
 As shown in Fig. 2.5, microfluidic biomaterials are compatible with the 
replication of 100-µm-scale microchannels.  As shown in Fig. 2.6, we achieve high 
cellular viabilities with mild stirring and injection.  We have observed similarly high 
viabilities for HepG2/C3A and L2 cell lines passed through the fabrication of 
microfluidic alginate scaffolds; these other cell types were used to demonstrate the 
versatility of this technique. 
 
C. Effect of shear imposed during the seeding and injection step on cell viability 
 We found that the degree of viability of chondrocytes after fabrication was 
sensitive to the magnitude of shear imposed during the dispersal and injection of the 
cells in the alginate solution.  After isolation, cells were pelleted in a centrifuge tube 
(50 mL).  A 4 % [w/v] alginate solution was poured onto the pellet and the cells were 
mildly re-suspended using a spatula (30 rpm for ~ 1 min).  The cell-seeded 4 % [w/v] 
alginate solution was taken into a syringe (5 mL) and injected through 3 cm of tygon 
tubing into the molding jigs at ~ 150 μL/min.  It was observed that the standard 
method employed for injection molding chondrocytes in lower concentration 
alginate32 led to significant loss in viability when used in 4 % [w/v] alginate solution.  
We believe that this difference is due to increased viscosity of 4 % [w/v] alginate 
solution. 
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Figure 2.3 Fabrication of microfluidic biomaterials.  A. Schematic diagram of the 
fabrication of microfluidic alginate scaffolds. ( )ic t  and ( )jc t  denote instantaneous 
concentration of solutes i  and j respectively in injected solutions.  The red line 
indicates PEI coating.  B. Schematic diagram of the fabrication of microfluidic 
collagen scaffolds and endothelialization.  The red line indicates glutaraldehyde 
coating. 
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Figure 2.4 Functionality of microfluidic biomaterials.  A. Fluorescence micrograph 
of a microfluidic alginate scaffold at an early time point during delivery of fluorescein 
to the scaffold via embedded microchannels.  B. Fluorescence micrograph of 
microfluidic collagen scaffolds at early time points during delivery of green-
fluorescent latex microbeads (i) and rhodamine B (ii) via microchannels. 
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Figure 2.5 Fidelity of microstructure.  A and B. Optical micrographs showing 
microstructure of 4 % [w/v] calcium alginate seeded with primary chondrocytes 
( 71 10 cell/mL× ).  C and D. Optical micrographs showing microstructure of 1 (C) and 
3 (D) % [w/v] collagen. 
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Figure 2.6 Process viability of cell-seeded microfluidic alginate scaffolds.  
Fluorescence micrograph showing cells stained by 5 μM calcein-AM (green – live) 
and 0.5 μM ethidium homodimer-1 (red – dead).  A. Chondrocytes  (corresponding to 
Fig. 2.5A).  B. HepG2 cells (2×106 cell/mL). C. L2 cells (1×106 cell/mL). 
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D. Microfluidic alginate scaffolds for tissue engineering 
 One of major challenges and key aspects in culturing engineered tissue 
constructs is to maintain a uniform metabolic environment within the bulk.  Figure 
2.7A qualitatively demonstrates that we can achieve this condition with appropriately 
chosen design parameters such as cell seeding density, interchannel distance, and 
scaffold thickness for a microfluidic biomaterial.  More detailed discussion about 
metabolic activity of cells (chondrocytes in this case) seeded in microfluidic alginate 
scaffolds is described in the following chapter. 
 The incorporation of more than one independent network within a microfluidic 
scaffold enables the maintenance of steady-state gradients in the concentration of 
solutes within the matrix (Fig. 2.1B).  Each network can serve as a source for certain 
solutes and as a sink for others such that gradients can be maintained at steady-state.  
Figure 2.7B shows the generation of gradients in a microfluidic scaffold with two 
independent networks (as in Fig. 2.1Dii) for reactive solutes.  The images were 
captured after several hours such that transient gradients had ample time to dissipate: 
the observed variations are features of the steady-state distributions of the solutes.  
This capability to form steady-state gradients in 3-D cultures will enable the study of 
cellular responses to physiologically relevant spatial variations of soluble factors. 
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Figure 2.7 Steady-state distributions of solutes delivered to microfluidic alginate 
scaffolds via embedded microchannels.  A. Fluorescence micrograph of uniformly 
stained primary chondrocytes (1×107 cell/mL) by 5 μM calcein-AM delivered via the 
embedded microchannels.  The image in A was taken after 160 min of delivery.  B. 
Fluorescence micrograph of chondrocyte-seeded (1×107 cell/mL) microfluidic 
scaffold after delivery of calcein-AM-green (5 μM; network 1) and calcein-AM-red (2 
μM; network 2).  C. Fluorescence micrograph of a cross-section of the top 
(micropatterned) layer (1×107 cell/mL) of the scaffold in C.  The images in B and C 
were taken after 220 min of delivery in both networks. 
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E. Microfluidic alginate scaffolds for tissue-scale tumor biology 
 Tumors consist of spatially and functionally distinct niches which may result 
from spatiotemporal variation in oxygen concentration within tissues of growing 
tumors.  Oxygen, and specifically lack thereof, or hypoxia, is a key factor regulating 
tumor angiogenesis4,41.  Hypoxic tumor cells up-regulate factors that promote 
angiogenesis, such as vascular endothelial growth factor (VEGF)42.  Microfluidic 
alginate scaffolds also enable tissue-scale biology, specifically a study of angiogenic 
activity of tumor cells in 3-D scaffolds, by recapitulating in vivo-like environments.  
Key steps include 1) control of cellular 3-D microenvironment, 2) capability to 
perform long-term cultures with maintaining sterility and functionality of a 
microfluidic scaffold, and 3) analytical access to soluble biochemical environment in a 
spatiotemporally resolved manner.  This approach also accompanies histological 
analyses and an analysis of angiogenic factor secretion as shown in Fig. 2.8.  Figure 
2.8A and B shows that a single-layered microfluidic alginate scaffold seeded with 
tumor cells maintain cellularity and high viability over 2 days.  Figure 2.8C 
demonstrates that there are more tumor cells exposed to hypoxia (< 1 % O2) at regions 
far from microchannels.  This is an example of a solid tumor in vivo where its 
periphery is well oxygenated but core oxygen-depleted, which is believed to induce 
tumor angiogenesis by secreting soluble factors such as VEGF and IL-8.  Figure 2.8D 
shows that the embedded microchannels can be used not only as pathways to deliver 
media but also as ‘taps’ to access biochemical environments and quantitatively 
measure angiogenic activity of tumor cells seeded in the bulk.  We note that we have 
also utilized the double-network to create two zones of distinct oxygen concentration 
(i.e., normoxia in network 1 and hypoxia in network 2) and cultured the scaffold for 6 
days (data not shown).  With these tools, more valuable future studies need to aim 
understanding details of angeogenic signaling of tumor cells in 3-D for example, by 
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integratively monitoring and controlling oxygen concentration, and measuring 
angiogenic activity within scaffolds in a spatiotemporally resolved manner.  This 
motivates 1) quantitative analyses of metabolic activity (e.g., oxygen consumption rate; 
Chapter 3), 2) the development of an oxygen-sensing system (Chapter 4) and 3) 
remodelable microfluidic biomaterials towards investigating direct tumor angiogenesis 
in tissue-scale.  In the following, we will demonstrate microfluidic collagen scaffolds 
as a platform for remodelable microfluidic biomaterials. 
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Figure 2.8 Microfluidic alginate scaffold for tissue-scale tumor biology.  A. 
Optical micrographs of a histological cross-section of a microfluidic alginate scaffold 
seeded with OSCC-3s (2×107 cell/mL) stained by H&E after 2 day-microfluidic 
culture.  B. Fluorescence micrograph of a cross-section of the scaffold showing cells 
stained by 5 μM calcein-AM (green – live) and 5 μM ethidium homodimer-1 (red – 
dead) after the culture.  C. Fluorescence micrographs of a histological cross-section of 
the scaffold stained by DAPI (blue - cell nuclei) and hypoxyprobe (green - hypoxic 
cells) after the culture.  D. Plot of cell-secreted pro-angiogenic factors (i.e., VEGF and 
IL-8) measured by ELISA after the culture. 
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F. Endothelialized microfluidic collagen 
 Microfluidic 1 and 2 % [w/v] collagen scaffolds were cultured with 1) growth 
media for first 2-3 days to allow for cell proliferation, and 2) vasculogenesis media for 
the rest of culture periods to promote EC invasion into the bulk of the gels.  The 
microfluidic collagen scaffolds were operated with gravity-driven flows by applying 
different volumes of media in the in- and outlet reservoirs on a daily basis.  We have 
observed that the gravity-driven flows reached an equilibrium state (i.e., no persistent 
flows in microchannels) in ~ 5 hr.  Therefore, it is fair to state that ECs were exposed 
to modulating flow rates over the culture periods.  Initial flow speed within 
microchannels by this gravity-driven pump ranged from 1.3 ~ 4.4 mm/s corresponding 
to 0.78 ~2.6 μL/min with an assumption that the cross-sectional area of a 
microchannel was 104 μm2 (100 μm × 100 μm).  The flow speed was estimated by 
delivering fluorescent latex microbeads. 
 With the given flow conditions, sealed microfluidic collagen seeded with ECs 
in microchannels maintained functionality and sterility and allowed for the formation 
of complete endothelia for at least 3 weeks (Fig. 2.9 and 2.10).  We found that initially 
seeded ECs attached and proliferated well on 2 % [w/v] collagen in 3 days (Fig. 2.9A) 
such that ECs spread out and formed a monolayer on three walls of collagen 
microchannels (Fig. 2.7B).  In 23 days, ECs formed a complete endothelium along 
microchannels (i.e., 3 collagen sides and 1 plexiglass side).  Figure 2.9C and D show 
lots of stained ECs on the collagen and a plexiglass side respectively.  We note that the 
endothelium was partially ripped off for better qualities of confocal microscopy.  
Therefore, some regions where there are no stained cells do not imply that the 
microfluidic endothelium was imperfect in the specific locations.  An endothelilum 
was formed in microchannels in 23 days, but there was no obvious EC invasion over 
the 21 day-culture of endothelialized microfluidic 2 % [w/v] collagen with 
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vasculogenesis media.  However, we observed that there were many short protrusions 
from ECs at the interface between endothelialized microchannels and the bulk of the 
collagen.  We believe that these protrusions may be anchors to initiate invasion.  This 
behavior is slower than what we have observed in our vertical invasion assays (ECs on 
top of flat collagen) where ECs start invading into 2 % [w/v] collagen in 21 days.  
Although we fixed and stained ECs without disassembling the device, it was necessary 
to remove the plexiglass side for confocal microscopy with high magnification and to 
achieve detailed cellular information.  We have resolved this issue by slightly 
modifying the jig such that the confocal microscopy can be done without the 
disassembly in the following case of endothelialized microfluidic 1 % [w/v] collagen 
(Fig. 2.10): the collagen network was sealed against a 1.2 mm-thick glass slide (Fig. 
2.3B). 
 A complete endothelium on both collagen (Fig. 2.10Ai) and glass side (Fig. 
2.10Aii) was also formed in microfluidic 1 % [w/v] collagen in 14 days (growth media 
for 3 days and vaculogenesis media for 11 days), yet no obvious invasion was found.  
It was observed that ECs started invading into flat 1 % [w/v] collagen in 14 days.  The 
interchannel connection seen in Fig. 2.10Aii is likely due to cell migration through the 
collagen-glass slide interface (dashed circles in Fig. 2.10Bii).  We confirmed that the 
device was still well-sealed by delivering fluorescent latex microbeads.  In 21 days, 
we observed that invading ECs formed lumens into the bulk of 1 % [w/v] collagen 
near the inlet and that there were invasion marks in the network region (data not 
shown).  We speculate that differences in culture conditions within endothelialized 
microfluidic collagen may have delayed cellular invasion dynamics, for instance, 
initial seeding density, growth factor and nutrient supply due to flow conditions, and 
geometric confinement.  In the following section, we will present our effort to look for 
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some clues by analyzing cell density and morphology in the endothelialized 
microfluidic collagen. 
 
G. Morphometric analyses of ECs 
 We have analyzed morphology of ECs on a monolayer by estimating cell 
density and cell shape index (CSI) on PDMS, flat 1 and 2 % [w/v] collagen, and 
microfluidic 1 and 2 % [w/v] collagen.  Figure 2.11B shows that EC density on PDMS 
is significantly higher than all other cases and that cell densities on collagen are not 
significantly different except for the two cases between ECs on flat 2 % [w/v] collagen 
and those on microfluidic 2 % [w/v] collagen.  We note that the latter significant 
difference is due to cell loss during the disassembly process for the confocal 
microscopy.  Because PDMS is a relatively rigid material (from cells’ point of view) 
and does not allow cellular remodeling at all, initially seeded ECs are likely to keep 
spreading and proliferating on PDMS.  Figure 2.11A qualitatively shows that ECs on 
PDMS have larger cell area (red; actin) compared with cells on 1 and 2 % [w/v] 
collagen.  This also suggests that PDMS is a very adhesive substrate on which cell 
adhesion and proliferation can be enhanced.  We argue that one should be careful 
when comparing cell density because cell density on a monolayer at a certain time 
point is dependent on initial seeding density.  Initial seeding density of ECs on PDMS 
might have been higher than other cases.  We also note that it is technically 
challenging to precisely control seeding density in microfluidic collagen.  Seeding 
ECs in microchannels with a syringe pump that would allow for more controlled and 
steady flows may help address this challenge. 
 CSI is defined as 2cell cell4 /A Pπ , where cellA is cell area and cellP  is cell perimeter.  
CSI varies from 0 (a perfect circle) to 1 (a straight line).  The estimation of CSI is a 
way to assess whether cells are elongated.  Figure 2.12 shows ECs in endothelialized 
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microfluidic collagen were significantly more elongated compared with cells on flat 
collagen as well as PDMS.  We have also found that CSI values at various locations 
(100 µm-wide and -high microchannels, and 400 µm-wide and 100µm-high in- and 
outlet regions) within a microfluidic collagen scaffold were not significantly different 
(data not shown).  This suggests that the morphology of ECs in microchannels were 
influenced by geometric confinement and flow conditions, or a combinatorial effect of 
the two.  For future studies, therefore, it is necessary to culture microfluidic collagen 
scaffolds with a syringe pump that allows for persistent flow conditions.  This will 
help identify significant factors affecting cell morphology and invasion.  Furthermore, 
an additional morphometric analysis that allows assessing the alignment of ECs in 
microchannels along flow directions is required for further studies.  These 
morphometric analyses of ECs suggest that invasions in the endothelialized 
microfluidic collagen might have been delayed due to periods of time over which 
morphological changes occurred. 
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Figure 2.9 Endothelialized microfluidic 2 % [w/v] collagen.  A. Confocal 
fluorescence micrograph showing endothelial cells on collagen side stained by YOYO 
(green - cell nuclei) and phalloidin (red - actin) on day 3.  B and D. Confocal 
fluorescence micrograph showing endothelialized microchannel walls from x-stacks.  
C. Confocal fluorescence micrographs showing endothelial cells on collagen side (i) 
and plexiglass side (ii) stained by DAPI (blue - cell nuclei) and phalloidin (red - actin) 
on day 23. 
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Figure 2.10 Endothelialized microfluidic 1 % [w/v] collagen.  A. Confocal 
fluorescence micrographs showing endothelial cells on collagen side (i) and glass side 
(ii) stained by DAPI (blue - cell nuclei) and phalloidin (green - actin) on day 14.  B. 
Confocal fluorescence micrograph showing endothelialized microchannel walls from 
x-stacks. 
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Figure 2.11 Endothelial cells on various substrates.  A. Fluorescence micrographs 
showing endothelial cells on PDMS (i), 1 % [w/v] collagen (ii) stained by DAPI (blue 
- cell nuclei) and phalloidin (red - actin), and 2 % [w/v] collagen (iii) stained by 
YOYO (green - cell nuclei) and phalloidin (red - actin) on day 14.  B. Plot of 
endothelial cell density on various substrates.  (*P<0.05; **P<0.01; ***P<0.001). 
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Figure 2.12 Morphometric analysis of endothelial cells.  Plot of cell shape index 
(CSI) for endothelial cells on various substrates.  (*P<0.05; **P<0.01; ***P<0.001). 
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Conclusions 
 We have demonstrated direct fabrication of a functional microfluidic structure 
within 3-D scaffolds of 1) calcium alginate seeded with multiple cell types and 2) 
collagen with ECs.  Embedded microchannels in microfluidic alginate scaffolds enable 
the maintenance of a uniform metabolic environment within the bulk of the scaffold 
and the creation of distinct soluble environments experienced by cells in their 3-D 
environment.  Microfluidic alginate scaffolds represent a new format for the design of 
cellular bioreactors43, bio-artificial organs44-45.  Important characteristics of 
microfluidic scaffolds as a bioreactor include:  (1) dispersion of cells within 
biocompatible, biodegradable, and biochemically tunable ECM9,32,46, (2) scalability to 
sub-millimetre dimensions, and (3) lithographic definition of fluid paths to enable 
precise control of distributions and fluxes of solutes.  Remaining challenges for this 
technique include:  (1) generalization of network structures to 3-D, (2) incorporation 
of multiple cell types in physiologically relevant geometries and (3) integration of 
distinct stimuli such as mechanical forces47 and patterns of extracellular chemistry48.  
3-D printing with cell-seeded calcium alginate49 and writing techniques50 could be 
important tools to form microfluidic scaffolds.  The development of the technique 
presented here opens new opportunities to study the response of cells to spatial and 
temporal variations of soluble factors within well-defined 3-D cultures.  In the context 
of tissue engineering, this tool may aid in growing thick sections of tissue without 
necrosis in the core, and in directing the development of cells, towards, for example, 
spatially differentiated tissues. 
 Pre-defined microchannels in microfluidic collagen scaffolds serve as 
templates for microvascular endothelialization and allow for the formation of 
complete endothelia.  These microfluidic collagen scaffolds can be also a valuable 
format for studies of vasculogenesis, (tumor) angiogenesis, and organogenesis of 
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lymph node in 3-D not only because both chemical and mechanical microenvironment 
can controlled but also because cells can remodel their 3-D environment.  The 
development of such remodelable microfluidic scaffolds could also allow finding 
mechanistic clues for the stabilization of microvasculature, for example, by seeding 
pericytes in the bulk. 
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CHAPTER 3 
MASS TRANSPORT IN MICROFLUIDIC BIOMATERIALS 
 
I. Introduction 
 In the previous chapter, we demonstrated the direct fabrication of functional 
microfluidic biomaterials using calcium alginate and collagen.  We also qualitatively 
showed that embedded microchannels within the microfluidic biomaterials enabled 
efficient exchange of solutes with the bulk of cellular 3-D microenvironment.  In 
designing and operating microfluidic biomaterials, we must take mass transport into 
account because diffusion of non-reactive solutes and diffusion-reaction of reactive 
solutes are the main processes within the microfluidic biomaterials.  Such 
considerations allow choosing appropriate design parameters such as interchannel 
distance cλ  and scaffold thickness, H in creating desired distributions of soluble 
chemical environment. 
 Figure 3.1 shows some parameters related to mass transport in microfluidic 
biomaterials: solutes are delivered by pressure-driven flows (flow speed, cu  [cm/s] ) 
to the bulk of the scaffold.  The exchange of solutes proceeds in two steps:  interfacial 
convective mass transfer between the flowing solutions and the walls of the 
microchannels (mass transfer coefficient, ck  [cm/s] ), and molecular diffusion 
between these walls and the bulk of the scaffold.  For reactive solutes, diffusion-
reaction processes define gradients of concentration at steady state.  As shown 
schematically in Fig. 3.1A (and also qualitatively illustrated in Fig. 2.1), for a solute 
delivered via the channels and consumed in the bulk, variations of concentration will 
occur over a characteristic distance, , 0~ /K s gD c Rλ  [cm], that we will call the Krogh 
length1; here ,s gD  
2[cm /s]  is the molecular diffusivity of the solute in the scaffold, R  
[mol/L s]⋅  is the consumption rate, and 0c  [mol/L]  is the concentration of the solute in 
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the channel.  For vital metabolites or toxic waste products, it is often desirable to 
minimize the variations in solute concentrations associated with these gradients; this 
condition can be achieved in a microfluidic scaffold in which the channel spacing, 
2c Kλ λ< .  For non-reactive solutes, the steady state distribution will be uniform 
unless both sources and sinks are embedded in the scaffold.  The scaffold thickness, H 
can also play a role in determining a transition length scale of the distribution of 
solutes between two distinct zones (created by two fluidic networks; Fig. 2.1Dii).   
A desirable mode of operation is achieved if the flow speed is high enough to: 1) 
avoid depletion of reagents along the length of the channels (achieved at high Peclêt 
number, ,/ /c c s c cPe u h D L h= >> ) and 2) ensure that resistance to convective mass 
transfer is much less than resistance to purely diffusive transfer within gel (achieved at 
high Biot number, ,/c s gBi k H D=  for non-reactive solutes or ,/c K s gBi k Dλ= for 
reactive solutes)2 (Fig. 3.1C and D).  Here, 2,  [cm /s]s cD  is diffusivity of a solute in the 
solution in the microchannels. 
 In this chapter, details of mass transport in microfluidic biomaterials are 
discussed.  The details include 1) diffusion of solutes, 2) temporal and spatial control 
and diffusion-reaction of metabolites in microfluidic biomaterials.  We will conclude 
with the implications of the mass transport considerations and new opportunities. 
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Figure 3.1 Schematic representations of mass transport in microfluidic 
biomaterials.  A and B. Cross-sectional views of microfluidic biomaterials.  
Dispersed cells are shown as double circles.  Microchannels are shown as squares.  
The pink shading represents steady-state distributions of solutes: in A, reactive solute 
is delivered via the channels and is consumed by cells as it diffuses into the matrix; in 
B, non-reactive solute is delivered via the two channels on the left and extracted by the 
channels on the right.  Geometric parameters are defined in A and B:  λK [cm] is the 
Krogh length, λc [cm] is the inter-channel distance, wc [cm] is the microchannel width 
and hc [cm] is the microchannel height.  cu  [cm/s]  is the flow speed in microchannels.  
[cm/s]ck  is the mass transfer coefficient of the flow in the microchannels.  H [cm] is 
the thickness of the scaffold.  C and D. Schematic diagrams showing convective mass 
transfer mediated by embedded microchannels at low (C) and high (D) flow speeds.  L 
[cm] is the microchannel length.  0  [mol/L]c  is the concentration of a solute injected 
from the inlet. 
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Materials and methods 
A. Measurement of diffusion in microfluidic biomaterials (Fluorescence 
measure After Microfluidic Illumination, FAMI) 
 Acellular microfluidic biomaterials were used to carry out transient diffusion 
experiments (Fig. 3.9 and 3.10) with 20 μM fluorescein (MW 376.27 Da ; Sigma-
Aldrich) and 6 μM fluorescein isothiocyanate (FITC)-BSA (MW 66 kDa; Sigma-
Aldrich) in 4 % [w/v] calcium alginate, and 10 μM FITC-dextran (MW 70 kDa; 
Sigma-Aldrich) in 1 % [w/v] collagen.  Fluorescein and FITC-BSA were dissolved in 
our standard pH-adjusted buffer solution containing 10 mM CaCl2, 15 mM N-(2-
hydroxyethyl)-piperazine-N’-2-ethanesulfonic acid (HEPES), and 127.5 mM NaCl.  
FITC-dextran was dissolved in Phosphate buffered saline (PBS).  The extra CaCl2 
maintained rigidity of the microfluidic alginate scaffold.  The fluorescent solutions 
were delivered into the microfluidic alginate and collagen via microchannels at a flow 
rate of 50 and 10 μL/min respectively.  As soon as the microchannels were filled, the 
delivery was stopped and fluorescence images were acquired at regular intervals using 
a stereomicroscope (MZ FLIII, Leica), a CCD (charge-coupled device) camera (Retiga 
1300, QImaging), and Qcapture Pro 5.1 (Qimaging) for microfluidic alginate and an 
inverted microscope (IX 81, Olympus), a CCD camera (Hamamatsu Orca CCD, 
Hamamatsu), and SlideBook4.2 (Olympus) for microfluidic collagen.  Image analyses 
including quantification of fluorescence intensity and fast Fourier transform were 
carried out in MATLAB (The MathWorks). 
 
B. Fabrication of 1-channel microfluidic system 
 1-channel microfluidic systems were fabricated similarly as described in 
Chapter 2 (Fig. 2.2 and 3.2):  1) a machined plexiglass mold was pre-coated 
sequentially with 1% [v/v] polyethylenimine (PEI) to allow adhesion of alginate, and 
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both 1 % [v/v] PEI and 0.1% [v/v] glutaraldehyde for collagen, with an aluminum 
plug inserted to block a microchannel, 2) either alginate or collagen was casted in the 
machined plexiglass mold, 3) Another machined plexiglass was placed to pressure-
seal a device.  Note that the aluminum plug was replaced with a rubber plug when 
sealing the device. 
 
C. Measurement of diffusion in 1-channel microfluidic system 
 The 1-channel microfluidic system was used to estimate diffusivity of FITC-
dextran (70 kDa) in 1 % [w/v] collagen.  The fluorescent solution was delivered into 
the slab of collagen via the microchannel at a flow rate of 50 μL/min (Fig. 3.2B and C).  
Fluorescence images were acquired at every 5 min for 60 min using the 
stereomicroscope.  Image analyses to estimate penetration depth, δ  were carried out 
in MATLAB. 
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Figure 3.2 Fabrication of 1-channel microfluidic system.  A. Schematic diagram of 
the fabrication of 1-channel microfluidic systems.  The red line indicates either PEI or 
glutaraldehyde coating.  B and C. Schematic illustration of the 1-channel microfluidic 
system: top-down view (C) and cross-sectional view (D).  The pink shading represents 
distributions of solutes diffusing into the scaffold. 
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D. Temporally and spatially resolved delivery of small molecules in microfluidic 
alginate scaffold 
 An acellular microfluidic alginate scaffold was used to sequentially deliver 
small molecules via the embedded microchannels in the single network (Fig. 2.1Di):  
(1) fluorescein solution and (2) rhodamine B solution were delivered through the 
network at a flow rate of 50 μL/min (Fig. 3.12A). 
 An acellular microfluidic scaffold was used to deliver a series of small 
molecules via the embedded microchannels in the two independent networks (Fig. 
2.1Dii):  (1) the pH-adjusted buffer without fluorescent dye, (2) fluorescein solution (5 
μM in buffer) and (3) rhodamine B solution (5 μM in buffer) were delivered through 
the networks at a flow rate of 50 μL/min (Fig. 3.13A and Ax.1). 
 A microfluidic scaffold seeded with chondrocytes (1×107 cell/mL) was stained 
with two different stains (Fig. 3.13C) as described in Chapter 2.  Image acquisition 
and analyses were carried out in the same way as described above. 
 
E. Visualization of diffusion-reaction of metabolites in microfluidic alginate 
scaffolds 
 Chondrocyte-seeded microfluidic alginate scaffolds with various seeding 
densities were used to visualize diffusion-reaction processes.  Microfluidic delivery of 
5 μmol/L calcein-AM-green, dissolved in the pH-adjusted buffer, was carried out for ~ 
2.5 h. The flow rate was set to be 10 μL/min. To obtain cross-sectional view, the 
microfluidic scaffolds were cut into thin (1 ~ 2 mm) samples. These images were used 
to measure radial intensity profiles around a concentric point in a microchannel. 
Images were acquired in the same way as for transient diffusion. ImageJ was used to 
measure the radial intensity profiles (Fig. 3.1). Finite element analyses were carried 
out in Comsol Multiphysics (COMSOL). 
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F. Analysis of distribution of fluorescent product in cross-sectional images 
 Cross-sectional images were cropped, and a region of interest was copied in a 
black-backgrounded canvas; the height of the canvas was twice that of the cropped 
image (Fig. 3.1).  A Radial distribution of calcein about a concentric point in a 
microchannel was then obtained using a plugin of Radial Profiles provided in ImageJ. 
 
G. Fabrication of thin discs seeded with OSCC-3 cells 
 Cylindrical calcium alginate discs (200 µm thick, 4 mm in diameter) were 
fabricated by 1) casting the cell-seeded alginate in a machined plexiglass mold, 2) 
placing a porous membrane, and 3) cross-linking with 60 mM CaCl2 (buffered with 15 
mM HEPES; osmotically balanced with 52.5 mM NaCl; pH-adjusted) for ~15 min.  
Cross-linked, cell-seeded discs were removed from the mold, and transferred to well 
plates. 
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Figure 3.3 Radial distribution of calcein about a microchannel.  Fluorescence 
micrograph of a cross-section of top (micropatterned) layer of a microfluidic alginate 
scaffold seeded with primary chondrocytes (7.3×107 cell/mL). 
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Figure 3.4 Fabrication of thin disc seeded with cells.  Schematic diagram of the 
fabrication of 200 µm-thick 4 % [w/v] alginate discs seeded with cells. 
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H. Measurement of oxygen consumption rate (OCR) and finite element modeling 
 OSCC-3 oxygen consumption was measured for cell-seeded 200 µm thick 
alginate discs.  Fabricated cell-seeded alginate discs were first cultured for 2-3 days at 
17 % O2 and pre-incubated overnight at 1, 5, 9, 13, and 17 % O2.prior to 
measurements.  Four discs were submerged in 2 mL media in a sealed glass chamber 
(Agilent Technologies Inc., Santa Clara, CA), and kept stirring at 37 oC.  Media was 
initially equilibrated at the pre-incubation O2 concentrations and 5 % CO2, and 
reduction in oxygen level due to cellular consumption was measured with a dissolved 
oxygen meter (Innovative Instruments, Inc., Tampa, FL) as illustrated in Fig. 3.5.  
Measurements were taken for 30 min, at a rate of one measurement per minute.  This 
process was repeated 4 times with fresh media used each time.  Consumption rate was 
calculated from a linear fit to the O2 level versus time (Fig. 3.18A).  For OCR at 17 % 
O2, consumption kinetics was treated as zeroth order in the range measured (from 13 
to 5 % O2) due to the linearity of the O2 level versus time curve.  Using this measured 
consumption rate, an assumed oxygen diffusivity (
2O
D ) for water3, and a cell seeding 
density ( cellρ ) of 2×10
7 cell/mL, the cross-sectional O2 profile in 200, 500, and 1000 
µm thick discs was computed by solution of the steady-state diffusion-reaction 
equation (
2 2 2
2
O O cell O ,cellD c Rρ∇ = − ).  The solution was obtained with finite element 
method (FEM), implemented with Comsol Multiphysics (Comsol, Inc., Burlington, 
MA), assuming a fixed boundary concentration at 17 % O2.  Delivery of O2 to the 
boundary surface was assumed not to be rate limiting, which was accomplished in 
practice by culturing discs on a shaker. 
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Figure 3.5 Schematic illustration of the measurement of oxygen consumption rate 
(OCR). 
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I. Statistical analysis 
 Plots represent mean±standard deviations (SD).  Analysis of variance 
(ANOVA) with Tukey post-test was used for statistical analysis (GraphPad Prism, La 
Jolla, CA) and significance denoted as *P<0.05; **P<0.01; ***P<0.001. 
 
Theoretical background 
A. Measurement of diffusivity using FAMI 
 For simplicity, we present analysis for early times after the injection of the dye 
into the scaffold ( 2 ,/ s gt H D< ) for which the diffusion occurs in a domain that is 
effectively infinite in extent along the x-axis (Fig. 3.6); the experiments presented in 
Fig. 3.9 and 3.10 are in this regime.  Using methods of image sources, this approach 
(in particular, the integration over x) can also be shown to be appropriate for all times 
in a domain bounded by parallel, impermeable boundaries.  At early times, the time-
dependent concentration distribution due to an instantaneous source, ( ),M x y  at t = 0 
can be expressed in integral form as: 
 
 ( ) ( ) ( ) ( )
2 2
, ,
', ' ' '
, , exp ' '
4 4s g s g
M x y x x y y
c x y t dx dy
D t D tπ
∞ ∞
−∞ −∞
 − + −
= − 
  
∫ ∫  (3.1) 
In equation 3.1, the axes are as defined as in Fig. 3.6A, with the x-axis into the page, 
through the thickness of the scaffold.  For fast injection (high Pe and high Bi), we 
neglect variations along z.  We have verified that the fluorescence intensity, ( )tyI , , in 
micrographs taken from above at low magnification (~10x), as in Fig. 3.9A and 3.9B, 
is linearly proportional to the concentration of dye and the thickness of the scaffold.  
Therefore, we expect the following relationship between intensity and concentration: 
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( ) ( ) ( ) ( ) ( )
( ) ( )
2 2
, ,0
2
,,
,
, , , exp
4 4
exp
42
H
s g s g
x
s gs g
M x y x x y y
I y t c x y t dx dx dy dx
D t D t
M y y y
dy
D tD t
α α
π
α
π
∞ ∞ ∞
−∞ −∞ −∞
∞
−∞
 ′ ′ ′ ′− + −
′ ′= ≈ − 
  
 ′ ′−
′= − 
  
∫ ∫ ∫ ∫
∫
(3.2) 
In equation 3.2, α  is a constant that depends on the intensity of the illumination, 
quantum yield of the fluorophor, the length of the exposure, and the sensitivity of the 
camera, and ( )yM x ′  is the x-integrated distribution of the initial source.  In the second 
step, we have used the assumption of early times to extend the bounds of the integral 
along x to ±∞.  In the absence of variations along z, ( ) ( )tyItyI z ,, = , the z-averaged 
intensity in Fig. 3.6B.  Performing a continuous Fourier transform on this x-integrated 
intensity in equation 3.2 gives the following expression for the amplitude of the 
fundamental Fourier mode: 
 
 ( ) ( )0 0ˆˆ , txI k t M k e τ−=  (3.3) 
, where the time constant for the decay, 20 ,1/ s gk Dτ =  and ( )kM xˆ  is the Fourier 
transform of ( )yM x ′ , defined as 
 
 ( ) ( )1ˆ
2
iky
x xM k M y e dyπ
∞ ′−
−∞
′ ′= ∫  (3.4) 
See Appendix 3 for detailed derivation. 
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Figure 3.6 Schematic representation of Fluorescence measure After Microfluidic 
Illumination (FAMI).  Schematic illustrations showing the initial (A) and subsequent 
(t > 0, B) distribution of a fluorescent solute delivered in a pulse into a set of 
uniformly spaced microchannels. 
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B. Measurement of diffusivity in 1-channel microfluidic system 
 Diffusivity of fluorescent solutes can be also estimated using 1-channel 
microfluidic system for early-time analysis.  For fast delivery (high Pe and high Bi), 
we again neglect variations along z.  At early times, we can treat the system as a semi-
infinite slab. In other words, the impermeable boundary at y = W can be considered as 
( ) ( ), , 0c W t c t≈ ∞ = .  Then, an analytical solution for the trainsient diffusion of a 
solute in a hydrogel ( 2 2,/ /s gc t D c y∂ ∂ = ∂ ∂ ) is given by the similarity method: 
 
 ( ) ( )0,c y t c erfc η=  (3.5) 
where η  is the similarity variable defined as 
 
 
,2 s g
y
D t
η =  (3.6) 
With a similar strategy described in the previous section, it is reasonable to state that 
( ) ( ) ( ), , ,zc y t I y t I y t≈ = .  Because the theoretical concentration profile of a 
fluorescent solute rapidly drops to 00.1c  at 1.163η =  (i.e., ( )1.1613 0.1erfc = ), we 
define penetration depth, δ  as 
 
 ,2.3 s gD tδ =  (3.7) 
For the experimentally acquired images, the penetration depth was length at which 
normalized fluroescence intensity was 0.1 (i.e., ( ) max, / 0.1I t Iδ = ). 
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Figure 3.7 Schematic representation of diffusion of solutes to a slab of hydrogel in 
1-channel microfluidic system.  The green shading represents distributions of solutes 
diffusing into the slab of hydrogel. 
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C. Transient enzymatic transformation (diffusion-reaction) of calcein-AM in 
alginate 
 Visualization of diffusion-reaction of a model metabolite (calcein-AM) is 
directly associated with enzymatic production of calcein (see Appendix 2 and Fig. 3.9).  
Given that cell cell
dP k S
dt
ρ= , a distribution of calcein within microfluidic scaffolds can 
be expressed as 
 
 ( ) ( )
0
, , , , , ,
t
cell cellP x y z t k S x y z t dtρ= ∫  (3.8) 
, where P  [mol/L] and S  [mol/L] are concentration of calcein and calcein-AM 
respectively.  If the distribution of calcein-AM reaches a steady state in a short time 
relative to the length of the experiment, the distribution of calcein reduces to 
 
 ( ) ( ), , , , ,ss cell cell ssP x y z t k tS x y zρ≈  (3.9) 
The corresponding fluorescence intensity of calcein can be written as 
 
 ( ) ( ) ( ), , , , , , , ,ss cell cell ssI x y z t P x y z t k tS x y zα αρ= =  (3.10) 
, where α  is again a constant relating concentration and intensity.  In addition, the 
observed intensity is the integrated intensity along the x-axis; 
 
 ( ) ( )
0
, , , , ,
H
I y z t I x y z t dx≡ ∫  (3.11) 
Figure 3.5 presents the transient distributions of calcein (A) and their collapse at long 
times, when normalized by the time of injection (B).  This behavior verifies that the 
distribution of calcein-AM reaches a steady state at long times and that measuring the 
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concentration of P via fluorescence gives a measure of the steady state distribution of 
reactant. 
 
D. Measurement of OCR 
 In a closed batch system across which there is no mass flux of oxygen, OCR, 
2O ,cell
 [mol/s cell]R ⋅  is defined as 
 
 
2
2
O
O ,cell
cell
dn
dtR
N
−
≡  (3.12) 
where 
2O
 [mol]n  is mole of oxygen dissolved in media and cell  [cell]N  is total number 
of cells in the system.  Equation 3.12 can be re-written with more practical parameters 
that were used in experiments: 
 
 
( )
2 2
2
O Ovial vial
O ,cell
cell disc cell disc
dc dcV VR
N dt V N dtρ
   
= − = −   
   
 (3.13) 
where 3vial  [m ]V  is volume of the glass vial (the closed system), 
3
disc  [m ]V  is volume 
of an alginate disc, 3cell  [cell/m ]ρ  is cell seeding density in the alginate disc, discN  is 
number of discs submerged in the vial during the measurement of OCR. 
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Figure 3.8 Transient distributions of calcein and their collapse at long times.  A. 
Plot of z-averaged intensity, ( )tyI z ,  measured in Fig. 3.15A at times (20 min (dark 
grey), 40 min (red), 60 min (green), 80 min (blue), 100 min (dark red), 120 min (dark 
green), 140 (dark blue), 160 min (pink)).  B. Plot of z-averaged intensity divided by 
time [h], ( ), /zI y t t . 
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Results and discussion 
A. Measurement of diffusivity in 4 % [w/v] alginate using FAMI 
 Permeability to diffusion of both small (e.g., biochemical factors) and large 
(e.g., secreted extracellular matrix (ECM) components) molecules is essential for any 
matrix for 3D cell culture, and for the function of a microfluidic scaffold in particular 
(Fig. 3.1).  We have developed a systematic method to measure diffusivity (also see 
Theoretical background) of fluorescent molecules within the 3D volume of the matrix 
that defines the microfluidic scaffold; this method is analogous to fluorescence 
recovery after photobleaching4.  A heterogeneous initial distribution of fluorescent dye 
is created by injection of a pulse of fluorescent solution into the channels of a 
microfluidic scaffold (network as in Fig. 2.1Di); after injection, the distribution of 
solute is allowed to evolve by pure diffusion towards a uniform state in the bulk of the 
microfluidic gel (Fig. 3.6 and 3.9A); the progression of this diffusive broadening is 
monitored in the amplitude of the fundamental Fourier mode of the z-averaged 
distribution, ( )0 ,zI k t
 , where the wavenumber 0 2 / ck π λ= .  Figure 3c shows the 
temporal evolution of ( )0ln ,zI k t   
  for fluorescein (MW 376.27 Da) and fluorescein 
isothiocyanate-bovine serum albumin (FITC-BSA, MW 66 kDa).  The observed single 
exponential decay indicates that both solutes follow Fickian diffusion (that is, constant 
macroscopic diffusivity) within the gel.  Given this behavior, the time constant for the 
decay (the negative of the slope) is 20 ,1/ s gk Dτ =  (also see Theoretical background) 
2.  
From fits of this decay, we find ,fluor gD
6 23.6 10 cm /s−= × ,0.60 fluor wD=  and ,BSA gD
7 21.5 10 cm /s−= × ,0.52 BSA wD=  for fluorescein and FITC-BSA respectively, where, 
,s wD  is the diffusivity of the solute in water
4-5.  Taken together these observations 
indicate that the diffusive motion of both small and macromolecules is unhindered 
within the pores of the matrix, and we conclude that the pore size of 4 % [w/v] 
calcium alginate is large relative to BSA (radius of gyration, RG = 3.6 nm6).  This 
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same technique should be useful to measure diffusivities in the matrix after 
remodeling and production of ECM has occurred within a microfluidic scaffold. 
 
B. Measurement of diffusivity in 1 % [w/v] collagen using FAMI 
 Diffusivity of a macromolecule in 1 % [w/v] collagen was measured in the 
same way as described in the previous section.  Figure 3.10B shows the temporal 
evolution of ( )0ln ,zI k t   
  for FITC-dextran (MW 70 kDa) where we find ,dextran gD
7 23.5 10 cm /s−= × .  This measured value is comparable with the diffusivity of FITC-
dextran (MW 70 kDa) in water, ,dextran wD
7 22.3 10 cm /s−= ×  
7.  Using Stokes-Einstein 
relation ( , / 6s w B w sD k T Rπη= ), where Bk  is Boltzmann constant, T is temperature, wη  
is viscosity of water, and sR  is radius of a solute ( (70 ) 7.1 nmdextran kDaR ≈ ), theoretically 
calculated diffusivity of dextran (70 kDa) in water is 7 23.9 10 cm /s−×  8.  We note that 
one should be careful not to have residual convective flows while allowing a 
fluorescent solute to evolve into the bulk of a gel by pure diffusion (i.e., at t > 0).  In 
the presence of convective flow at t > 0, the FAMI analysis underestimates diffusivity 
because the continous (in time) source (fluorescence) in microchannels at t > 0 causes 
intensity to decay more slowly.  We have verified this hypothesis by carrying out 
FAMI experiments in the presence of persistent convective flows (0.1, 1, and 10 
µL/min; data not shown).  We also note that dextran is a linear chain polymer and that 
its diffusion in hydrogels can be more complicated due to interactions between dextran 
and a hydrogl matrix9.  For future measurements in collagen, non-adhesive globular 
proteins that are conjugated with a fluorophore would be preferrable. 
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Figure 3.9 Measurement of diffusivity in 4 % [w/v] alginate using FAMI.  A. 
Fluorescence micrographs showing the initial (i) and subsequent (t = 30 s, ii) 
distribution of fluorescein delivered in a pulse into a set of uniformly spaced 
microchannels.  B. Plot of the z-averaged fluorescence intensity, ( )tyI z , , measured in 
the images in A.  The plot was obtained from a single sample.  The results were 
consistent sample to sample.  The experimental data points are mean values of the 
fluorescence intensity (234 pixels in the z direction) in the images.  Standard 
deviations were smaller than the symbols.  C. Log-linear plot of time evolution of the 
fundamental Fourier mode ( 0 2 / ck π λ= ) of intensity profiles such as those in B for 
fluorescein (circles) and FITC-BSA (triangles). 
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Figure 3.10 Measurement of diffusivity in 1 % [w/v] collagen using FAMI.  A. 
Fluorescence micrographs showing the initial (i) and subsequent (t = 100 s, ii) 
distribution of FITC-dextran (70 kDa) delivered in a pulse into a set of uniformly 
spaced microchannels.  B. Log-linear plot of time evolution of the fundamental 
Fourier mode ( 0 2 / ck π λ= ) of intensity profiles for FITC-dextran. 
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C. Measurement of diffusivity in 1-channel microfluidic system 
 We have also measured diffusivity of the FITC-dextran in 1 % [w/v] collagen 
by designing a simpler 1-channel microfluidic system (Fig.3.2) based on a classical 
mass transport topic (i.e., diffusion in a semi-infinite slab; also see Theoretical 
background).  Because a solute can be evolve only through one side wall of a gel (Fig. 
3.2), we can treat the system as 1-D.  As a fluorescent solute is continuosly delivered 
via the single channel, the solute is allowed to laterally diffuse into a gel.  At early 
times ( 2 ,/d s gt W Dτ = ), penetration depth, δ  is proportional to ,s gD t .  The 
penetration depths were estimated by analyzing acquired fluorescence images at times 
(Fig. 3.11A and B; also see Materials and methods and Theoretical background).  We 
found ,dextran gD
7 24.3 10 cm /s−= ×  which was also similar to the measured diffusivity 
from the FAMI and ,dextran wD .  This measurement served as an additional way to verify 
the FAMI analyses as described above and allowed eliminating experimental 
ambiguousness regarding the residual convective flows in the microchannel during the 
FAMI in case a microfluidic biomaterial is sensitive to small disturbance, causing 
unexpected convective flows during the FAMI.  We note that too fast flow rates in the 
microchannel (therefore, too high pressures) may cause lateral convection into 
especially soft gels, resulting in overestimating diffusivity.  The fluorescence 
micrograph shown in Fig. 3.11Ai does not represent the case.  The imperfect diffusion 
broadening appeared because the interface between the microchannel and the gel was 
not sharp and slightly deformed by an air bubble that was accidentally induced prior to 
the measurement.  The slightly large value of diffusivity could have been due to the 
imperfectness of the gel. 
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Figure 3.11 Measurement of diffusivity in 1 % [w/v] collagen using 1-channel 
microfluidic system.  A. Fluorescence micrographs showing an early (t = 14 min, i) 
and later (t = 60 min, ii) distribution of FITC-dextran (70 kDa) delivered in 1-channel 
microfluidic system.   [mm]δ  is the penetration depth of a fluorescent solute.  B. Plot 
of background-subtracted, z-averaged fluorescence intensity, measured in the images 
in A.  C. Plot of time evolution of the penetration depth, δ  of FITC-dextran estimated 
from the images in A and the plot in B. 
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D. Effective diffusion in a porous material 
 To clarify our interpretation of the dynamics of fluorescein and FITC-BSA as 
“unhindered” pore diffusion (Fig. 3.9), we introduce the basic concepts of pore 
diffusion:  for any solute that can move freely within and between the pores of a 
porous material, the effective macroscopic diffusivity will be related to its free 
diffusivity by a single coefficient, poreC  < 1, that is related to the geometry of the 
pores: 
 
 effg pore w w
eff
AlD C D D
l A
  
= =      
 (3.14) 
where  [m]l  is a macroscopic length over which diffusion occurs within the porous 
material,  [m]effl  is an effective length of the path of the solute through pores, 
2 [m ]A  
is a macroscopic cross-sectional area of the porous material through which the solute 
motion, 2 [m ]effA  is a reduced area available for flow of the solute, and 
2 [cm /s]wD  is 
the diffusivity of the solute in water10.  Our experiments with fluorescein and FITC-
BSA indicate that Cpore ~ 0.5 for 4 % [w/v] calcium alginate. 
 We also highlight the observations that indicate conclusively that mass transfer 
within the gel is diffusive (not convective):  1) the quantitative agreement between 
purely diffusive model and transient profiles (Fig. 3.9); note that Darcy convection of 
the solute would lead to a sharp solute front and non-diffusive temporal scaling11 and 
2) the measured coefficients of pore diffusion scale in the expected way with 
molecular weight and free diffusivity; if a convective mechanism were at play, there 
should be no dependence of the rate of broadening on molecular weight. 
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E. Temporal control 
 We use pressure-driven flow of solutions through the microfluidic biomaterials 
to maintain hydration and mediate convective mass transfer to the bulk of the gels.  As 
stated above in Introduction section, high Peclêt number ( ,/ /c c s c cPe u h D L h= >> ) 
and high Biot number ( 1Bi  ; ,/c s gBi k H D= for non-reactive solutes or 
,/c K s gBi k Dλ= for reactive solutes) are required to avoid depletion of reagents along 
the length of the channels.  When these conditions are not met (low Pe and Bi), 
gradients will develop both axially and transversely in both the fluid and the gel, as 
shown in Fig. 3.1C.  When these conditions are met (high Pe and Bi), the 
concentration of solute at the inlet is delivered directly to the internal surfaces along 
the microchannels, as shown in Fig. 3.1D.  In this regime, the mass transfer process is 
controlled by pure diffusion-reaction within the bulk of the scaffold with concentration 
boundary conditions defined by the inlet concentrations.  The desirable mode of 
operation is required to achieve temporal control.  Figure 3.12A shows snapshots of a 
microfluidic scaffold during delivery of fluorescein (frames 1 and 2) and simultaneous 
delivery of rhodamine B and extraction of fluorescein (frames 3 and 4) at high Pe and 
Bi ( 8 cm/scu = , 41.3 10= ×fluorPe , 
42.5 10rhodPe = ×  >> / cL h , 300fluorBi =  and 
370rhodBi = ).  These images show that (1) the solutes within the scaffold can be 
changed over time via convective mass transfer and (2) at sufficiently high flow 
speeds, this temporal modulation occurs in a spatially uniform manner across the 
entire of the network (Fig. 3.12B).  This temporal control will enable culture 
conditions to be tuned rapidly and uniformly to study dynamic response and to direct 
development of tissues. 
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Figure 3.12 Temporal control in microfluidic biomaterials.  A. Fluorescence 
micrographs of the microfluidic scaffold at time points during sequential delivery of 
solutes (fluorescein (green) and rhodamine B (red)) to the scaffold via embedded 
microchannels.  B. Plot of normalized y-averaged intensity, ( )tzI y , , of fluorescein 
(green) and rhodamine B (red) in a sequence of images as in A.  The plot was obtained 
from a single sample.  The results were consistent sample to sample.  The 
experimental data points are mean values of fluorescence intensity (291 pixels in the 
y-direction) in the images.  Standard deviations are smaller than the symbols. 
  
98 
F. Spatial control 
 As qualitatively described in the previous chapter (Fig. 2.6B and C), the 
double-network (as in Fig. 2.1Dii) allows maintaining gradients of solutes at steady 
state for both non-reactive and reactive solutes.  The steady-state distribution of a non-
reactive solute is uniform in the absence of sinks (Fig. 3.12A and B).  Figure 3.13 
shows the generation of gradients in microfluidic alginate scaffolds with two 
independent networks for non-reactive solutes (Fig. 3.13A and B; also see Fig. A4.1) 
and reactive solutes (Fig. 3.13C-E).  The non-uniformity seen in the red zone in Fig. 
3.13C is due to slight imperfections in the network that led to lower Pe in several 
channels.  For the non-reactive low-molecular-weight solutes, the linear extent of the 
transition zones between regions of distinct chemistry is ~1 mm, as seen in the 
intensity profiles in Fig. 3.13B.  Finite element models of this system indicate that this 
distance is controlled by the thickness of the scaffold (H = 2 mm) for this geometry.  
Sharper gradients can be attained in this system by reducing the total thickness of the 
scaffold; for H < λc we predict that the gradient will be defined by λc.  Figure 3.14 
presents computational calculations of the distributions of non-reactive solutes in 
scaffolds of two different thicknesses.  These calculations illustrate that the avaerage 
sharpness of the gradient achieved varies with the thickness in these cases for which 
the thickness is large compared to the interchannel spacing, cλ .  For reactive species, 
the extent of the transition between regions is ~0.5 mm for both solutes, as seen in the 
profiles in Fig. 3.13E.  The fact that this distance is similar to the extent of the decay 
of intensity at the outside edges of the networks indicates that consumption of the 
reactive dyes is controlling the gradients in this case.  In the following, we will further 
present the quantitative analysis of cellular consumption of one of the reactive dyes 
(i.e., calcein-AM-green) in microfluidic alginate scaffolds. 
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Figure 3.13 Spatial control in microfluidic biomaterials.  A. Fluorescence 
micrograph of acellular microfluidic scaffold after delivery of solutions of fluorescein 
(5 μM; network 1) and rhodamine B (5 μM; network 2) at 50 μL/min 
( 41.3 10= ×fluorPe  and 
42.5 10rhodPe = × ).  The image was taken after 240 min; 
fluorescein had been delivered for 120 min and rhodamine B for 240 min (also see Fig. 
A4.1).  B. Normalized intensity of fluorescein and rhodamine B along the y axis from 
the image in A.  The plot was obtained from a single sample.  The results were 
consistent sample to sample.  C. Fluorescence micrograph of chondrocyte-seeded 
(1×107 cell/mL) microfluidic scaffold after delivery of calcein-AM-green (5 μM; 
network 1) and calcein-AM-red (2 μM; network 2) at 75 μL/min ( 42.7 10− = ×calc gPe  
and 42.5 10− = ×calc rPe ).  D. Fluorescence micrograph of a cross-section of the top 
(micropatterned) layer (1×107 cell/mL) of the scaffold in C.  The images in C and D 
were taken after 220 min of delivery in both networks.  E. Normalized intensity of 
calcein-AM-green and calcein-AM-red along the y axis in the image in C.  The plot 
was obtained from a single sample.  The results were consistent sample to sample. 
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Figure 3.14 Steady-state distribution of a non-reactive solute delivered via the 
embedded microchannels in network 1 and extracted via those in network 2.  
Computationally calculated concentration profiles within a microfluidic scaffold with 
the thickness of 2 mm (A) and 1 mm (B).  Concentration boundary conditions were 
maintained at the channel wall ( 1wallc =  in network 1; 0wallc =  in network 2), and no-
flux conditions were maintained at the top and bottom boundaries. 
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G. Quantitative analysis of metabolic diffusion-reaction processes in 3-D 
 With complete analysis of the distribution of fluorescent product in cross-
sectional images as in Fig. 3.15B (also see Fig. 3.3), we can quantify metabolic 
diffusion-reaction processes within the 3D scaffold.  Figure 3.15C shows the radial 
profile of fluorescence around microchannels in scaffolds seeded with cells at three 
different number densities: cellρ  = 1×10
7, 2.5×107, and 7.3×107 cell/mL.  As expected, 
the zone of metabolic activity decays over a shorter distance at higher densities of 
cells.  Furthermore, the observed profiles are in good agreement with computations.  
The computations were made with an effective first-order rate constant, eff cell cellk kρ=  
-1[s ] , with a single value for the cellular rate constant, 111 10  mL/cell scellk
−= × ⋅  (Fig. 
3.16).  These observations indicate that a continuum treatment of transport within a 
matrix seeded with discrete cells is appropriate and that cellk  is constant with respect to 
both the position and the density of the cells.  The rate constant we infer from the 
comparison of experimental and computational profiles in Fig. 3.15C is six times 
lower than that measured for cells in suspension culture: / 1/ 6scaff suspcell cellk k = .  This 
difference could be due to specific responses of the cells to the different culture 
environments; such differences between suspension or monolayer culture and 3-D 
culture have been noted before12-17 and understanding their causes will require the type 
of quantitative tools for controlling and monitoring culture conditions in 3-D that we 
present here. 
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Figure 3.15 Delivery of metabolites via microfluidic network.  A. Fluorescence 
micrographs of a chondrocyte-seeded (2.5×107 cell/mL) microfluidic scaffold  after 
delivery of 5 μM calcein-AM-green through microfluidic network for 2 h.  B. 
Fluorescence micrograph of a cross-section of the top (micropatterned) layer (2.5×107 
cell/mL) of the scaffold in A.  C. Radial profiles of experimentally measured calcein 
intensity ( maxExp. Exp./I I ; symbols) and computationally calculated calcein-AM 
concentration ( maxFEM FEM/c c ; solid lines) at various seeding densities (1×10
7 (red), 
2.5×107 (green), and 7.3×107 (blue) cell/mL).  The experimental data points are mean 
values of the normalized intensity of the calcein around the microchannels (three 
channels for 1×107 cell/mL, four channels for 2.5×107 cell/mL, and five channels for 
7.3×107 cell/mL) in images such as in B.  Each plot presenting experimental data was 
obtained from a single sample.  The error bars indicate standard deviations.  2R  of 
0.97, 0.97, and 0.98;  RMSE of 0.030, 0.056, and 0.035 for 1×107, 2.5×107, and 
7.3×107 cell/mL, respectively (also see Appendix 5). 
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Figure 3.16 Distribution of a reactive solute delivered via the embedded 
microchannels within a microfluidic scaffold with variably spaced microchannels.  
Concentration of calcein-AM calculated by finite element method with an assumption 
of first order kinetics with 6 2, 2.4 10  cm /s
−
− = ×calc g gD , 
111 10  mL/cell scellk
−= × ⋅ , and 
72.5 10  cell/mLcellρ = × .  Concentration boundary conditions were maintained at the 
channel walls ( 1wallc = ), and no-flux conditions were maintained at the top and bottom 
boundaries.  The distributions are shown for t = 120 min (A) and steady state (B). 
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H. Diffusion-reaction of a metabolite (oxygen) in alginate 
 Quantitative measurement of metabolic activity (i.e., oxygen consumption rate, 
OCR) of cells in 3-D allows estimating oxygen depletion length or Krogh lengh, Kλ .  
As briefly stated in the previous chapter and also demonstrated above, such estimation 
is essential in designing microfluidic biomaterials (i.e., scaffold thickness, H and 
interchannel distance, cλ ).  As shown in Fig. 2.8C, it is clear that there was a mixed 
distribution of normoxic (near microchannels) and hypoxic cells (far from 
microchannels) within a single scaffold due to significant gradients of oxygen 
concentration created by cellular consumption.  The measurement of OCR allows 
appropriately choosing the design parameters such that we can 1) avoid creating 
necrotic regions within tissue constructs in the context of tissue engineering, and 2) 
elucidate oxygen-dependent cellular activity in the context of tissue-scale biology.  
We have adapted this principle to study oxygen-dependent angiogenic activity of 
tumor cells in 3-D by culturing 200 µm-thick alginate discs seeded with OSCC-3s.  
We have chosen 200 µm to achieve uniform distributions of oxygen concentration.  
Figure 3.17 shows histological sections of the tumor cell-seeded alginate discs stained 
with H&E and hypoxyprobe on day 6.  Similarly as shown Fig. 2.8, cellularity was 
maintained through the both cultures at 1 and 17 % O2, and hypoxic cells (brown) 
were uniformly stained only in the disc cultured at 1 % O2 (Fig. 3.17).  This confirms 
that we have successfully separated hypoxic and normoxic regions.  These regions 
represent hypoxic core and normoxic periphery in a solid tumor. 
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Figure 3.17 Histological images of alginate discs seeded with OSCC-3s.  Optical 
micrographs showing histological cross-sections of 4 % [w/v] alginate seeded with 
OSCC-3s ( 72 10  cell/mL× ), cultured at 1 (top) and 17 (bottom) % O2 for 6 days, 
stained with H&E (left) and hypoxyprobe (right) after the culture.  Brown circles are 
hypoxic cells. 
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 Cellular O2 consumption was similar between OSCC-3s cultured in alginate 
(
2
17
O ,cell 5.4 0.2 10 mol/s cell
scaffR −= ± × ⋅ ), and those measured in suspension 
(
2
17
O ,cell 4.8 0.5 10  mol/s cell
suspR −= ± × ⋅ ), indicating that encapsulation within alginate did 
not significantly affect the metabolic activity of these cells.  Furthermore, these rates 
were similar to the O2 consumption rate reported for other tumor cells18-19.  Finite 
element modeling of the steady-state O2 distribution within the engineered tumors 
(cell seeding density, measured O2 consumption and a reported O2 diffusivity were 
used as inputs) indicated uniformity of oxygen concentration within 200 μm-thick 
tumor models (central and peripheral 
2O
c  differed by < 2 % for the initial seeding 
density); whereas significant non-uniformity was predicted for tumor models ≥ 500 
μm in thickness (> 25 % difference between central and peripheral 
2O
c  values at the 
initial seeding density for a 1 mm thick scaffold) (Fig. 3.19).  Theoretically calculated 
2 20 O cell O ,cell
/K c D Rλ ρ=  with the assumption of zeroth order kinetics is 668 µm 
which confirms that 200 µm was indeed thin enough to achieve uniform oxygen 
concentration within the tumor cell-seeded alginate discs. 
 We have also measured OCR of OSCC-3s cultured at different oxygen 
concentrations.  Figure 3.18B shows that 1) OCR at 17 % O2 is significantly larger 
than that at other pre-incubation oxygen concentrations, and 2) the measured OCRs of 
OSCC-3s pre-incubated at 1, 5, 9, and 13 % O2 are similar (except for the case 
between 1 and 9 % O2).  Generally, it is reasonable to state that oxygen consumption 
kinetics generally follows Michaelis-Menten kinetics: 
 
 2
2
2
,cell O
O ,cell
O
m
M
v c
R
K c
=
+
 (3.15) 
, where ,cell  [mol/s cell]mv ⋅  is maximum consumption rate, and 
3 [mol/m ]MK  is 
Michaelis-Menten constant.  The consumption kinetics falls to zeroth order 
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(
2O cell ,cellm
R vρ≈ ) when 
2O M
c K  and first order ( ( )
2 2O cell ,cell O
/m MR v K cρ≈ ) when 
2O M
c K .  Figure 3.18B seemingly implies that oxygen consumption kinetics of 
OSCC-3s seeded in alginate is neither zeroth nor first order.  However, we have 
observed that the linearity of 
2O
c  decrease was maintained consistently throughout the 
four measurements at every pre-incubation 
2O
c .  We note that oxygen concentration 
within the 2 mL-glass chamber decreased by a factor of ~3 for OCR at 17 % O2 (Fig. 
3.18A).  In addition, reported MK  values range from 
510−  to 3 37 10  mol/m−× 20; 17 % 
O2 corresponds to ~1.7 3mol/m .  This indicates that it is valid to assume that the 
kinetics is zeroth order.  The discrepancy between our observations could result from 
the following two reasons: 1) ,cellmv  may be a function of pre-incubation 2Oc  such that 
cells have adapted to become metabolically low over the pre-incubation period (no 
such pre-incubation period for 17 % O2), and 2) measured OCR values of the cells 
pre-incubated at lower oxygen concentrations do not represent actual OCR at the 
lower concentrations due to technical difficulty of the measurement at low 
2O
c .  For 
example, oxygen concentration of media pre-incubated at 1 % O2 rapidly increased up 
to ~ 6 % when an actual measurement was initiated.  This is because the ambient 
oxygen was rapidly diffusing into the glass chamber filled with the pre-incubated 
media while four discs were transferred to the chamber.  This technical difficulty 
could be resolved by pre-incubating open chambers where four discs have been 
already submerged in media.  We expect that this approach eliminates at least the 
ambiguity caused by the disc-transfer process.  For future experiments, it is also 
required to allow the measurements to last until the linearity breaks down to find out 
cellular response time scales to change their metabolic activity. 
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Figure 3.18 Oxygen consumption of OSCC-3s seeded in alginate discs.  A. Plot of 
time evolution of oxygen concentration in disc-suspended media within a sealed glass 
chamber.  B. Plot of oxygen consumption rate of OSCC-3 pre-incubated at various 
oxygen concentrations. 
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Figure 3.19 Steady-state distributions of oxygen within tumor cell-seeded alginate 
discs.  A-C. Concentration of oxygen calculated by finite element method with an 
assumption of zeroth order kinetics with 
2
5 2
O 2.76 10  cm /sD
−= × , 30 0.17 mol/mc = , 
2
17
O ,cell 5.4 10 mol/s cellR
−= × ⋅ , 7cell 2 10ρ = ×  cell/mL, H = 1 (A), 0.5 (B), and 0.2 (C) 
mm.  Concentration boundary conditions were maintained at all surfaces of the discs 
( 0c c= ). 
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Conclusions 
 In this chapter, we have presented detailed mass transport considerations in 
microfluidic biomaterials where diffusion and diffusion-reaction processes controlled 
by convective delivery of solutes via microchannels are essential.  These microfluidic 
channels enable quantitative control of the soluble environment experienced by the 
cells in their 3D environment.  The FAMI technique allows measuring diffusivity of 
small and macromolecules within microfluidic biomaterials, and should be also useful 
to measure diffusivity of solutes after remodeling and deposition of ECM components 
has occurred within microfluidic scaffolds.  In addition to the diffusivity 
measurements, the quantitative analyses of metabolic diffusion-reaction processes 
within microfluidic biomaterials allow determining important design parameters for 
tissue engineering and tissue-scale biology.  More specifically, oxygen transport is the 
key not only in maintaining metabolic activity of cells within growing engineered 
tissue constructs but also in elucidating roles of oxygen in various physiological and 
pathological processes in tissue-scale (e.g., differentiation and phenotypic behavior of 
stem cells, angiogenic activity of tumor cells, tumor angiogenesis in 3-D scaffolds).  A 
remaining challenge is to run multiple replicates of microfluidic biomaterials for long 
periods of time (weeks) without significantly loosing functionality.  There is still a 
lack of microscopy techniques and equipments that allow monitoring systems of 
interest in real time.  Customizable and relatively small-sized microscopy technique21 
that can be operated in incubators may aid to study dynamic biological processes.  
Combining with other useful tools to monitor oxygen distribution in a spatiotemporal 
manner will also open new opportunities. 
  
113 
REFERENCES 
 
1. Fournier, R.L., Basic transport phenomena in biomedical engineering, 1st ed. 
(Taylor & Francis, London, 1999). 
2. Bird, R.B. et al., Transport Phenomena, 2nd ed. (John Wiley & Sons, Inc., 
Hoboken, 2002). 
3. Spaeth, E.E. & Friedlan.Sk, Diffusion of oxygen, carbon dioxide, and inert gas 
in flowing blood. Biophys. J. 7 (6), 827-851 (1967). 
4. Gribbon, P. & Hardingham, T.E., Macromolecular diffusion of biological 
polymers measured by confocal fluorescence recovery after photobleaching. 
Biophys. J. 75 (2), 1032-1039 (1998). 
5. Moore, A.W. & Jorgenson, J.W., Study of zone broadening in optically gated 
high-speed capillary electrophoresis. Anal. Chem. 65 (24), 3550-3560 (1993). 
6. Schwuchow, J.M. et al., Tip-growing cells of the moss Ceratodon purpureus 
are gravitropic in high-density media. Plant Physiol. 130 (4), 2095-2100 
(2002). 
7. Periasamy, N. & Verkman, A.S., Analysis of fluorophore diffusion by 
continuous distributions of diffusion coefficients: Application to 
photobleaching measurements of multicomponent and anomalous diffusion. 
Biophys. J. 75 (1), 557-567 (1998). 
8. Bohrer, M.P. et al., Influence of molecular configuration on the passage of 
macromolecules across the glomerular capillary wall. J. Gen. Physiol. 74 (5), 
583-593 (1979). 
9. Williams, J.C. et al., Partition and permeation of dextran in polyacrylamide gel. 
Biophys. J. 75 (1), 493-502 (1998). 
114 
10. Scheidegger, A.E., The physics of flow through porous media. (University of 
Toronto, Toronto, 1960). 
11. Neeves, K.B. et al., Fabrication and characterization of microfluidic probes for 
convection enhanced drug delivery. J. Control. Release 111 (3), 252-262 
(2006). 
12. Benya, P.D. & Shaffer, J.D., Dedifferntiated chodrocytes reexpress the 
differentiated collagen phenotype when cultured in agarose gels. Cell 30 (1), 
215-224 (1982). 
13. Liu, H. et al., Re-expression of differentiated proteoglycan phenotype by 
dedifferentiated human chondrocytes during culture in alginate beads. Biochim. 
Biophys. Acta. 1425 (3), 505-515 (1998). 
14. Coward, S.M. et al., Proliferation rates of HepG2 cells encapsulated in alginate 
are increased in a microgravity environment compared with static cultures. 
Artif. Organs 29 (2), 152-158 (2005). 
15. Sivaraman, A. et al., A microscale in vitro physiological model of the liver: 
Predictive screens for drug metabolism and enzyme induction. Curr. Drug. 
Metab. 6 (6), 569-591 (2005). 
16. El-Ali, J. et al., Cells on chips. Nature 442 (7101), 403-411 (2006). 
17. Matsumoto, T. et al., Mechanical strain regulates endothelial cell patterning in 
vitro. Tissue Eng. 13 (1), 207-217 (2007). 
18. Muellerklieser, W. et al., A new photometric method for oxygen consumption 
measurements in cell suspensions. J. Appl. Physiol. 61 (2), 449-455 (1986). 
19. Spaeth, E.E. & Friedlan.Sk, Diffusion of oxygen, carbon dioxide, and inert gas 
in flowing blood. Biophys. J. 7 (6), 827-& (1967). 
20. Lovett, M. et al., Vascularization Strategies for Tissue Engineering. Tissue Eng. 
Part B-Rev. 15 (3), 353-370 (2009). 
115 
21. Sung, J.H., Choi, J. Y., Kim, D, Shuler, M. L., Fluorescence optical detection 
in situ for real-time monitoring of cytochrome P450 enzymatic activity of liver 
cells in multiple microfluidic devices. Biotechnol. Bioeng. 104 (3), 516-525 
(2009). 
 
 
116 
CHAPTER 4 
DISPERSIBLE OXYGEN-SENSING PARTICLES FOR APPLICATIONS IN VITRO 
AND IN VIVO 
 
I. Introduction 
 In the previous chapter, we demonstrated quantitative analyses of metabolic 
activity of cells within microfluidic biomaterials.  We also measured the oxygen 
consumption rate of cells and showed that it was a necessary piece of information in 
designing microfluidic biomaterials.  In this chapter, we present the development of a 
powerful tool for oxygen-sensing, which can also be combined with microfluidic 
biomaterials.  There has been remarkably increased interest in sensing oxygen levels 
in biomedical fields for the preceding few years1-3.  Strategies for measurement of 
oxygen levels include commercially available oxygen electrodes4 and oxygen-sensing 
luminophores1,5.  However, the oxygen electrodes are difficult to adapt to the small 
size scales relevant to oxygen diffusion limits within tissue.  In addition, the electrodes, 
based on electrochemical reduction of oxygen, cause oxygen consumption and have 
relatively long response times6.  In the context of dispersed luminophores, either an 
optical sensing matrix or biology is confined in a certain place, which does not allow 
fully mapping the distribution of oxygen levels within cell-seeded tissue scaffolds.  To 
overcome these difficulties, we propose to develop oxygen-sensing particles that are 
stably dispersible in aqueous environments and biocompatible.  Figure 4.1 shows our 
strategy: 1) the synthesis of the oxygen-sensing micro- and nanoparticles using 
oxygen-sensitive phosphors and monomers, 2) characterization of the particles, 3) 
calibration of the particles with the measurement of phosphorescence lifetimes, and 4) 
demonstrations for visualization and measurement of oxygen-depletion lengths in 
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tumor cell-seeded alginate, in vitro and oxygen imaging in blood vessels in vivo.  We 
will then conclude with some remaining challenges and future directions. 
 
Materials and methods 
A. Synthesis of oxygen-sensing microparticles 
 Oxygen-sensing polymeric microparticles were synthesized via dispersion 
polymerization7 using Pt(II) meso-Tetra(pentafluorophenyl)porphine (PtTFPP; MW 
1168.62 Da; Frontier Scientific Inc., Logan, UT) as an oxygen-sensitive phosphor8 and 
poly(styrene) (PS; Sigma-Aldrich, St. Louis, MO) as an encapsulating polymer9.  A 
reaction medium was prepared with 4.45 % [w/w] poly(vinyl pyrrolidone) (PVP; 
Sigma-Aldrich, St. Louis, MO) dissolved in 90 % [v/v] ethanol.  A monomer medium 
was prepared with 10 % [w/w] styrene (monomer), 0.5 % [w/w] 2,2’-
azobisisobutyronitrile (AIBN; initiator; Sigma-Aldrich, St. Louis, MO), and 1 % [w/w] 
PtTFPP.  After allowing each medium to be well-mixed for 1.5 hr, the monomer 
medium was transferred into the reaction medium.  Dispersion polymerization was 
then allowed for 24 hr with mild stirring in a 70 ºC silicone oil bath.  Synthesized 
oxygen-sensing microparticles were washed several times with 10 % [v/v] ethanol and 
kept dispersed in water at room temperature prior to usage (also see Appendix 6). 
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Figure 4.1 Schematic illustration of experimental approach for oxygen-sensing. 
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Figure 4.2 Chemical structure of oxygen-sensitive phosphors and monomers used 
in this study.  A. Oxygen-sensitive phosphors.  PtTFPP, Ru-PEG stand for Pt(II) 
meso-Tetra(pentafluorophenyl)porphine and [Ru(dmb-PEG)2(pyr-bpy)]Cl2 
respectively.  B. Monomers used for synthesizing polymeric particles.  UAN stands 
for urethane acrylate nonionomer. 
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B. Synthesis of oxygen-sensing nanoparticles 
 Oxygen-sensing polymeric nanoparticles were synthesized via emulsion 
polymerization using either PtTFPP or [Ru(dmb-PEG)2(pyr-bpy)]Cl2 (Ru-PEG; 
provided by Schmehl group at Tulane University, New Orleans, LA) as oxygen-
sensitive phosphors and poly(urethane acrylate nonionomer) (PUAN; provided by 
Kim group at Kangwon National University, Samcheok, Korea) as an encapsulating 
polymer.  First, a phosphor was pre-partitioned in amphiphilic precursor, urethane 
acrylate nonionomer (UAN):  1) ~ 4 µmol of a phosphor was dissolved in 3 ~ 4 mL of 
methylene chloride (MC), 2) 1 g of UAN was dissolved in the phosphor-dissolved MC, 
and 3) MC was allowed to evaporate in a fume hood for ~ 8 h.  After the phosphor-
partitioned UAN was fully re-dissolved in 9 g of potassium persulfate (KPS; thermal 
initiator)-dissolved deionized (DI) water (2 mg/mL), emulsion polymerization was 
then allowed with strong agitation in a 65 ºC silicone oil bath for 5 h.  Nitrogen gas 
was applied into the reaction medium for first 2 h.  Oxygen-sensing nanoparticle 
suspensions were dialyzed with a molecular weight cutoff of 50,000 for 2 days and 
stored at room temperature prior to usage (also see Appendices 7 and 8). 
 
C. Measurement of the size distribution of micro- and nanoparticles using 
Dynamic Light Scattering (DLS) 
 The size distribution of oxygen-sensing micro- and nanoparticles suspended in 
water was measured using Zetasizer Nano-ZS (Malvern Instruments Ltd., 
Worcestershire, UK).  400 µL of each suspension at a concentration of < 1 % [w/v] 
(microparticles) or 10 % [w/v] (nanoparticles) was used for a measurement and 
analyzed with 4 mW He-Ne laser (633 nm) to avoid unnecessary excitation from the 
phosphors that might affect DLS measurements.  Each measurement consisted of 40 ~ 
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50 repeated sub-measurements and size distributions were computed automatically in 
Zetasizer Software (www.malvern.com). 
 
D. Transmission Electron Microscopy (TEM) 
 Nanoparticles were suspended in water at a concentration of approximately 1 % 
[w/v] solid content.  A 5 µL droplet of this solution was applied to a freshly glow-
discharged 300 mesh, carbon-coated formvar grid (Ted Pella Inc., Redding, CA).  
After a 2 min-incubation, the nanoparticle suspension was removed from the grid by 
wicking with filter paper, the grid was washed with distilled water, and a 5 µL droplet 
of 1% [w/v] uranyl acetate (UA) staining solution was applied to the grid for 1 min.  
After the staining solution was removed, the grid was allowed to air dry at room 
temperature.  The grids were imaged at a magnification of x180,000 using a G2 Spirit 
Tecnai (120 kV) transmission electron microscope (FEI, Hilsboro, OR). 
 
E. Calibration of oxygen-sensing particles by the measurement of 
phosphorescence lifetime 
 Oxygen-sensing nanoparticles suspended in aqueous dispersants (i.e., water, 
ethanol, and alginate) were calibrated to obtain Stern-Volmer plots (phosphorescence 
lifetime vs. oxygen concentration) by measuring phosphorescence lifetime at various 
oxygen concentrations between 0 and 40 % O2.  Oxygen levels were controlled using 
an OxyDial gas mixer (Starr Life Sciences Co., Oakmont, PA). 
 Lifetime measurements were made on a two photon microscope consisting of a 
Ti:Sapphire laser (Millennia Xs/Tsunami combination, Spectra Physics, Mountain 
View, CA) directed into a modified BioRad MRC 600 laser scanner interfaced with a 
modified (fixed-stage) upright microscope (Olympus AX-70, Center Valley, PA).  A 
350-80 BKLA Pockel’s Cell (Conoptics, Danbury, CT) with custom-made electronics 
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provided beam intensity modulation and blanking during scanner flyback.  880nm 
light (~440 nm excitation) was focused into the specimen with a large-barrel Olympus 
20x/0.95 NA water immersion dipping objective.  Emission was separated with a 750 
nm long-pass dichroic, filtered with a HQ650/100M emission filter (both from 
Chroma Technology, Rockingham, VT) and detected with a GAsP PMT (H7422P-40, 
Hamamatsu, Hamamatsu City, Japan), amplified, and directed into the external ports 
of the BioRad acquisition electronics. 
 The Pockel’s Cell was used to deliver repeated pulses followed by monitoring 
periods with no laser power (< 3 % corresponding to < 0.1 % excitation).  
Phosphorescence curves were acquired using a SR430 multichannel scaler (Stanford 
Research Systems, Sunnyvale,CA) and the electronics were synchronized for repeated 
5 µs-pulse patterns using a DG535 digital delay/pulse generator (Stanford Research 
Systems).  The decay curves were fit to single exponentials using SigmaPlot (Systat 
Software Inc., San Jose, CA).  More detailed information about the multi-photon 
microscopy can be found from work done by Williams, et al.10. 
 
F. 2-D culture of tumor cells with oxygen-sensing particles 
 Oral squamous cell carcinoma (OSCC-3; provided by Fischbach group at 
Cornell University) cells were cultured in BD FalconTM 12-well plates (BD 
Biosciences, San Jose, CA), at 37 ºC, 5 % CO2, for 1 week, either without or with 
oxygen-sensing particles.  OSCC-3s were initially plated at a density of 10,000 
cell/well, and fed with Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen Co., 
Carlabad, CA) with 10 % [v/v] fetal bovine serum (FBS; Lonza Inc., Walkersville, 
MD) and 1 % [v/v] penicillin/streptomycin (PS; 120 U/mL; Gibco, Grand Island, NY).  
Various doses of oxygen-sensing particles (0.02, 0.05, 0.1, 1, and 10 % [w/v] for Ru-
PEG-PUAN nanoparticles, and 5×107 bead/mL for PtTFPP-PS microparticles) were 
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prepared by re-suspending sterile particles in culture media.  Microparticles were 
sterilized by suspending in 70 % [v/v] ethanol for several hours and nanoparticles by 
syringe-filtering through a 200 nm-pore membrane.  At the end of the culture, cells 
were trypsinized and counted for comparison between cases. 
 
G. 3-D culture of tumor cells seeded in oxygen-sensing particle-dispersed 
alginate discs 
 Sterile oxygen-sensing particles were first dispersed in phenol red-free DMEM 
(Invitrogen): 1 % [w/v] for nanoparticles.  4 % [w/v] oxygen-sensing particle-
dispersed alginate was prepared by dissolving lyopholized alginate (Protanal LF; FMC 
Biopolymer, Philadelphia, PA) in the media.  Then, trypsinized OSCC-3s were gently 
suspended in the alginate and calcium alginate discs (200 µm thick, 4 mm in diameter) 
were fabricated as described in Chapter 3 (Fig. 3.x).  Alginate discs seeded with both 
OSCC-3s and oxygen-sensing particles were cultured in 24-well plates at 37 ºC, 5% 
CO2 for 7 days. 
 
H. Live/dead assay 
 Viability of OSCC-3s seeded in oxygen-sensing particle-dispersed alginate 
discs was qualitatively estimated on day 0 and 7.  Alginate discs were submerged in a 
live/dead staining solution (5 μM calcein-AM-green and 5 μM ethidium homodimer-1; 
Invitrogen) in a pH-adjusted buffer solution.  The submerged discs were incubated for 
1 h prior to fluorescence microscopy.  Images were taken on an inverted microscope 
(Axio Observer; Carl Zeiss Inc., Thornwood, NY).  ImageJ enabled the merging of 
green and red fluorescence images. 
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I. DNA assay 
 Alginate discs were dissolved using ethylenediaminetetraacetic acid (EDTA, 
EMD Chemicals, Gibbstown, NJ), released cells were rinsed, and then lysed in 
Caron’s buffer.  DNA content was measured using Quant-iT™ PicoGreen® dsDNA 
reagent (Invitrogen), and cell number calculated using a measured value of 15.1 pg 
DNA/OSCC-3 cell on day 0 and 7. 
 
J. Direct imaging of phosphorescence 
 PtTFPP was excited at 392 nm and corresponding phosphorescence images 
were acquired at 650 nm using a stereomicroscope (Model MZ FLIII, Leica, Allendale, 
NJ), a CCD camera (Model Retiga 1300, QImaging, Surrey, Canada), and QCapture 
Pro 5.1 (QImaging, Surrey, Canada).  Acquired images were then analyzed and color-
mapped using Matlab (The Mathworks Inc., Natick, MA). 
 
K. In vivo oxygen imaging 
 Female FVB mice (4-6 week old) were anesthetized with 1-2 % isoflurane gas, 
adjusted to maintain a breathing rate of 100 breaths/min.  Each mouse was positioned 
in dorsal recumbency on one side of the stage on top of a heating pad with a rectal 
feedback probe (FHC Inc.) set to maintain core temperature at 36.5 ºC.  Its left limb 
was extended into a separate chamber for perfusion with saline, and a minor incision 
through the skin was made to expose the saphenous vessels, leaving the fascia intact.  
Once positioned under the microscope, the extended hindlimb was perfused with 
warm saline, and the breath rate and core temperature were continuously monitored 
for assuring animal health.  Several minutes before imaging the mouse received an 
intracardiac injection with the Ru-PEG-PUAN particles (3 µL/g mouse weight).   
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 The vasculature was imaged with a custom-built multiphoton microscope 
described previously11 and above.  Excitation light was focused into the vasculature 
using an Olympus 20X/0.95NA water-immersion objective that provided a large field 
of view and several mm of necessary working distance.  The illumination wavelength 
was tuned to 780 nm and nonlinear emissions were collected in epifluorescence mode 
and separated from the excitation beam using a 750DCXRU long-pass dichroic filter 
(Chroma Technology, Rockingham, VT).  The resulting nonlinear emissions were 
spectrally split by a 560DCXRU into blue- (BGG22, Chroma) and red- (650DF100MP, 
Chroma) pseudocolored channels.  The blue emission (autofluorescence and collagen 
SHG) was detected with a bi-alkali PMT (HC125-02, Hamamatsu) and the Ru-PEG 
emission was detected using a red-sensitive GaAsP photocathode PMT (H7422P-40, 
Hamamatsu) with custom-designed amplifier circuitry. 
 
L. Statistical analysis 
 Plots represent mean±standard deviations (SD).  Analysis of variance 
(ANOVA) with Tukey post-test was used for statistical analysis (GraphPad Prism, La 
Jolla, CA) and significance denoted as *P<0.05; **P<0.01; ***P<0.001; 
****P<0.0001. 
 
Results and discussion 
A. Oxygen-sensing by use of phosphors 
 Oxygen-sensitive phosphors, typically metal-ligand complexes, emit 
phosphorescence as they fall down to singlet ground state where all electrons are spin-
paired from triplet excited state where one set of electron spins is unpaired.  However, 
energy transfer between oxygen molecules that diffuse and collide with oxygen-
sensitive phosphors at their triplet excited state (energy donor) can occur such that the 
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phosphors fall into their ground state without emitting phosphorescence.  This process 
is called collisional quenching and can be applied to oxygen-sensing systems; higher 
concentration of oxygen (quencher) decreases phosphorescence.  Not only 
phosphorescence but also phosphorescence lifetime of an oxygen-sensitive phosphor 
follows the same principle.  Stern and Volmer first proposed that the ratio between 
luminescence lifetime in the absence of quenching molecules and that in the presence 
of those is linearly proportional to the concentration of the quenching molecule: 
 
 0 1 SVK Q
τ
τ
= +  (4.1) 
, where  [s]τ  is phosphorescence lifetime, SVK  is Stern-Volmer constant 
3[m /mol] , 
and 3 [mol/m ]Q  is concentration of quenching molecule.  Subscript 0 denotes the 
absence of oxygen.  For ideal collisional quenching of the triplet excited state by 
molecular oxygen, the phosphorescence intensity should vary in the same ratio as the 
lifetime12: 
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, where I  is phosphorescence intensity.  Therefore, we can quantify oxygen 
concentration from the measurement of phosphorescence or lifetime in principle.  In 
the following, we will characterize oxygen-sensitive phosphor-incorporated micro- 
and nanoparticles that we have synthesized. 
 
B. Synthesis and characterization of oxygen-sensing micro- and nanoparticles 
 We have successfully incorporated two oxygen-sensitive phosphors, PtTFPP 
and Ru-PEG, into polymeric micro- and nanoparticles by polymerization of phosphor-
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monomer mixture.  These oxygen-sensing particles are dispersible in water such that 
they can be used in biological environments in vitro and in vivo such as cell-seeded 
biomaterials and animal models.  We have first chosen PS as an encapsulating 
polymer because 1) it is one of the most well known polymeric materials with which 
synthesis of microparticles is relatively simple, and 2) it has been also used for 
luminescence sensing13-14.  The concentration of a radical initiator, AIBN was chosen 
to control the average size of PS microparticles.  Measured average size of PtTFPP-PS 
by dynamic light scattering was ~ 2 µm in diameter (Fig. 4.3A and Table 4.1).  Water-
dispersibility of PtTFPP-PS microparticles could result from a possibility that PVP 
(stabilizer) has been incorporated in PS matrix to some extent.  Residual PVP in the 
dispersion polymerization medium was removed by washing synthesized 
microparticles several times with 10 % [v/v] ethanol. 
 We have also tried PDMS and poly(methyl methacrylate) (PMMA) to 
synthesize microparticles incorporated with PtTFPP.  However, it was practically very 
difficult to control a size distribution of PDMS microparticles in emulsion, and water 
appeared to decrease oxygen sensitivity of PtTFPP significantly when it is 
incorporated in PMMA microparticles.  We note that synthesis of Ru-PEG-PS 
microparticles was not feasible because water-soluble Ru-PEG appeared to remain in 
the reaction medium (90% [v/v] ethanol) instead of being incorporated in hydrophobic 
PS during emulsion polymerization. 
 UAN is an amphiphilic precursor that is mainly composed of hydrophobic 
poly(propylene oxide)-based segment (PPO segment; MW 700 Da for the synthesis 
presented here) and hydrophilic poly(ethylene oxide) segment (PEO segment; MW 
1,500 Da for the synthesis presented here).  Because the UAN precursors are water-
dispersible by forming micelles (inner layer: PPO, outer layer: PEO), no stabilizer or 
surfactant was required during emulsion polymerization.  Synthesis of PUAN 
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nanoparticles is effectively polymerizing the micelles and cross-linking acrylate chains 
in UAN by a radical initiator, KPS in water as a reaction medium.  The size of PPO 
and PEO segments determines the thickness of hydrophobic and hydrophilic layers 
respectively.  The combination of the two main segments determines the size of 
nanoparticles.  Average diameters of PtTFPP-PUAN and Ru-PEG-PUAN are 42 and 
55 nm respectively (Fig. 4.3B and Table 4.1).  We believe that thickness of 
hydrophilic layer in these nanoparticles is 3-4 nm.  The size difference between 
PtTFPP-PUAN and Ru-PEG-PUAN is likely due to experimental conditions that may 
have varied randomly during polymerization.  Figure 4.3B shows that PUAN 
nanoparticles in the TEM image appear to be deformed spheres.  This is likely due to 
TEM processes where water was removed.  PUAN is a relatively soft polymer, and 
PUAN nanoparticles are very stable in water owing to steric stabilization of PEO 
chains onto their surface.  However, removal of water could cause aggregation and 
deformation of the nanoparticles.  Synthesized oxygen-sensing nanoparticles were 
dialyzed with a molecular cutoff of 50 kDa to ensure to filter free phosphor molecules 
that were possibly not incorporated in PUAN.  This process is especially required with 
Ru-PEG-PUAN because Ru-PEG is also amphiphilic and water-soluble.  Because 
PtTFPP is water-insoluble, we highly doubt that unincorporated PtTFPP will be left in 
the reaction medium.  We have not observed any noticeable PtTFPP aggregates after 
the emulsion polymerization in water.  We have also verified that no Ru-PEG micelles 
larger than the 50 kDa MW cutoff formed by attempting to measure the size of 
nanoscale micelles with Ru-PEG dissolved in water.  If the phosphor did form 
micelles (above critical micelle concentration (CMC)), light induced reactions would 
be affected by variations in the concentration of luminophore (which we have not 
seen).  Furthermore, possibly formed Ru-PEG micelles in water are more likely to be 
dialyzed in the presence of 6-7 L of water (effectively going below CMC). 
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 Oxygen-sensitive phosphors can be also incorporated in PUAN by a two-step 
process: 1) synthesis of PUAN nanoparticles and 2) incorporation of the phosphors 
into PUAN.  We found that incorporation efficiency was greatly enhanced by the 
single-step process as stated above. 
 
C. Calibration of oxygen-sensing particles with measurement of phosphorescence 
lifetime 
 We have calibrated oxygen-sensing particles suspended in water with lifetime 
measurements that allow for quantitative and consistent analyses in monitoring 
oxygen concentrations.  The  lifetime measurements are also known to be independent 
of optical artifacts (e.g., scattering within a matrix) and the concentration of a 
phosphor15.  With the complete calibration over a range of oxygen concentration, we 
can obtain information about sensitivity of the oxygen-sensing particles.  In addition, 
the calibration allows for back-calculation of actual oxygen concentration at regions of 
interest (e.g., cell-seeded scaffolds, vasculature in animals).  Figures 4.4 and 4.5 show 
Stern-Volmer plots - the linear relationship between oxygen concentration and 0 /τ τ  
as shown in the Stern-Volmer equation (Eq. 4.2) - from which Stern-Volmer constant, 
KSV (sensitivity of a phosphor) can be estimated.  As expected, 0 /τ τ  linearly increases 
as 
2O
c  increases for the all oxygen-sensing particles (Fig. 4.4).  We find that oxygen-
sensitivities of PtTFPP-PS, PtTFPP-PUAN, and Ru-PEG-PUAN are similar (Table 4.1) 
although a lifetime response to 40 % O2 of PtTFPP-PS microparticles is slightly 
smaller compared with PUAN nanoparticles.  We note that the response of oxygen-
sensing particles in alginate is similar to that in aqueous suspension (Fig. 4.5A and B).  
Therefore, it is valid to use the calibration performed in water for other aqueous 
environments.  Figure 4.5C shows that oxygen sensitivity of PtTFPP dissolved in 
ethanol is very similar to that of PtTFPP-incorporated oxygen-sensing particles up to 
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21 % O2 (also see Table 4.1 and 4.2) and that PtTFPP-PUAN nanoparticles appears to 
perform better at 40 % O2.  This observation indicates that no significant interaction 
between PtTFPP and polymeric matrices is involved in affecting oxygen sensitivity 
within a biologically relevant range of oxygen concentration (i.e., 0-21 % O2).  
However, oxygen sensitivity of Ru-PEG dissolved in water appears to be higher than 
that of Ru-PEG-PUAN (Fig. 4.5D).  This seemingly suggests that it is better to use 
solely Ru-PEG for oxygen-sensing.  However, we have observed that Ru-PEG 
dissolved a buffer solution caused animal death (data not shown), which implies that 
the phosphor itself is toxic to cells. 
 This calibration should be also done with direct phosphorescence imaging 
which one can perform in a laboratory without sophisticated optical equipments used 
for the lifetime measurement.  A cross-comparison between the calibration with the 
lifetime measurement and direct phosphorescence imaging would allow choosing an 
optimal combination of an oxygen-sensitive phosphor, encapsulating polymeric 
material.  Our observations reveal that micron-sized luminescent particles (possibly, 
any particles bigger than excitation/emission wavelength) may cause optical artifacts, 
for example, scattering.  By the fact that the PUAN nanoparticle suspensions are 
remarkably optically clear, it would be preferable to use PUAN-based oxygen-sensing 
particles for our applications that will be introduced later in this chapter.  Overall, we 
believe that Ru-PEG-PUAN nanoparticles would perform better for oxygen-sensing.  
In the following, we will further discuss about biocompatibility of the oxygen-sensing 
particles. 
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Figure. 4.3 Microscope images of oxygen-sensing micro- and nanoparticles.  A. 
Bright field image of PtTFPP-PS microparticles.  B. Transmission electron 
microscopy (TEM) image of Ru-PEG-PUAN nanoparticles. 
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Figure 4.4 Stern-Volmer plots for oxygen-sensing particles suspended in water. 
PtTFPP-PS (red circle), PtTFPP-PUAN (green triangle), and Ru-PEG-PUAN (blue 
square).  Fitted lines are linear regression plots based on Eq. 4.2 (
20 O
/ 1 SVK cτ τ = + ): 
solid line for PtTFPP-PS, dash line for PtTFPP-PUAN, and dotted line for Ru-PEG-
PUAN. 
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Figure 4.5 Stern-Volmer plots for oxygen-sensing particles dispersed in alginate, 
and for oxygen-sensitive phosphors.  A. PtTFPP-PS in water (filled red circle and 
solid line) and alginate (empty red circle and dash-dotted line).  B. Ru-PEG-PUAN in 
water (filled blue square and dotted line) and alginate (empty blue square and dash-
dotted line).  C. PtTFPP-PS in water (filled red circle and solid line), PtTFPP-PUAN 
in water (green triangle and dash line), and PtTFPP in ethanol (dotted red circle and 
dash-double dotted line).  D. Ru-PEG-PUAN in water (filled blue square and dotted 
line) and Ru-PEG in water (dotted blue square and dash-double dotted line). 
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Table 4.1 Average diameter, polydispersity index, and oxygen sensitivity (Stern-
Volmer constant) of oxygen-sensing particles 
 
 
Average 
diameter [nm] 
Polydispersity 
index 
O2 sensitivity in 
water [m3/mol] 
PtTFPP-PS 2034 ± 69.72 0.201 ± 0.033 2.04 
PtTFPP-PUAN 42.28 ± 0.6280 0.211 ± 0.006 3.08 
Ru-PEG-PUAN 54.90 ± 0.5823 0.196 ± 0.005 3.2 
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Table 4.2 Oxygen sensitivity of oxygen-sensing particles dispersed in alginate, 
and oxygen-sensitive phosphors 
 
 
PtTFPP-PS in 
alginate 
PtTFPP in 
ethanol 
Ru-PEG-
PUAN in 
alginate 
Ru-PEG in 
water 
O2 sensitivity 
[m3/mol] 
2.3 2.5 3.7 9.3 
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D. Biocompatibility oxygen-sensing micro- and nanoparticles 
 As briefly mentioned in the previous section, an oxygen-sensitive phosphor (or 
any heavy metal complex) could cause cell death possibly due to direct contact 
between the phosphor and cells.  We have examined cytotoxicity of our oxygen-
sensing micro- and nanoparticles by both 2-D and 3-D cultures of tumor cells in the 
presence of the particles.  For the 2-D culture, oxygen-sensing particles were 
suspended in culture media.  For the 3-D culture, the particles were dispersed in 200 
µm-thick alginate discs. 
 We have found that ≤ 0.1 % [v/v] Ru-PEG-PUAN nanoparticles suspended in 
media did not affect viability of OSCC-3s growing on well plates in 7 days (Fig. 4.6A) 
and that PtTFPP-PS microparticles ( 75 10  bead/mL× ) and higher volume fractions (1 
and 10 % [v/v]) of Ru-PEG-PUAN nanoparticles resulted in less proliferation 
compared with control (no particles) in 6 days (Fig. 4.6B).  OSCC-3s were initially 
seeded at 410  cell/well.  We note that PtTFPP-PS microparticles that were suspended 
relatively well in water started settling down on the bottom of wells in a day and 
significantly covered cell monolayers and areas on which the cells could have 
proliferated for the rest of the culture period (data not shown).  OSCC-3s with 
PtTFPP-PS still proliferated at least by a factor of ~ 10 in 6 days.  Figure 4.7 shows 
that OSCC-3s in alginate dispersed with both oxygen-sensing micro- and 
nanoparticles remained viable for 7 days (Fig. 4.7A) and proliferated by a factor of ~3 
over the culture period (Fig. 4.7B).  In addition, there was no significant difference 
between the two cases on each day.  We note that both the extent of proliferation and 
estimated cell number from DNA assay observed here are within a typical range in 1 
week-cultures of OSCC-3s in 200 µm-thick alginate discs without oxygen-sensing 
particles.  From the both 2-D and 3-D cultures, we conclude that the oxygen-sensitive 
phosphors encapsulated in PS micro- and PUAN nanoparticles do not cause significant 
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cell death from direct contact.  Note that the oxygen-sensitive phosphors are still likely 
to be present on the surface of the polymeric matrices after the synthesis.  However, it 
is still questionable whether the oxygen-sensing particles may cause phototoxicity to 
cells after the exposure to excitation light (i.e., 392 nm for direct phosphorescence 
imaging and ~800 nm for lifetime measurements with multiphoton microscopy).  
Future studies should address this question if reactive oxygen species (i.e., singlet 
excited oxygen molecules generated by the collisional quenching) affect cell viability 
because the main reason for dispersing the particles is for oxygen imaging and 
quantification of oxygen concentration from the lifetime measurements.  Furthermore, 
biocompatibility of the oxygen-sensing particles, in vivo should be examined.  Our 
preliminary observation shows that PtTFPP-PS (< 1 % [w/v]), PtTFPP-PUAN (1 % 
[w/v]; 3.4 µmol of PtTFPP incorporated in PUAN), and Ru-PEG-PUAN (1 % [w/v]; 
4.5 µmol of Ru-PEG incorporated in PUAN) injected into the vasculature of mice did 
not cause acute death for > 7 days (data not shown). 
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Figure 4.6 Plots of cell number after 2-D culture of OSCC-3s with oxygen-sensing 
particles.  A. Counted cells after 6 day-culture.  B. Counted cells after 7 day-culture.  
Error bars are standard error of the mean (SEM).  (*P<0.05 and ***P<0.001). 
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Figure 4.7 Live/dead and DNA assay after 3-D culture of OSCC-3s in oxygen-
sensing particle-dispersed 4 % [w/v] alginate.  A. Fluorescence micrographs 
showing cells stained by 5 μM calcein-AM (green – live) and 5 μM ethidium 
homodimer-1 (red – dead).  Cells with Ru-PEG-PUAN on day 0 (i) and 7 (ii).  Cells 
with PtTFPP-PS on day 0 (iii) and 7 (iv).  B. Plot of cell number calculated from DNA 
assay.  Error bars are standard error of the mean (SEM).  (****P<0.0001). 
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E. Demonstration of temporal and spatial control of oxygen concentration within 
microfluidic alginate scaffolds dispersed with oxygen-sensing microparticles 
 As demonstrated in the previous chapters, microfluidic biomaterials are useful 
tools to control soluble 3-D microenvironment.  Using oxygen-sensing particles 
dispersed within microfluidic biomaterials, oxygen concentration can be not only 
controlled but also monitored.  Figure 4.8A shows colormapped phosphorescence 
micrographs of a microfluidic alginate scaffold seeded with PtTFPP-PS microparticles 
(5×107 particle/mL) over the sequential delivery of a deoxygenated buffer solution 
(~0 % of saturation, “hypoxic”; frames i-iii) and an oxygenated buffer solution (21 % 
of saturation concentration of oxygen, “normoxic”; frames iv-vi) (also see Fig. 4.8B).  
Oxygen quenches PtTFPP such that the observed phosphorescence intensity decreases 
in well-oxygenated regions.  The incorporation of two independent networks, one 
hypoxic and one normoxic, within a monolithic scaffold (inset in Fig. 4.8C) allows for 
the maintenance of steady-state gradients.  Each network can serve as a source and a 
sink for oxygen (Fig. 4.8C and D).  These results confirm that 1) the oxygen-sensitive 
phosphor encapsulated in polymeric microparticles is functional, 2) the oxygen-
quenching mechanism is reversible, and 3) oxygen concentration within scaffolds can 
be not only controlled but also monitored in a spatiotemporal manner.  This capability 
would allow elucidating roles of oxygen in angiogenic signaling of tumor cells in 3-D 
scaffolds. 
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Figure 4.8 Demonstration of temporal and spatial control of oxygen 
concentration within oxygen-sensing microfluidic scaffolds.  A. Phosphorescence 
micrographs of an oxygen-sensing alginate scaffold at time points during the 
sequential delivery of a hypoxic buffer solution (i-iii) and a normoxic buffer solution 
(iv-vi) via embedded microchannels.  B. Normalized, mean phosphorescence intensity 
from the images in A.  C. Normalized phosphorescence micrograph from an oxygen-
sensing alginate scaffold operated with a normoxic buffer solution in the left network 
and a hypoxic solution in the right.  Inset shows structure of network.  The scaffold 
was 500 µm thick with inter-channel distance of 200 µm.  D. Normalized, z-averaged 
phosphorescence intensity from the image in C. 
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F. Visualization and optical measurement of oxygen-depletion lengths in a simple 
microfluidic tumor model, in vitro 
 As discussed in Chapter 3, the quantitative analysis of metabolic activity of 
cells in microfluidic biomaterials is essential and valuable in designing microfluidic 
tissue scaffolds for tissue-scale biology as well as tissue engineering.  In addition to 
the measurement of OCR, we can also visualize and optically measure oxygen-
depletion lengths (Krogh lenghs) using the oxyen-sensing particles.  The Krogh 
length16, λK is inversely proportional to the square root of cell seeding density, ρcell, 
assuming that oxygen consumption rate is zeroth order: 
 
 2
2
0
cell O ,cell
O
K
c D
R
λ
ρ
≈  (4.3) 
Prior to experimentally testing this hypothesis, we have demonstrated this approach as 
another example in a simple microfluidic tumor model (i.e., a microfluidic alginate 
scaffold seed with OSCC-3 cells).  We used the 1-channel microfluidic system for this 
demonstration (Fig. 4.9).  Phosphorescence micrographs in Fig. 4.10A and C present 
oxygen distribution within the tumor cell-seeded scaffold before and after the delivery 
of normoxic culture media (DMEM with 10 % [v/v] FBS).  Gradients of oxygen were 
created by diffusion and cellular consumption, and approached a steady-state within 
20 min.  The average profiles of phosphorescence along the z-direction (Fig 4.10B and 
D) show that the oxygen gradient length scale increases as cell seeding density is 
decreased by a factor of 5.  Furthermore, the normalized profile of background-
subtracted phosphorescence for the two cell seeding densities indicates that an 
effective Krogh length, defined as a length scale at which the normalized 
phosphorescence is 0.2, for 1×106 and 5×106 cell/mL is 2.2 and 1.3 mm respectively 
(Fig. 4.10E).  Estimated oxygen consumption rates, 
2O ,cell
R  using the equation above 
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are 1.1×10-16 and 6.1×10-17 mol/s cell for 1×106 and 5×106 cell/mL respectively.  
These estimated rates are comparable to what we have measured from the 
measurement of OCR presented in the previous chapter (5.4×10-17 mol/s cell at 17 % 
O2) and the oxygen consumption rate in rabbit corneal stroma17 although optically 
measured values appears to be overestimated in the case of 1×106 cell/mL.  The 
difference may be due to optical artifacts or culture conditions (e.g., temperature, 
ambient oxygen concentration).  Future experiments should include 1) the same 
analysis with the oxygen-sensing nanoparticles, 2) lifetime measurement in 
quantifying Krogh lengths, and 3) more careful considerations in providing 
appropriate culture environment during the operation.  Our preliminary measurement 
of spatially resolved oxygen concentration in the microfluidic tumor model, using the 
lifetime measurement and the calibration, shows that oxygen concentration decreases 
from 21 % (microchannel side) to ~10 % (bulk of tumor cell-seeded alginate; 5×106 
cell/mL) over 3.5 mm (data not shown).  This indicates that 
2O ,cell
R  might have been 
reduced due to lower temperature (~ 22 ºC) at which the measurement was carried out, 
compared with temperature inside an incubator (37 ºC).  In addition, cell seeding 
density needs to be chosen relevantly such that oxygen-depletion length scales are 
compatible with optical resolutions.  Figure 4.11A and B show finite element models 
for oxygen consumption at steady-state (
2 2 2
2
O O cell O ,cellD c Rρ∇ = − ) by cells in the 
microfluidic tumor model, where important input parameters are 30 0.17 mol/mc = (17 % 
O2) and 
2O ,cell
R  = 175.4 10−×  mol/s cell⋅ .  We have confirmed transient solutions 
indicate that the distributions have already approached to state-state within 60 min as 
observed in the experiments (data not shown).  However, oxygen-depletion length 
scales do not agree with the experimental observations.  Specifically, oxygen 
concentration does not appear to be depleted over the width of the scaffold, W = 4 mm 
at 1×106 cell/mL whereas oxygen is completely depleted at ~ 500 µm at 5×106 cell/mL 
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(Fig. 4.11 A and B).  Moreover, the theoretical estimation of the Krogh length does 
not appear to agree with finite element models as cell seeding density increases (> 
1×106 cell/mL).  Fig. 4.11C is a log-log plot of 2Kλ  versus cellρ .  The slope value for 
the finite element models is -1.35, indicating Kλ  is proportional to ( )
1.35
cellρ
− .  This 
suggests that the simple argument in estimating oxygen-depletion length scale may 
have to be revised, but experimental validation should be carried out first. 
 
G. In vivo O2 imaging with oxygen-sensing nanoparticles 
 Because synthesized oxygen-sensing particles can be dispersed well in aqueous 
environments and show biocompatibility, they can be also used for oxygen imaging, in 
vivo.  We have demonstrated that one of our oxygen-sensing nanoparticles (Ru-PEG-
PUAN) is useful to monitor oxygen levels in blood streams by injecting the particles 
into the vasculature (saphenous vessels) of mice and measuring lifetimes (Fig. 4.12).  
Figure 4.12C shows that oxygen concentration in vein is clearly lower than that in 
artery.  This preliminary demonstration confirms that the dispersible oxygen-sensing 
particles are valuable tools for oxygen-sensing in vivo as well as in vitro applications. 
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Figure 4.9 Schematic representation of oxygen-sensing microfluidic scaffold 
seeded with cells (top-down view).  Dispersed cells are depicted as double circles and 
oxygen-sensing particles as red circles.  The pink shading represents steady-state 
distribution of oxygen within cell-seeded scaffold.  The Krogh length, λK, is the 
characteristic distance over which oxygen diffuses into the scaffold from the 
microchannel.  c0 is oxygen concentration at the scaffold-microchannel interface. 
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Figure 4.10 Visualization and optical measurement of Krogh lengths in a simple 
microfluidic tumor model.  A and C. Phosphorescence micrographs of oxygen-
sensing microfluidic scaffolds seeded with OSCC-3s (A: 5×106 cell/mL, C: 1×106 
cell/mL) at time points.  B and D. Z-averaged phosphorescence intensity from the 
images in A and C.  E. Background-subtracted, z-averaged, and normalized 
phosphorescence intensity from the images at 120 min in A and C. 
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Figure 4.11 Computational model for oxygen consumption in simple microfluidic 
tumor model.  A. Steady-state distribution of oxygen concentration calculated by 
finite element method with an assumption of zeroth order kinetics with 4 mmW =
2
5 2
O 2.76 10  cm /sD
−= × , 30 0.17 mol/mc = , 2
17
O ,cell 5.4 10 mol/s cellR
−= × ⋅ , 
6
cell 1 10ρ = ×  (i) and 
65 10×  (ii) cell/mL.  Concentration boundary conditions were 
maintained at the channel walls ( 0 0yc c= = ), and no-flux conditions were maintained at 
other boundaries.  B. Plot of normalized concentration (
2O 0
/c c ; solid lines) along y-
direction, calculated in A, at cell seeding densities of 1×106 (red) and 5×106 (orange) 
cell/mL.  C. Log-log plot of Krogh lengths, Kλ  estimated from the finite element 
method (black) and Eq. 4.3 (white) at various seeding densities (1×106, 1.12×106, 
2×106, and 5×106 cell/mL). 
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Figure 4.12 In vivo oxygen imaging.  A. Schematic illustration of experimental setup.  
B. Image showing saphenous vessels of a mouse as in A.  C. Plot of phosphorescence 
lifetime decay of Ru-PEG-PUAN nanoparticles in vein (blue) and artery (red). 
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Conclusions 
 We have synthesized oxygen-sensing particles in both micro- and nanoscale 
that are stably dispersible, biocompatible in aqueous environments, by encapsulating 
oxygen-sensitive phosphors in polymeric matrices.  Calibration of these particles 
allows estimating oxygen-sensitivity and quantifying oxygen concentration with 
optical measurements.  Both direct phosphorescence imaging and phosphorescence 
lifetime measurement with multi-photon microscopy can be used in monitoring 
oxygen levels.  Combining this tool with microfluidic biomaterials, we can not only 
control but also monitor oxygen concentration in a spatiotemporal manner.  This opens 
a great opportunity for in vitro biological applications.  For example, the measurement 
of spatially resolved distributions of oxygen concentration allows estimating oxygen-
depletion length scales within 3-D scaffolds seeded with cells.  This serves as one of 
key parameters in designing microfluidic tissue scaffolds.  In addition, 
spatiotemporally resolved oxygen-sensing allows elucidating oxygen-dependent 
physiological processes (e.g., phenotypic behavior of stem cells, cellular function in 
liver) and pathological processes (e.g., angiogenic activity of tumor cells, tumor 
angiogenesis) in tissue-scale.  The oxygen-sensing particles are also powerful for 
quantifying oxygen levels in blood streams without causing animal death, and even 
smaller particles may be potentially useful to monitor oxygen concentration in animal 
tissues.  Remaining challenges are to 1) develop techniques in maintaining long-term 
cultures with real time imaging in a non-invasive way and 2) synthesize a few 
nanometer scale particles that can freely diffuse between vasculature and tissue 
without causing destruction of cell membrane.  Overall, the dispersible oxygen-
sensing particles can be powerful tools for applications both in vitro and in vivo. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 After a broad introduction to regenerative medicine, tissue engineering, and 
tissue-scale biology as well as the state of the art of the fields in Chapter 1, we 
presented the development of microfluidic biomaterials that could be used as enabling 
tools for tissue engineering and tissue-scale biology, in vitro in Chapter 2.  Successful 
fabrication of functional microfluidic networks within both calcium alginate and 
collagen requires important characteristics: 1) dispersion of cells within scaffold 
biomaterials,2) biocompatibility of the fabrication, 3) scalability to sub-millimeter 
dimensions, and 4) lithographic definition of fluid paths to enable precise control of 
distributions and fluxes of solutes.  Embedded microchannels in microfluidic 
biomaterials enable maintaining a uniform metabolic environment within the bulk of 
the scaffold, creating distinct soluble environments experienced by cells in their 3-D 
environment, and accessing to biochemical environment created by cells.  We also 
demonstrated that pre-defined microchannels in microfluidic collagen scaffolds served 
as templates for microvascular endothelialization.  Microfluidic collagen scaffolds are 
a potentially more valuable platform for studies of vasculogenesis, (tumor) 
angiogenesis, and organogenesis of lymph node in 3-D not only because both 
chemical and mechanical microenvironment can controlled but also because cells can 
remodel their 3-D environment.  The development of such remodelable microfluidic 
scaffolds could also aid to find mechanistic clues in the stabilization of 
microvasculature, for example, by seeding pericytes, fibroblasts, and smooth muscle 
cells in the bulk.  In the context of tissue engineering, this tool may aid in growing 
thick sections of tissue without necrosis in the core, and in directing the development 
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of cells towards spatially differentiated tissues; for example, an integrated cartilage-
bone composite tissue by seeding mesenchymal stem cells (MSCs). 
 In Chapter 3, we presented mass transport considerations in microfluidic 
biomaterials.  Such considerations include quantitative measurements of diffusion and 
diffusion-reaction of solutes, which should be also used in designing and operating 
microfluidic biomaterials.  Appropriately chosen design parameters allow both 
spatiotemporal control of the soluble environment experienced by cell in 3-D, by 
efficient exchange of solutes via embedded microchannels.  Specifically,as stated in 
Chapter 1, oxygen transport is the key not only in maintaining metabolic activity of 
cells within growing engineered tissue constructs but also in elucidating roles of 
oxygen in various physiological and pathological processes in tissue scale.  Systematic 
control of oxygen within microfluidic biomaterials, combined with the quantitative 
measurement of metabolic activity, would promote investigating differentiation and 
phenotypic behavior of stem cells, angiogenic signaling of tumor cells, tumor 
angiogenesis in 3-D scaffolds.  A remaining challenge is to run multiple replicates of 
microfluidic biomaterials for long periods of time (weeks) without significantly 
loosing functionality.  There is still a lack of microscopy techniques and equipments 
that allow monitoring systems of interest in real time.  Development of customizable 
and maybe portable in some sense microscopes that can be operated in incubators may 
aid to study dynamic biological processes. 
 In Chapter 4, we described the development of an additional tool for oxygen-
sensing.  We showed the synthesis of oxygen-sensing micro- and nanoparticles in 
which oxygen-sensitive phosphors were incorporated.  Unlike conventional yet still 
generally useful techniques to probe oxygen levels (e.g., dissolved oxygen meters with 
electrodes), the oxygen-sensing particles allow monitoring oxygen concentration in a 
spatiotemporally resolved manner when they are combined with microfluidic 
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biomaterials.  We have demonstrated that the particles are stably dispersible in 
aqueous environment and biocompatible as well.  We have also demonstrated the 
direct visualization and optical measurement of oxygen-depletion lengths within cell-
seeded 3-D scaffolds in vitro.  The use of oxygen-sensing particles can be extended in 
quantifying oxygen levels in blood streams without causing animal death.  Even 
smaller particles may be potentially useful to monitor oxygen concentration in animal 
tissues to capture real-time in vivo physiology.  Remaining challenges are to 1) 
develop techniques in maintaining long-term cultures with real-time imaging in a 
continuously non-invasive way and 2) synthesize a few nanometer scale particles that 
can freely diffuse between vasculature and tissue without causing destruction of cell 
membrane.  With greatly increasing interest in oxygen-sensing for biological 
applications, this technology could open new opportunities and lead to vast impact in 
the field of tissue-scale biology as well as tissue engineering. 
 Specific future directions related to tissue-scale tumor biology include further 
investigation of 1) angiogenic activity and signaling of tumor cells in 3-D scaffolds, 
and 2) direct angiogenesis.  Microfluidic alginate can serve as a structurally inert 
scaffold in terms of remodeling that allows examining angiogenic activity of tumor 
cells prior to the initiation of angiogenesis.  An underlying hypothesis is that paracrine 
signaling from hypoxic cells up-regulates the expression of angiogenic factors in 
normoxic region (Fig. 5.1E and F).  Embedded microchannels within a double-
network scaffold (Fig. 5.1A) enable not only creating a steady-state gradient of 
oxygen to recapitulate hypoxic core and normoxic periphery in solid tumor (Fig. 5.1E 
and F) but also locally sampling angiogenic factors secreted by cells in the bulk (Fig. 
5.1B).  For systematic comparisons, exogenous angiogenic factors could be delivered 
via microchannels in the hypoxic zone as mimic of tumor cell secretion (Fig. 5.1C).  
In addition, angiogenic factor-blocking antibodies or cell-based techniques such as 
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siRNA could be used to inactivate effects of the hypoxic core (Fig. 5.1D).  
Furthermore, dynamic angiogenic responses of tumor cells could be examined by 
temporally modulating oxygen concentration.  Quantitative measurement of 
distributions of angiogenic factors may allow developing a model to predict tumor 
progression. 
 Remodelable microfluidic collagen could aid in finding mechanistic clues in 
direct angiogenesis.  For example, to test a hypothesis that there may be the threshold 
of oxygen level and that of secretion level of angiogenic factors to drive tumor 
angiogenesis, an endothelialized microfluidic network within a tumor cell-seeded 
scaffold could be allowed to undergo direct angiogenesis; controlled oxygen 
concentration as an input stimulus and secreted angiogenic factors as an output 
indication (Fig. 5.2A).  Recent studies have found evidence that chemoattracting 
factors stimulate to release bone marrow derived (BMD) endothelial cells (ECs) from 
bone marrow (stimulated by mobilizing factors such as tissue ischemia), and to recruit 
them to angiogenesis sites1-6.  These suggest that the recruited BMD ECs may become 
newly assembling ECs or at least facilitate angiogenesis.  Therefore, it may be feasible 
to enhance the extent of angiogenesis by delivering BMD ECs (Fig. 5.2B) and 
additionally delivering angiogenic factors (Fig. 5.2C) via endothelialized 
microchannels.  Furthermore, we could test whether angiogenic factors secreted by 
tumor cells recruit BMD ECs via vascular vessels, by connecting two microfluidic 
endothelialized collagen scaffolds; one for tumor part and the other for bone marrow 
part (Fig. 5.2D).  Fluorescently labeled bone marrow cells (BMCs) would allow 
tracking recruited cells.  Improved understandings of tumor angiogenesis in tissue 
scale may aid in developing anti-angiogenic treatment, and could also be extended to 
tissue engineering applications towards angiogenesis and vascularization within 
engineered 3-D tissues.  
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Figure 5.1 Microfluidic tumor model in calcium alginate.  A. Schematic top-down 
view of microfluidic tumor with two independent networks.  The left side mimics the 
hypoxic conditions of the core of the tumor; the right side mimics the peripheral zone 
and surrounding tissue.  Black lines represent embedded microchannels.  Grey lines 
represent channels used as chemical “taps” to monitor local concentrations of soluble 
factors.  B-D. Schematic cross-sectional views of model tumor, each representing a 
different experiment:  in B, microchannels impose gradients in the concentration of 
oxygen and tumor cells respond to create distributions of angiogenic factors.  In C, 
hypoxia and exogenous VEGF are delivered to model tumor zone, without cells.  In D, 
VEGF activity is blocked.  Red shading indicates oxygen concentration.  Blue shading 
indicates VEGF concentration.  E. Schematic representation of solid tumor (tan), host 
tissue (pink), and vascular structure (brown).  F. Hypothetical plots of the 
concentrations of oxygen, VEGF, and IL-8, in the tumor and surrounding tissue. 
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Figure 5.2 Collagen-based microfluidic tumor models for direct angiogenesis 
study.  A-C. Single-network design.  
2
[mol]Oc  is inlet concentration of oxygen.  D. 
Interconnected network design. 
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APPENDIX 1 
SUPPLEMENTARY METHOD: FABRICATION OF MICROFLUIDIC ALGINATE 
SCAFFOLDS 
 
I. Jig components 
 Figure A1.1 shows a photo with all of the parts used in the jigs for molding 
and operating microfluidic scaffolds: 
 O-rings (Fig. A1i):  an O-ring (McMaster-Carr®, Robbinsville, New Jersey) 
was inserted in a 2-mm recess on the bottom of an aluminum part (Figure A1.1ii).  
Inserted O-rings served as gaskets to prevent CaCl2 solution from leaking during the 
cross-linking step. 
 Aluminum parts (Fig. A1.1ii, v, vi, vii, and ix):  machined aluminum parts 
served as rigid frames to provide thermal stability and mechanical strength when 
autoclaved, and precision when assembled to form a sealed microfluidic scaffold. 
 Perforated aluminum support (Fig. A1.1iii):  perforated aluminum sheets (812 
μm thick, 838 μm in diameter round perforations; Small Parts, Inc., Miami Lakes, 
Florida) were cut, and screw holes and injection ports were created.  Tygon tubing (1 
mm in inner diameter; Small Parts, Inc., Miami Lakes, Florida) was glued on one of 
the ports using cyanoacrylate adhesive (Super Glue Corp., Rancho Cucamonga, 
California). 
 Plastic sheets:  Plastic sheem sheets (AccuTrex Products, Inc., Canonsburg, 
Pennsylvania) were cut, and screw holes and windows were created with a scalpel. 
 Poly(dimethylsiloxane) (PDMS) stamp (Fig. A1.1viii):  a mold was pre-
assembled with a lithographically defined SU-8 master (see Materials and methods in 
Chapter 2) and jig parts for top layer of the microfluidic scaffold (Fig. A1.1ii, vi, and 
vii).  PDMS (Sylgard 184, Dow Corning, Midland, Michigan) was poured as a pre-
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polymer into the mold and cured in two steps:  24 h at room temperature and followed 
by 1 h at 65 °C.  This two-step process was necessary to avoid deformation of the 
stamp due to thermal expansion during the initial cross-linking of the pre-polymer. 
 
Assembly of molds for calcium alginate 
 Coating with poly(ethylenimine):  a solution of poly(ethylenimine) (PEI) (MW 
750,000; branched.; Sigma-Aldrich, St. Louis, Missouri) was made at 0.1 % [v/v] in 
water.  Components v and xi were oxidized for 1 min in a plasma cleaner/sterilizer 
(Model PDC-001, Harrick Plasma, Ithaca, New York) at the highest RF power.  
Immediately following oxidation, ~ 28 μL/cm2 (corresponding to a total of 250 μL)of 
the solution of PEI was applied onto the surfaces of each part.  These parts were 
allowed to dry in a sterile hood overnight. 
 Mold for top layer of calcium alginate:  the PDMS stamp was oxidized for 1 
min in the plasma cleaner/sterilizer.  This oxygen plasma treatment was performed 
immediately before each fabrication run in order to increase wettability of the PDMS 
stamp by uncross-linked alginate during the injection step.  A mold for the top layer of 
the scaffold was formed by stacking the following parts:  i, ii, iii, iv, v, vi, viii, and vii. 
 Mold for bottom layer of calcium alginate:  a mold for the bottom layer of the 
scaffold was formed by stacking the following parts:  i, ii, iii, iv, v, vi, xi, and ix. 
 
Assembly of cartrigde for operation of microfluidic scaffold 
 Once cross-linked with CaCl2 solution, the top and bottom layers of calcium 
alginate were assembled into the functional microfluidic scaffold.  The complete 
cartridge is formed as a stack of the following parts (Fig. A1.1):  ii, x, xii, v with the 
top layer of calcium alginate inside the window, xiii, v with the bottom layer of 
alginate inside the window, xi, vi, and ix.  
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Figure A1.1  Assembling jig parts used to fabricate microfluidic scaffold 
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APPENDIX 2 
ENZYMATIC CONSUMPTION OF CALCEIN-AM 
 
 Experiments with cells in suspension were performed to study the enzymatic 
consumption of calcein-AM by primary chondrocytes in suspension.  Isolated 
chondrocytes and solutions of calcein-AM with various concentrations (i.e., 1.25, 2.5, 
5, 10, 20 μM) were dispensed into wells of a 96-well plate.  In addition, cells without 
calcein-AM, calcein-AM without the cells, and completely pre-cleaved calcein (Carlo, 
D. D., Aghdam, N. & Lee, L. P. Single-cell enzyme concentrations, kinetics, and 
inhibition analysis using high-density hydrodynamic cell isolation arrays. Anal. Chem. 
78 (14), 4925-4930 (2006)) without the cells were dispensed for estimating 
background, autohydrolization, and intracellular concentrations of calcein respectively.  
Fluorescence was measured in a microplate reader (Model SynergeTM HT, BioTek, 
Winooski, VA) every minute for 1 h.  The intensity of both the background and 
autohydrolization were subtracted from the raw fluorescence intensity of calcein.  
After converting the corrected intensity to concentration of calcein (product 
concentration, P [mol/L]) production rate at early times (i.e., 5 ~ 15 min when P 
linearly increased over time) was obtained.  It was found that the enzymatic kinetics 
was first order with respect to the concentration of calcein-AM (substrate 
concentration, S [mol/L]) with a rate constant, suspeff cell cellk kρ= , where  the cellular rate 
constant, 115.9 10  mL/cell ssuspcellk
−= × ⋅ . 
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Figure A2.1  Schematic illustration of diffusion-reaction process for calcein-AM 
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APPENDIX 3 
DETAILED DERIVATION OF THE ANALYSIS OF FLUORESCENCE 
MEASURE AFTER MICROFLUIDIC ILLUMINATION (FAMI) 
 
 Suppose that instantaneous microfluidic illumination of a fluorescent dye 
occurs at t = 0 (Fig. 3.6A).  Then, we can allow for only diffusion of the dye into the 
bulk of hydrogels, experimentally by stopping the delivery of the dye via 
microchannels.  Concentration of the dye in the gel is a function of position (x, y, z) 
and time (t); that is, ( ), , ,c c x y z t= .  Diffusion of the dye in the gel is governed by 
 
 2c D c
t
∂
= ∇
∂
, (A3.1) 
 where D [m2/s] is diffusivity.  We assume that concentration of the dye is linearly 
proportional to fluorescence intensity; it is necessary to confirm the linearity prior to 
FAMI.  We also assume that observed fluorescence intensity (I) for each image is 
integrated intensity along x-direction which is the thickness of a microfluidic gel.  In 
other words, ( ), ,I I y z t= . 
 The observed fluorescence intensity is averaged along z-axis assuming that 
there is no variation of concentration of the dye in z-direction.  This requires the 
operation of microfluidic gels with Peclet number as stated in Chapter 3.  z-averaged 
fluorescence intensity can be defined as 
 
 ( ) ( )
0
1, , ,
L
I y t I y z t dz
L
≡ ∫ . (A3.2) 
From the governing equation (Eq. A3.1) and assumptions above, 
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 with an instantaneous point source (as illustrated in Fig. 3.6A), 
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 (A3.4) 
An analytical solution to Eq. A3.3 is the transient 1-D Green’s function: 
 
 ( )
21, exp
42
yG y t
DtDtπ
 
= − 
 
 (A3.5) 
To find a real solution with a spatially continuous source, method of convolution can 
be used: 
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Then, perform continuous Fourier transform to convert ( ),I y t  to ( ),I k t  where k is 
spatial frequency: 
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 where 1I  is defined as 
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By letting ( )'' 2 'y y ikDt y≡ + −  and ''dy dy= , 
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 where 
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Then, the transformed intensity, ( ),I k t  becomes 
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 where ( )',A y t  is 
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Therefore, the transformed intensity, ( ),I k t  is 
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The transformed intensity at a characteristic spatial frequency, 0 2 / ck π λ≡ , 
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2
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Fourier transformed values are often complex numbers.  Typically, absolute values 
can be used: 
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By taking natural log in Eq. A3.15, 
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Therefore, diffusivity, D can be estimated from a plot of time vs. magnitude of Fourier 
transformed peak at the characteristic spatial frequency: 
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APPENDIX 4 
SPATIALLY RESOLVED DELIVERY OF NON-REACTIVE SOLUTES VIA 
EMBEDDED MICROFLUIDIC NETWORKS 
 
 An acellular microfluidic scaffold was used to deliver a series of small 
molecules via the embedded microchannels in the two independent networks (Fig. 
2.1Dii): 1) the pH-adjusted buffer without fluorescent dye, 2) fluorescein solution (5 
μM in buffer), and 3) rhodamine B solution (5 μM in buffer) were delivered through 
the networks at a flow rate of 50 μL/min. 
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Figure A4.1 Spatially resolved delivery of non-reactive solutes via embedded 
microfluidic networks.  Fluorescence micrographs of two-network microfluidic 
scaffold (acellular) after A. 2 hr-delivery of the pH-adjusted buffer through network 1 
and 5 μM rhodamine B, dissolved in the pH-adjusted buffer, through network 2.  B. 2 
hr-delivery of 5 μM fluorescein, dissolved in the pH adjusted buffer, through network 
1 and rhodamine B through network 2. C. 2 hr-delivery of fluorescein through 
network 1 and the pH-adjusted buffer through network 2. 
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APPENDIX 5 
QUANTITATIVE COMPARISON BETWEEN EXPERIMENTAL AND 
COMPUTATIONAL RESULTS PRESENTED IN FIG. 3.15C 
 
 To quantitatively compare how well the computational curves fit with the 
experimental results, square correlation coefficient ( 2R ) and root mean square error 
(RMSE) are calculated at each cell seeding density: 
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 where N  is a number of data points at a cell seeding density.  We note that 
computational data points, corresponding to experimental ones, were selected at each 
cell seeding density so that experimentN  is equal to computationN . 
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APPENDIX 6 
SUPPLEMENTARY METHOD: SYNTHESIS OF PTTFPP-PS MICROPARTICLES 
 
 This appendix describes a protocol for the synthesis of PtTFPP-PS 
microparticles via dispersion polymerization (also refer to Chapter 4 and Fig. 4.3A).  
Suppose that we would like to make 10 g of 10 % [w/w] microparticle suspension, 
• Monomer: styrene = 10 % [w/w] = 1 g 
• Initiator: 2,2’-azobisisobutyronitrile (AIBN) = 0.5 % [w/w] = 0.05 g 
• Stabilizer: poly(vinyl pyrrolidone) (PVP) = 4.45 % [w/w] = 0.445 g 
• Solvent: 90 % [v/v] ethanol = 10 g - styrene - AIBN - PVP = 8.505 g 
o Ethanol = 8.505 × 0.9 = 7.6545 g 
o DI water = 8.505 × 0.1 = 0.8505 g 
• Oxygen-sensitive phosphor: Platinum(II)-5,10,15,20-tetrakis-(2,3,4,5,6-
pentafluorphenyl)-porphyrin (PtTFPP) = 1 % [w/w] = 0.1 g 
 
Dispersion polymerization 
1. Prepare two separate mixtures in two 20 mL-glass vials 
• Mixture 1 (vial 1): EtOH, DI water, and PVP 
• Mixture 2 (vial 2): Styrene, AIBN, and PtTFPP 
2. Stir the mixtures for 1.5 hr 
3. In the mean time, heat a silicone oil bath to 70 °C 
4. Pour the mixture 2 into the mixture 1 
5. (Optional) Apply N2 (g) to the reaction vial to allow for the exchange of the 
gas atmosphere for N2 (g) 
• Radicals from oxygen can potentially initiate the polymerization 
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• We want only AIBN to initiate the polymerization because the 
concentration of AIBN controls the size of microparticles 
• Ideally, bubble N2 (g) directly into the reaction vial (also see 
Appendices 7 and 8) 
6. Seal the vial with parafilm 
7. Clamp the vial to a ring stand so as to suspend it in the oil bath 
8. Stir the oil bath at 60 rpm 
9. Allow the dispersion polymerization for 24 hr at 70 °C 
 
Post-processes after the synthesis 
1. Remove the vial from the oil bath and allow it to cool down to room 
temperature 
2. While cooling, prepare 10 % [v/v] ethanol 
3. After cooling, centrifuge the polymerization product for 3 min at 3000 rpm 
4. Remove the supernatant 
5. Add approximately 20 mL of 10 % [v/v] ethanol to the pellet 
6. Re-suspend the pellet in 10 % [v/v] ethanol 
7. Centrifuge the suspension for 3 min at 3000 rpm 
8. Repeat steps 4-7 until the supernatant is clear (~ 4 times) 
9. (Optional) Remove the final supernatant 
10. (Optional) Allow the pellet (PtTFPP-PS microparticles) to dry overnight 
 
 Refer to more references that describe aspects of this synthesis1-4. 
  
 175 
REFERENCES 
 
1. Amao, Y. et al., Oxygen sensing based on lifetime of photoexcited triplet state 
of platinum porphyrin-polystyrene film using time-resolved spectroscopy. J. 
Porphyr. Phthalocyanines 4 (3), 292-299 (2000). 
2. Im, S.H. et al., Synthesis of polystyrene beads loaded with dual luminophors 
for self-referenced oxygen sensing. Talanta 67 (3), 492-497 (2005). 
3. Kimura, F. et al., Dual luminophore polystyrene microspheres for pressure-
sensitive luminescent imaging. Meas. Sci. Technol. 17, 1254-1260 (2005). 
4. Lee, S.K. & Okura, I., Photostable optical oxygen sensing material: Platinum 
tetrakis(pentafluorophenyl)porphyrin immobilized in polystyrene. Anal. 
Commun. 34 (6), 185-188 (1997). 
 
 176 
APPENDIX 7 
SUPPLEMENTARY METHOD: SYNTHESIS OF RU-PEG-PUAN 
NANOPARTICLES 
 
 This appendix describes a protocol for the synthesis of Ru-PEG-PUAN 
nanoparticles via emulsion polymerization (also refer to Chapter 4 and Fig. 4.3B).  
Suppose that we would like to make 10 g of 10 % [w/w] nanoparticle suspension, 
• Monomer: urethane acrylate nonionomer (UAN)1-2 = 10 % [w/w] = 1 g 
• Initiator: potassium persulfate (KPS) = 0.2 % [w/w] = 0.02 g 
• Solvent: DI water = 9 g 
• Oxygen-sensitive phosphor: [Ru(dmb-PEG)2(pyr-bpy)]Cl2 (Ru-PEG; MW 
1150.3301) = 0.052 % [w/w] = 5.2 mg (4.5 µmol) 
 
Emulsion polymerization 
1. Mix 1 g of UAN with ~3 mL of 1.5 mM Ru-PEG dissolved in methylene 
chloride (MC) 
2. Vortex several times to make sure that both Ru-PEG and UAN are 
homogeneously dissolved 
3. Allow MC to evaporate 
4. Dissolve the solid mixture of Ru-PEG and UAN in 9 mL of KPS-dissolved in 
DI water (2 mg/mL) (Fig. A7.1A) 
• Strongly agitated for ~30 min 
• Magnetic stir bar 
5. Transfer Ru-PEG-UAN-KPS-dissolved in DI water to a 50 mL flask with the 
magnetic stir bar (Fig. A7.1B) 
• Submerge the flask in a silicone oil bath 
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i. Make sure to submerge just the reaction volume 
• Bubble N2 (g) directly into the solution 
6. Agitate the flask at 650 rpm 
7. Increase temperature to 65 ºC 
8. Stop applying N2 (g) after ~2 hr-purging 
9. Allow emulsion polymerization for another 3 hr 
10. Stop polymerization by turning off the hot plate 
11. Transfer UAN nanoparticle-suspended water to a 30 mL-conical tube (Fig. 
A7.1C) 
12. Store the tube at room temperature in the dark 
 
 Refer to more references that describe aspects of this synthesis1-2. 
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Figure A7.1 Synthesis of Ru-PEG-PUAN nanoparticles.  A. Ru-PEG-partitioned 
UAN in 9 mL of KPS-dissolved in DI water.  B. The reaction flask with bubbling N2 
(g).  C. Synthesized Ru-PEG-PUAN nanoparticles suspended in water. 
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APPENDIX 8 
SUPPLEMENTARY METHOD: SYNTHESIS OF PtTFPP-PUAN 
NANOPARTICLES 
 
 This appendix describes a protocol for the synthesis of PtTFPP-PUAN 
nanoparticles via emulsion polymerization (also refer to Chapter 4).  Suppose that we 
would like to make 9 g of 10 % [w/w] nanoparticle suspension, 
• Monomer: urethane acrylate nonionomer (UAN) = 10 % [w/w] = 0.9 g 
• Initiator: potassium persulfate (KPS) = 0.2 % [w/w] = 0.018 g 
• Solvent: DI water = 8.1 g 
• Oxygen-sensitive phosphor: Platinum(II)-5,10,15,20-tetrakis-(2,3,4,5,6-
pentafluorphenyl)-porphyrin (PtTFPP; MW 1168.62) = 0.044 % [w/w] = 4 mg 
(3.4 µmol) 
 
Emulsion polymerization 
1. Dissolve 0.9 g of UAN in ~4 mL of methylene chloride (MC) 
2. Add ~80 µL of ~43 mM PtTFPP in MC 
3. Vortex several times to make sure that both PtTFPP and UAN are 
homogeneously dissolved (Fig. A8.1A) 
4. Allow MC to evaporate for ~2 days (Fig. A8.1B) 
5. Dissolve the solid mixture of PtTFPP and UAN in 8.1 mL of KPS-dissolved in 
DI water (2 mg/mL) 
• Strongly agitated for ~30 min 
• Magnetic stir bar 
6. Transfer PtTFPP-UAN-KPS-dissolved in DI water to a 50 mL flask with the 
magnetic stir bar (Fig. A8.1C) 
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• Submerge the flask in a silicone oil bath 
i. Make sure to submerge just the reaction volume 
• Bubble N2 (g) directly into the solution 
7. Agitate the flask at 650 rpm 
8. Increase temperature to 65 ºC 
9. Stop applying N2 (g) after ~2 hr-purging (Fig. A8.1D) 
10. Allow emulsion polymerization for another 3 hr 
11. Stop polymerization by turning off the hot plate 
12. Transfer UAN nanoparticle-suspended water to a 30 mL-conical tube (Fig. 
A8.1E) 
13. Store the tube at room temperature in the dark 
 
 Refer to the references listed in Appendix 7. 
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Figure A8.1 Synthesis of PtTFPP-PUAN nanoparticles.  A. PtTFPP and UAN 
dissolved in MC.  B. Ru-PEG-partitioned UAN.  C. The reaction flask with bubbling 
N2 (g).  D. The reation flask immediately after stopping N2-bubbling during the 
polymerization.  E. Synthesized PtTFPP-PUAN nanoparticles suspended in water. 
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APPENDIX 9 
COMPUTATIONAL AND ANALYTICAL APPROACHES TO MODEL 
BIOMINERALIZATION IN HYDROGELS 
 
I. Introduction 
 Calcium phosphate (CP) is a major component of bone and teeth1-2 and exists 
as a biogenic crystalline phase, hydroxyapatite (HA; Ca10(PO4)6OH2)2-3 in vivo.  The 
formation of HA, via a process of biomineralization, is biologically regulated, leading 
to the creation of organic-inorganic composites (e.g., bone-cartilage interface; Fig. 
A9.1); a transition from compliant cartilage to biomineralized bone is made through an 
intermediate continuous region called calcified cartilage.  This transition region is 
known as the tidemark between bone and cartilage.  The osteochondral interface 
typically occurs over a sub-milimeter scale and has mechanical properties that bridge 
those of the two dissimilar tissues.  It has been proposed that in vivo concentration 
gradients of inhibitors and promoters are involved in regulating the formation of the 
bone mineral, HA4-7.  Such gradients of biomacromolecules may establish the location 
of the tidemark and contribute to the successful integration of cartilage with bone.  For 
example, ariticular chondrocytes are known to synthesize pyrophosphate (PPi), which 
is a soluble and potent inhibitor of the HA formation7-9.  If the balance of interactions 
between the biomacromolecules and tissue matrices is broken under certain 
pathological conditions, abnormal biomineralization can occur and cause detrimental 
effects in tissues and organs6-7.  Therefore, it is important to study the 
biomineralization to identify matrix molecules involved and elucidate their roles.  
Improved understandings would also lead to success in designing new organic-
inorganic composite materials that could be used for tissue engineering and 
therapeutic purposes.  
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Figure A9.1 Histological section of bone-cartilage interface.  Image was obtained 
from http://faculty.une.edu/com/abell/histo/histolab3.htm. 
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 In understanding the mineralization process of HA, in vitro hydrogel 
precipitation methods, used for the past decades for the growth of large crystals10, 
have been applied to elucidate the roles of biomacromolecules11.  Such in vitro 
hydrogel precipitation methods in the absence of cells aid to characterize the chemical 
process in a more controlled manner, compared with in vivo studies.  In addition, the 
hydrogel precipitation methods have advantages that solution precipitation methods do 
not provide: 1) small amounts of biomolecules are required to reduce the volume of 
precipitation, and 2) diffusion-reaction of molecules and ions in gels allows the 
recapitulation of physiological environment.  Silverman and Boskey introduced the 
double-diffusion system (DDS), where calcium ions are delivered from one end and 
phosphate ions from the other, for the purposes described above11 (also see Fig. A9.2). 
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Figure A9.2 Schematic diagram of the dynamic hydroxyapatite formation system 
(the double-diffusion system (DDS)).  Image was obtained from Silverman, L. & 
Boskey, A.L., Diffusion systems for evaluation of biomineralization. Calcif. Tissue Int. 
75 (6), 494-501 (2004). 
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 Along with experimental observations, it would be also valuable to model the 
formation of HA (i.e., precipitation of calcium phosphate) in the DDS because models 
can be applied in a predictive role.  Using the models as our guide, we could predict: 1) 
when a precipitation event will occur, 2) where it will be within a hydrogel, and 3) the 
expected composition of the mineralized band.  However, the formation of HA is 
believed to be mediated by the formation of intermediate CP precursors such as 
amorphous calcium phosphate (ACP), dicalcium phosphate dihydrate (DCPD), and 
octacalcium phosphate (OCP)2-3,12.  In addition, it is a complex multi-step process with 
seemingly high order kinetics (i.e., 9th order with respect to calcium, phosphate, and 
hydroxyl ions) where supersaturation, nucleation, and crystal growth are involved12-14.  
The global reaction for the crystallization of HA in aqueous environment is given by 
 
 2 34 5 4 35Ca 3PO OH Ca (PO ) (OH)
+ − −+ + →  (A9.1) 
Despite a large number of both experimental and theoretical studies aimed to decipher 
details about the mechanisms and kinetics of the formation of HA12-17, most studies 
are based on the solution precipitation methods.  From the perspective of mass 
transport, these studies have a fundamental difference; in the solution precipitation 
methods, reacting ions are convectively well-stirred whereas, the DDS is a 
continuously fed unstirred reactor (CFUR) that results in the creation of spatially 
distinct regions (i.e., regions for the free diffusion of the ions and a region for the fast 
crystal formation).  This complicated nature of the formation of HA and the lack of 
necessary information (e.g., interfacial tension between HA and a gel matrix) make it 
difficult to model the system.  Furthermore, although a supersaturation threshold can 
be identified experimentally (i.e., critical concentrations of calcium and phosphate 
ions at a given position and time) and has been widely used to predict the formation of 
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HA for decades18, it has not led to the identification of a specific reaction mechanism 
in the DDS. 
 In order to generate predictions of the dynamics and mass transport of the 
system, our attempt to use continuum equations to simulate the concentration profiles 
confronted divergence limitations due to the complex nature of the high order kinetics 
of the formation of HA embedded in supersaturation (S); the continuum model is 
extremely unstable due to the high local variability of supersaturation, which is the 
driving force for crystal growth.  This model is based on the assumption that the rate-
limiting step follows the global stoichiometry that is high-ordered (Eq. A9.1).  We 
note that orders higher than three for an elementary reaction are extremely rare in 
homogeneous chemical reactions because the kinetic order of reactions is directly 
dependent on the probability of physical contact between the reacting species; the 
probability for quadrimolecular collisions to occur in a single step is negligibly small.  
Such high orders may become probable in heterogeneous reactions such as adsorption 
or crystal growth where multimolecular aggregates and multistep processes are 
involved.  A different approach that can be considered is to simulate all the dynamics 
(chemical and physical) by the implementation of Kinetic Monte Carlo (KMC) 
method.  Along with Molecular Dynamics (MD), this approach has been widely used 
to understand crystal growth phenomena on a molecular level, by treating the growth 
process as a stochastic and probabilistic description19-20. 
 In this appendix, we report a computational model that presents an alternative 
solution to the limitations.  A multiscale computational modeling approach, by 
hybridizing KMC with finite difference (FD), offers the advantage of separating the 
diffusion time scale (treating it as a bulk property of the system) from the reaction 
time scales of nucleation and growth.  In addition, the discretization of the reaction 
tube in the DDS (also see Fig. A9.5A) enables the evaluation of local dynamics.  This 
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technique allows modeling the formation of HA under the assumption of 
stoichiometric mechanisms of the crystallization.  Then, we present an analytical 
approach to model a general diffusion-limited mA + nB → C (inert) type reaction in 
the DDS.  Such diffusion-limited reactions include many physical, chemical, and 
biochemical reactions, including precipitation and crystal formation.  We focus on 
finding the location of a confined reaction layer (i.e., the depletion sink) and its 
characteristics.  We also present our effort to model the inhibition of the HA formation 
(i.e., the formation of calcium pyrophosphate (CPP)) in the DDS (also see Fig. A9.3B), 
using the finite element method (FEM).  It is also a relatively simple diffusion-limited 
reaction compared with the formation of HA, and serves as a basis not only to validate 
our analytical model but also to extract detailed kinetic information for further 
investigation of the crystal formation (e.g., the width of crystal bands).  We will then 
conclude with our current assessment of the computational models as predictive tools 
and future directions towards exploiting the biomineralization processes. 
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Figure A9.3 Schematic representation of double-diffusion system.  A. The 
formation of hydroxyapatite (HA).  B. The formation of calcium pyrophosphate (CPP).  
The pink shadings represent the concentration of calcium ions.  The blue shading 
represents the concentration of phosphate ions.  The green shading represents the 
concentration of pyrophosphate ions. 
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Formation of HA 
 The global reaction for the crystallization of HA in aqueous environment is 
given by 
 
 2 34 5 4 35Ca 3PO OH Ca (PO ) (OH)
+ − −+ + →  (A9.2) 
However, the crystallization process is known to occur by two distinct steps: 
nucleation and growth (Fig. A9.4). 
 
A. Nucleation 
 The model for nucleation rate considered is based on the classical 
heterogeneous nucleation: 
 
 ( )
3 2
n 3 3 2
( )' exp
ln( )
I
B
v fR K P
k T S
βγ θ 
= − 
 
 (A9.3) 
β is a geometrical factor and in our model it has a value of 16π/3 representing a 
spherical nucleus.  Iγ  is the interfacial tension between the calcium phosphate and the 
solution and has a value of 104 mJ/m2.  v  is the molecular volume of a HA unit 
determined by its crystal structure and has a value of 263.24 Å3.  ( )f θ  is the contact 
angle function given by the classical theory of heterogeneous nucleation21, and it has 
values from 0 to 1.  The contact angle function can be estimated based on the shape of 
HA on a substrate surface (e.g., gelatin or agarose).  An angle of 0° corresponds to a 
value of the contact angle function of 0, while and angle of 180° corresponds to a 
value of 1 and represents homogeneous nucleation.  We have chosen the contact angle 
function to have a value of 1/2 since its variation does not affect significantly the 
nucleation rate.  Bk  is Boltzmann’s constant and T is the solution temperature (taken 
as ambient).  K’ is a constant that was determined from experiments and has a value of 
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1.364x1028 L-1s-1.  The parameters described above are based on a theoretical study of 
calcium phosphate precipitation in simulated body fluid, a solution with calcium and 
phosphate ions, and a physiological pH value (i.e. pH 7.4)13.  Supersaturation of HA, 
SHA is defined as 
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=  (A9.4) 
 where a represents activity of each ion and Ksp (2.35×10-59) is the solubility product 
for HA crystal.  The activities are defined as the product of the molar fraction and the 
activity coefficient for each ion.  The activity coefficients (γ ) for each ion can be 
obtained from the modified Debye-Hückel equation: 
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 (A9.5) 
 where A is the Debye-Hückel constant dependent on temperature (A = 0.5211 at 37°), 
zi is the charge number of the ion and I is the total ionic strength of the solution and is 
defined as 
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 where ci is the molar concentration of each ion unit. OH- concentration is always 
fixed by unchanging pH.  The nucleation rate is also proportional to the probability 
that the appropriate ion units of calcium phosphate meet to compose a nucleus in 
solution.  This probability is defined as 
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 (A9.7) 
 
B. Crystal growth 
 The model for crystal growth rate is proportional to the relative solution 
supersaturation, σ, with respect to HA, defined as 
 cg
n
cgR k σ=  (A9.8) 
 where n is the apparent order of the crystallization process and cgk  is the rate constant.  
Both if these values are determined by fitting experimental data of crystal growth (n = 
1.87 and cgk  = 2.59201x10
22 m-2s-1)14.  The relative supersaturation is defined as 
 1/9 1Sσ = −  (A9.9) 
 where S is the supersaturation as in Eq. A9.3. 
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Figure A9.4 Schematic illustration of the formation of HA.  A. Nucleation.  B. 
Crystal growth. 
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C. Implementation of multiscale computational modeling: finite difference (FD)-
Kinetic Monte Carlo (KMC) 
 Multiscale computational modeling approaches can be used for 1) metal 
electrodepositing on a surface22 or 2) a fluid phase in bulk and catalytic surface 
reactions within catalytic flow reactors23, where macroscopic modeling at a continuum 
level does not fully capture near-surface chemistry and detailed reaction mechanisms.  
Such multiscale modeling approaches are carried out by coupling continuum-level 
modeling with molecular level simulations. 
 In order to describe both the diffusion of calcium and phosphate ions in the 
bulk of the DDS, and the crystallization process of HA, we have developed similar 
multiscale modeling by coupling finite difference (FD) and Kinetic Monte Carlo 
(KMC).  Then, the diffusion of the ions is modeled on a macro-scale while the 
nucleation and crystal growth are modeled on a micro-scale.  The diffusion equation 
 
 
2
2
i i
i
c cD
t x
∂ ∂
=
∂ ∂
 (A9.10) 
has been solved for each ion in the system using the Crank-Nicholson implicit method, 
dividing the double-diffusion system in several volume elements of length ∆x (Fig. 
A9.5).  The transient 1-D diffusion equation becomes 
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 (A9.11) 
 where m is the element and і is the ion species.  Since there is no reaction (due to 
decoupling), the R term is zero for all positions except for the first and last elements 
where R corresponds to the boundary conditions (constant boundary concentrations).  
Since equation A9.10 is dependent on the concentrations at the m element, m-1 
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element, and m+1 element, we obtain a system of linear equations that can be solved 
using matrices: 
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 (A9.12) 
The result is a matrix of the variation of concentration with respect to time for each 
single element, so we can predict the concentration profile of the microchannel after a 
time Δt. 
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Figure A9.5 Schematic representation of the multiscale modeling, FD-KMC, 
showing macro to micro-scale transition.  A. FD in macroscale.  B. KMC in 
microscale. 
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Figure A9.5 depicts how a single volume element is considered as a perfect Stirred 
Tank Reactor (STR), yet this element is still too large to perform KMC.  Therefore, it 
is divided into many sub-volumes of the same length ( x∆ ); their radus is small 
enough that a concentration of 0.1 mol/L (reference concentration) corresponds to 
only 500 ions.  This additional step is not preferable but necessary to lower 
computational load.  Ideally, KMC could capture stochastic concentration fluctuations 
of ions within the entire single volume element, leading to increase of sampling 
species.  In addition, radial symmetry is assumed within each element; the radial flux 
of any ion is the same towards and out of a sub-volume, such that only axial diffusion 
should be considered.  The characteristic time of such diffusion (for any single ion) 
has been calculated from Einstein’s result for Brownian motion.  Then, we can 
consider 6 pseudo-reactions for the KMC approach: 
 
 ( ) ( )2Ca2 2
in out
Ca Cak ++ +→  (A9.13) 
 ( ) ( )3PO43 34 4in outPO PO
k −− −→  (A9.14) 
 ( ) ( )Cl
in out
Cl Clk −− −→  (A9.15) 
 ( ) ( )NH44 4in outNH NH
k ++ +→  (A9.16) 
 2 3 *4Ca PO OH Nn
kn m q+ − −+ + →  (A9.17) 
 2 34Ca PO OH HAcg
kn m q+ − −′ ′ ′+ + →  (A9.18) 
If we consider, for example, the double-diffusion system divided in 15 elements, there 
are a total of 60 pseudo-reactions competing on the KMC and one is chosen randomly, 
based on their propensity functions (Guillespie’s method).  A reaction time is sampled 
using KMC criteria.  Because HA cannot precipitate until Ca+2 and PO4-3 encounter 
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each other, the algorithm only takes diffusion into account until Ca+2 and PO4-3 
concentrations, at any single point, reach a value that makes nucleation feasible.  Once 
they encounter, the algorithm makes a scale change in order to evaluate the probability 
of nucleation or growth following the KMC criteria. 
 Even though KMC is useful to deal with nucleation and growth pseudo-
reactions, it is not practical to model diffusion using KMC, because of the size of the 
double-diffusion system.  Therefore, we have linked KMC with FD when a diffusion 
pseudo-reaction is chosen based on randomly fluctuating probabilities; in other words, 
1) no nucleation or growth occurs during the KMC sampled time that also randomly 
fluctuates, and 2) all the ions diffuse during the time interval based on the macroscopic 
diffusion with the Crank-Nicholson implicit method.  On the other hand, if a 
nucleation or growth pseudo-reaction is chosen as a single event, no ion diffuses while 
the pseudo-reaction occurs. 
 The complexity of the model can be increased by adding a nucleation inhibitor 
to the system, which would occur if cells (chondrocytes) are seeded at a specific 
position of the double-diffusion system and start producing inhibitors such as 
pyrophosphate.  As an example, our algorithm incorporates an inhibition factor (I*) as 
a calcium ion sink: 
 
 * 2 *I  Ca CaI++ →  (A9.19) 
 The MATLAB code for the FD-KMC is appended in Appendix 10. 
 
D. Results and discussion 
 With input parameters summarized in Table A9.1, we have simulated the 
formation of HA, using the FD-KMC.  Calcium and phosphate ions were allowed to 
diffuse from the two ends of the DDS and to form HA.  The location of the first crystal 
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that is formed determines a “sink” for both, calcium and phosphate ions.  However, we 
note that this does not imply that crystallization does not take place in neighboring 
locations.  Figure A9.6C and D shows that HA forms at slightly away from the center 
towards the phosphate side and that the size of HA crystal is ~ 1.2 nm.  The crystal 
radius was estimated with 
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 (A9.20) 
 where HAn  is number of HA crystal.  Although we have not directly compared the 
crystal size estimated from the FD-KMC with experimental measurements, the plots 
allow for the qualitative comparison of the location of HA.  The computational result 
shows reasonable agreement with experimental observations (Fig. A9A and B).  Note 
that the simulation was run with experimentally measured diffusivity of calcium (i.e., 
10 26 10  m /s−× ) and phosphate (i.e., 10 23.9 10  m /s−× ) ions within gelatin.  Yet, HA 
forms at about the center of gelatin (Fig. A9.6A).  Interestingly, in both experiment 
and simulation, the formation of HA is slightly shifted towards the phosphate side in 
agarose (Fig. A9.6B).  These experimental observations suggest that crystal-matrix 
interactions may be involved in the formation of HA.  In addition, the disagreement 
between the computational result and the experimental observation in gelatin is likely 
due to a possibility that input parameters such as interfacial surface tension, rates of 
nucleation and crystal growth could be different in gel matrices.  The quoted values 
are reported ones that have been measured or estimated in solution. 
 In an effort to predict the effect of an inhibitor, we have placed a steady source 
of a calcium chelator at element 6 and allowed it to diffuse along the DDS.  As 
expected, the presence of an inhibitor displaces the “sink” location, for both calcium 
and phosphate ions (Fig. A9.6E).  The location of the inhibitor determines where the 
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first and largest crystal forms.  This can be explained by the fact that nucleation rates 
are orders of magnitude smaller than growth rates.  The outcome of this situation is 
that once a nucleus is formed, crystal growth takes place very rapidly and drives the 
consumption of reacting ions.  Figure A9.6D and F indicate that the size of HA crystal 
formed in the presence with an inhibitor is smaller than that without the inhibitor.  
This is because the crystallization reaction requires more phosphate ions than calcium 
for it to begin while the inhibitor continuously chelates calcium ions.  We have 
observed that locating the inhibitor (i.e. calcium chelator) at the phosphate side hardly 
affected the formation of HA (data not shown).  These computational results suggest 
that once specific roles of inhibitors are identified, we could control the formation of 
HA in a spatially resolved manner. 
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Table A9.1 Input parameters used in the FD-KMC 
 
Calcium boundary concentration 20,Cac +  0.1 mol/L 
Phosphate boundary condition 3
40,PO
c −  0.1 mol/L 
Hydroxyl ion concentration 
OH
c −  72.5 10−×  mol/L 
Diffusivity of calcium ion 2CaD +  
106 10−× 2m /s  
Diffusivity of phosphate ion 3
4PO
D −  103.9 10−× 2m /s  
Diffusivity of chloride ion24 
Cl
D −  92 10−× 2m /s  
Diffusivity of almonium ion24 
4NH
D +  91.9 10−× 2m /s  
Diffusivity of inhibitor ID  102 10−× 2m /s  
Rate of inhibitor production IR  75 10−× mol/L s⋅  
Rate constant for nucleation13 K’ 281.36 10−× 1/L s⋅  
Interfacial surface tension 
between HA and water13 
Iγ  0.104 
2J/m  
Molecular volume of HA13 v  282.63 10−× 3m /mol  
Contact angle function13 f 0.5 
Solubility product of HA13 ,sp HAK  592.35 10−×  
Rate constant for crystal growth14 cgk  222.59 10× 21/m s⋅  
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Figure A9.6 Formation of HA in the DDS: experimental observations and FD-
KMC results. A and B. Optical micrographs showing the formation of HA within 
gelatin (A) and agarose (B) on day 5.  C. Spatial distribution of ions in the absence of 
an inhibitor on day 5.  D. Spatial distribution of HA and its crystal size without the 
inhibitor.  E. Spatial distribution of ions in the presence of an inhibitor (a Ca2+ chelator 
produced at element 6) on day 5.  F. Spatial distribution of HA and its crystal size with 
the inhibitor. 
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Formation of CPP 
 Articular chondrocytes synthesize inorganic pyrophosphate to prevent cartilage 
from being mineralized.  However, excess production of pyrophosphate can also cause 
pathological chondrocalcinosis, the deposition of too much CPP in cartilage6,25.  
Compared with HA, little is known about the mechanisms of CPP26-27.  The global 
reaction for the formation of CPP in aqueous environment is given by 
 
 ( )CPP2 42 7 2 2 72Ca P O Ca P Ok+ −+ →  (A9.21) 
Figure A9.7 shows the formation of CPP in gelatin, observed on day 7, by allowing 
for the diffusion of calcium and pyrophosphate ions in the DDS.  The variation of 
calcium boundary conditions (i.e., 20,Cac + = 50, 100, and 400 mM), results in the 
formation of CPP at different locations: ~0.54L (Fig. A9.7A), ~0.5L (Fig. A9.7B), and 
0.65L (Fig. A9.7C).  Although the formation of CPP is accompanied by nucleation 
and crystal growth just as the formation of HA is, we focus on modeling the 
phenomenological precipitation event as shown in Eq. A9.21 mainly because similar 
complexity arises from the lack of kinetic information about the formation of CPP 
crystal and other forms of CPP such as amorphous or hydrated forms. 
 The ions and CPP within the DDS are governed by a series of diffusion-
reactions: 
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∂ ∂
= −
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 (A9.22) 
 CPP
c R
t
∂
=
∂
 (A9.23) 
 where ic  is concentration of calcium or pyrophosphate ion, iD  is diffusivity of the 
ions, iν  is stoichiometric coefficient of the ions, and R is the macroscopic reaction rate 
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that is unknown but could be hypothetically expressed as the product of the 
concentration of calcium and pyrophosphate ions with effective reaction orders.  We 
assume that produced CPP is immobile within a hydrogel.  In the following sections, 
we present a simple analytical analysis and computational models using the finite 
element method (FEM) to predict primarily the location of CPP formed in the DDS. 
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Figure A9.7 Formation of CPP in the DDS: experimental observations.  A-C. 
Optical micrographs showing the formation of CPP within gelatin on day 7.  The DDS 
(6 cm long) was fed with 100 mM of pyrophosphate (PPi; right) and various 
concentrations of calcium (Ca): 50 (A), 100 (B), and 400 (C) mM. 
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A. Analyti4cal approach to model diffusion-limited reaction 
 The very small solubility product of HA (2.35×10-59)13 and CPP (4.47×10-19)28 
reveals that the crystal formation occurs instantaneously when ions encounter (i.e., 
extremely fast reaction).  Unlike solution-based systems, where reacting ions are 
convectively well-stirred, the DDS (Fig. A9.2 and A9.3) is a continuously fed 
unstirred reactor (CFUR) that allows for a reaction between the two counter-diffusing 
ions within hydrogels.  If Damköhler number (Da), the ratio of reaction rate to 
diffusion rate ( 20 /Da kc L D≡  for a 2nd order reaction), is large enough in the system, 
such rapid reaction (e.g., crystal formation) is not be reaction-limited but “diffusion-
limited”; diffusing species initially separated in space irreversibly form an inert 
product (e.g., solid phase crystal) on contact, leading to the creation of a depletion 
zone or sink.  Diffusion-limited reactions are readily found in many physical, chemical, 
and biochemical reactions such as catalysis29-31, diffusion-limited aggregation32, 
chemical vapor deposition33, gasification34, Liesgang pattern formation10,35, and 
Turning pattern formation36-37, including precipitation38 and crystal growth presented 
in this appendix.  In 1988, Gálfi and Rácz established a simplified analytical model of 
a diffusion-limited A + B → C type reaction in a geometry where initially separated 
reactants A and B counter-diffuse and form a product C, to investigate the long time 
behavior of the reaction zone (i.e., the distribution of the product C)39; their main 
results are 1) the center of the reaction zone scales with 1/2t , and 2) the width of the 
reaction zone is proportional to 1/6t .  Since then, many other studies have used 
analytical, computational, and experimental approaches to elucidate diffusion-limited 
reactions40-45.  Note that Koza reported a thorough study, providing generalizable 
analytical treatments in 199644.  This section describes a similar analytical approach, 
primarily focusing on finding the location of a confined reaction layer (i.e., the 
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depletion sink; at position, Rx ) and its characteristics for a general diffusion-limited 
mA + nB → C (inert) type reaction in the DDS. 
 For simplicity, we consider a steady-state case where the concentration of both 
reactants A and B linearly decreases to zero as schematically illustrated in Fig. A9.8 
(solid lines).  In addition, we assume that the reactants are not accumulated at x = xR 
due to the infinitely rapid reaction (Fig. A9.8).  This quasi-steady-state assumption 
leads to 
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 with conditions below: 
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where R  is reaction rate that is unknown but may be expressed with an assumption 
that the reaction occurs with both reactants A and B involved in a single step: 
 
 A B
m nR kc c=  (A9.27) 
 where k  is rate constant and m and n are reaction orders (positive integers) with 
respect to A and B respectively.  We note that this rate law is a possible hypothesis.  
We also note that we will not consider any details about the rate constant in finding Rx .  
The flux of the reactants should satisfy the following condition: 
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 (A9.28) 
where AJ  and BJ  are fluxes of the reactants A and B respectively.  A0c  and B0c  are 
the boundary concentration of the reactants.  By rearranging Eq. A9.28, an equation 
for the location of the depletion sink, Rx  is obtained as 
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 (A9.29) 
Eq. A9.29 indicates that the location of the depletion sink, xR at steady-state is 
independent of the rate constant, k.  In addition, it can be used to control the reaction 
location by changing the feeding concentration of the reactants A and B (solid lines in 
Fig. A9.9).  This information could be potentially very useful in designing 
experimental systems.  Figure A9.9 also shows that xR varies with the ratio of the 
stoichiometric coefficients, m/n at a given set of boundary conditions.  Because the 
location of the depletion sink is where the product C is generated, experimentally 
measured xR (e.g., the location of formed CPP at steady-state) could aid to predict the 
ratio of the effective reaction orders with the assumption of A B
m nR kc c= .  Note that this 
feasibility can be valid only if a reaction occurs in a single step.  We also note that the 
green line in Fig. A9.9 (i.e., m/n = 2) corresponds to the analytical prediction of the 
sink location at steady-state for the formation of CPP; the reactants A and B represent 
calcium and pyrophosphate respectively and the product C represents CPP.  
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Figure A9.8 Schematic diagram of steady-state distributions of reactants A and B 
for diffusion-limited reaction in the DDS.  Solid lines (pink for A and blue for B) 
are the linearly decreasing concentration from the sources (boundaries at x = 0 and L) 
to the fast reaction zone at x = xR. 
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Figure A9.9 Non-dimensionalized location of the sink, xR/L at steady-state: 
analytical model.  The analytical model, Eq. A9.29 is plotted as a function of cA0/cB0 
with various m/n’s.  6 2A 6.5 10  cm /sD
−= ×  and 6 2B 3.16 10  cm /sD
−= × . 
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B. Finite element models of the CPP formation 
 We have also developed finite element models assess the effects of multiple 
variables in the DDS on the final outcome (e.g., steepness of the gradient, width of the 
precipitation band, etc.).  Then, we have compared and contrasted the validity of 
modeling the formation of CPP as a computationally simpler 2nd order system versus 
a 3rd order system.  Much faster reaction rate compared with diffusion rate (i.e., high 
Da) allows for the implementation of the 2nd order while at the same time achieving 
the same mathematical end result and reducing the computational power required for 
the model.  A series of experiments as shown in Fig. A9.7 has been used to verify the 
effectiveness of the model to predict the results of systematically varying the reaction 
conditions.  We have also compared the computational models with the analytical 
model presented in the previous section.  Comparison between the calculations and the 
experiments also allows for the prediction of the rate constant, CPPk . 
 As stated above, the reaction rate for the formation of CPP, R (also see Eqs. 
A9.22 and A9.23) can be hypothetically expressed with 2nd or 3rd order reaction term 
defined as 
 
 Ca CPPPPi CPP Ca PPi
1
2
dc dcdcR k c c
dt dt dt
= − = − = ≡  (A9.30) 
 2Ca CPPPPi CPP Ca PPi
1
2
dc dcdcR k c c
dt dt dt
= − = − = ≡  (A9.31) 
Finite element models were computed using COMSOL Multiphysics (Comsol, Inc., 
Burlington, MA; also see Appendix 11). 
 Transient finite element models, run with Eqs. A9.22-23, A9.30-31, and input 
parameters summarized in Table A9.2, indicate that the reaction order (i.e., 2nd or 3rd 
order) does not result in differences in the location of produced CPP (red solid and 
dash lines, and green solid and dash lines in Fig. A9.10).  This lack of dependence 
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arises from the fact that both cases correspond to high Da ( 4 510 ~ 10 ), defined as 
2
CPP 0 / ik c L D  for the 2nd order reaction and 
2 2
CPP 0 / ik c L D  for the 3rd order reaction.  
Therefore, we can treat the formation of CPP as a diffusion-limited (still transient) 
process.  In addition, 2nd order is the simplest model that is compatible with the 
experiments (red circles in Fig. A9.10).  We note that a single value of 
5 3
CPP 3 10  m /mol sk
−= × ⋅  resulted in good agreement with the experimentally observed 
location of CPP; experimentally observed band positions are ~0.54L, ~0.5L, and 0.65L 
and computationally estimated band positions are 0.55L, 0.49L, and 0.67L for 
Ca0 PPi0/c c  = 0.5, 1, and 4 respectively (also see Fig. A9.7 and A9.10). 
 Compared with the analytical model obtained for steady-state (black solid line 
in Fig. A9.10), the transient finite element models indicate that the location of the sink, 
Rx  clearly varies over times.  At steady-state, Rx  is stationary, but inequality of fluxes 
of the counter-diffusing reactants at early times results in the temporal shift of Rx .  
Specifically, a larger flux of one of the reactants causes the motion of the sink towards 
a smaller flux.  Then, the sink location will eventually reach an asymptotically 
stationary state as the fluxes become same; for the computational models of the 
formation of CPP, the system reaches an asymptotic state after 10 days.  We note that 
increase of Da (i.e., increase of the rate constant CPPk ), leads to decrease of time over 
which the sink location, xR reaches an asymptotic state (data not shown).  We also note 
that Rx  increases over times when cCa0/cPPi0 > ~1.4 (Fig. A9.10 and A9.11A) and the 
opposite is true when cCa0/cPPi0 < ~1.4 (Fig. A9.10 and A9.11B).  In addition Rx  is 
almost immobile when cA0/cB0 ~1.4 (Fig. A9.10 and Fig. A9.11C). 
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Table A9.2 Input parameters used in the FEM 
 
Calcium boundary concentration Ca0c  0.05, 0.1, or 0.4 mol/L 
Phosphate boundary condition PPi0c  0.1 mol/L 
Diffusivity of calcium ion CaD  106.5 10−× 2m /s  
Diffusivity of phosphate ion PPiD  103.16 10−× 2m /s  
Rate constant for 2nd order kinetics 2ndCPPk  
53 10−× 3m /mol s⋅  
Rate constant for 3rd order kinetics 3rdCPPk  
53 10−× 6 2m /mol s⋅  
Length of the DDS L  6 cm 
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Figure A9.10 Non-dimensionalized location of the sink, xR/L: analytical model, 
finite element models, and experimental observations for the formation of CPP.  
Black lines represent the analytical model (Eq. A9.29) with m/n = 2 (solid) and 1 
(dash).  Red and green solid lines represent 2nd order finite element models with 
2nd 5
CPP 3 10k
−= × 3m /mol s⋅ .  Red and green dash lines represent 3rd order finite element 
models with 3rd 5 6 2CPP 3 10  m /mol sk
−= × ⋅ .  Red circles represent experimental 
observations as shown in Fig. A9.7. 
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Figure A9.11 Temporal evolution of the concentration of CPP calculated from 
transient finite element models.  A-C. Plots of the non-dimensionalized 
concentration of the product C at various time points for the 2nd order kinetics 
( A BR kc c= , k = 
53 10  −× 3m /mol s⋅ ): cCa0/cPPi0 = 2 (A), 0.5 (B), and 1.4 (C). 
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 Figure A9.12 shows the total concentration of calcium (Fig. A9.12A) and 
pyrophosphate ions (Fig. A9.12B) calculated as follows 
 
 Ca,total Ca CPP
PPi,total PPi CPP
2c c c
c c c
= +
= +
 (A9.32) 
The zones denoted by 1, 2, and 3 in Fig. A9.12 represent sections that were used to 
experimentally measure the concentration of the ions.  Comparison of the average 
concentration in the sections 1, 2, and 3 between the experiment and the 2nd order 
finite element model (Table A9.3), indicates that the computational model still has 
weakness in predicting actual distributions of the concentration of the ions in the 
section 3 compared with those in the sections 1 and 2.  This relatively poor agreement 
could result from two possibilities: 1) the width of the reaction layer (i.e., the 
production of CPP) in the experiment is significantly thinner than that calculated in the 
finite element model, and 2) the spatial resolution of the experimentally dissected 
sections is not high enough by the fact that the formation of CPP occurs at the 
interface between the section 2 and 3.  Future work would have to include the 
measurement of 1) diffusivity of pyrophosphate in gelatin gels and 2) the ion 
composition of CPP at various time points such that we can correlate the optical 
density of CPP with the concentration of the ions.  Testing of finite element models 
against experimental results for the formation of HA, has shown that the complex 
nature of the 9th order reaction is not yet achievable using a simplified 2nd order 
computation.  For the creation of this model we determine the rate constant as a fitting 
parameter, without any consideration to the true order of this reaction.  In an effort to 
find this value experimentally we could reduce the scale of the system (e.g., using 
microfluidics) to determine not only the rate constant but also the true reaction order 
of the system.  
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Figure A9.12 Total concentration of calcium and pyrophosphate ions in the DDS.  
A. Plot of non-dimensionalized calcium ions.  B. Non-dimensionalized pyrophosphate 
ions.  c0 = 100 mM.  “1”, “2”, and “3” denote section numbers. 
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Table A9.3 Comparison of average concentration of calcium and phosphate ions 
in sections 1, 2, and 3 between experiment and finite element model 
 
Section Experiment FEM 
 Ca [mM] PPi [mM] Ca [mM] PPi [mM] 
1 23.92 1.23 27.5 0.17 
2 54.97 28.5 55.9 29.4 
3 1.03 16.85 36.4 31.4 
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 Figure A9.13 shows the steady-state distribution of calcium for the 2nd order 
reaction.  At high Da (> 310 ), the concentration of calcium linearly decreases to zero 
towards the sink (x ~ 3 cm).  This trend is typical for diffusion-limited fast reactions.  
However, as Da decreases, the slow kinetics are reflected in the concentration profile; 
the concentration is not completely depleted at the sink location.  We note that when 
Da < 310 , the non-zero values beyond the reaction zone of calcium invalidate the 
assumptions of the analytical model; in other words, calcium encounters 
pyrophosphate beyond xR.  In those cases, the diffusion-reaction process is not 
diffusion-limited.  For Da ~ 010 , the reaction is very slow and the concentration 
profile at steady-state is linear, as expected for simple diffusion from a source to a sink. 
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Figure A9.13 Computationally calculated steady-state distributions of calcium in 
the DDS.  Plot of the non-dimensionalized concentration of clacium for the 2nd order 
kinetics ( A BR kc c= , 
5 33 10  m /mol sk −= × ⋅ ) with various Da, defined as 
2
Ca0 Ca/Da kL c D= .  
6 2
Ca 6.5 10  cm /sD
−= ×  and 6 2PPi 3.16 10  cm /sD
−= × . 
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 For diffusion-limited fast reactions, the justifiable quasi-steady-state 
approximation allows for the analytical estimation of the sink location with the 
reaction rate unknown.  Transient finite element analyses reveal that the sink location 
reaches an asymptotically stationary state over ~10 days for the case of Da ~ 104.  A 
seemingly missing aspect in this section is discussion about the width of the reaction 
layer.  Koza reported a generalized expression of the half width, w for diffusion-
limited mA + nB → C type reactions based on the scaling ansatz39-40,44: 
 
 1 1 1A B
m n m n m nw D D k J+ + − − −≡  (A9.33) 
The scaling ansatz, first proposed by Gálfi and Rácz, is a method to describe the long 
time behavior of diffusion-limited reactions within the reaction layer; it is based on an 
assumption that the half width of the reaction layer, w grows with time as tα  with α < 
1/239,44.  Note that this length scale is smaller than diffusion length scale for the 
reactants (i.e., ~D iD tλ ).  Eq. A9.33 implies that the width of the reaction layer 
depends on detailed information about the reaction rate such as the rate constant, k.  
Therefore, future work towards investing the transient nature of w, for example, by 
experimentally measuring the width of the reaction layer, may allow us to extract 
kinetic information of biomineralization processes. 
 
Conclusions and future work 
 We have successfully initiated a computational model for the formation of 
hydroxyapatite in the double-diffusion system.  Our multiscale FD-KMC model 
demonstrated the potential to model the high order crystallization process.  This 
technique could serve as a useful method to validate and predict experimental 
observations.  In addition, our algorithm is flexible enough to make modifications for 
the addition of an inhibitor or a promoter, and pre-existing nuclei sites.  Yet, the FD-
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KMC is seemingly less powerful largely due to its application to the formation of HA 
in the DDS that has not been fully understood; for example, input parameters have not 
measured specifically in our gel matrices.  We note that such measurement still 
remains a challenge.  Exploration of parameter space with this FD-KMC could aid the 
investigation of kinetic information of biomineralization processes. 
 We have presented an analytical approach to model a general diffusion-limited 
reaction in the DDS.  By identifying spatially distinct regions, we have derived an 
analytical expression to find the location of the reaction layer even without any 
information of the reaction rate.  Our analytical model shows that the location of the 
depletion zone is independent of the rate constant and a function of diffusivity, feeding 
concentration of reactants, and the order of the reaction in each species.  The 
analytical model also has the potential in designing future experiments because it can 
be used to control the location of the reaction.  We have utilized steady-state and 
transient finite element models to test the analytical model.  The finite element models 
reveal that the location of the reaction layer, in fact, shifts over time.  To further 
investigate the width of the reaction layer as well as its transient nature, detailed 
kinetic information such as the rate constant should be experimentally measured or 
computationally estimated.  Our analytical model could serve as a useful basis to 
elucidate biomineralization processes in the DDS. 
 We have also developed finite element models to assess the effective order of 
biomineralization processes in the DDS.  The location, width, and concentration 
profile of the precipitation bands are useful outcome parameters that can be also 
validated with experimental observations and measurements.  For this FEM, we used 
the formation of calcium pyrophosphate, a stoichiometrically 3rd order reaction, as a 
basis for creating a FEM that may be adapted to model the formation of the more 
complex hydroxyapatite, a 9th order reaction; however, we note that the formation of 
 224 
hydroxyapatite is believed to be a multistep process including nucleation and crystal 
growth, elucidating the rate limiting step is an outstanding challenge.  We have 
compared and contrasted the accuracy of modeling the formation of CPP as a 
computationally simpler 2nd order system versus a 3rd order system.  The diffusion-
limited fast reaction allows for the implementation of simpler kinetic orders while 
reducing the computational power required for the model.  The predictions are 
quantitatively similar to experimental observations.  In the current FEM model we 
designed, only the band position has been experimentally confirmed and the rate 
constant has been estimated.  Though the trends for band location, band width, and 
maximum concentration appear to be very similar for both 2nd and 3rd order reactions, 
the absolute values for both reactions show poor agreement with those observed 
experimentally.  Future work would have to include the measurement of 1) diffusivity 
of pyrophosphate in gelatin gels and 2) the ion composition of CPP at various time 
points such that we can correlate the optical density of CPP with the concentration of 
the ions.  Comparison of our current finite element models to experimental results for 
the formation of HA, have shown that the complex nature of the 9th order reaction is 
not yet achievable using a simplified 2nd order computation.  Current experimental 
double-diffusion system is limited in finding such kinetic information because it is 
inherently difficult to capture kinetics in the diffusion-limited reaction.  In an effort 
towards developing better predictive models, it would be worth developing an 
experimental system that allows the reduction of the system scale to determine not 
only the rate constant but also the true reaction order of the system.  For example, a 
millimeter-scale hydrogel enclosed between two microfluidic channels (i.e., 
microfluidic double-diffusion system; Fig. A9.13), could allow such investigation 
because steady-state is achievable in a short period of time with controlled input 
concentrations.  Specifically, significantly lower Da ( 2 0 /i iDa kL c D=  for 2nd order 
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kinetics) could be achieved by reducing the length of the DDS, L such that the 
formation of HA or CPP is not diffusion-limited anymore; in the case of CPP, L = 2 
mm and 0ic  = 25 mM lead to Da ~ 10
0, and the microfluidic DDS would reach steady-
state in 2 ~ 3 hr.  It would be also relatively simple to run multiple devices at a time on 
bench-top.  Furthermore, the microfluidic DDS might aid to elucidate the dynamic 
growth of crystals in situ with microscopy techniques.  From the theoretical 
perspective, it would be worthwhile to continue to study the Gálfi and Rácz problem 
that could lead to more both theoretically and experimentally strategic approaches to 
decipher the biomineralization processes. 
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Figure A9.14 Schematic illustration of microfluidic double-diffusion system. 
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APPENDIX 10 
MATLAB CODE FOR FD-KMC 
 
Below is the MATLAB code for the FD-KMC presented in Appendix 9. 
 
clear 
clc 
% Initial Conditions 
Ca_feed_conc=0.1; 
PO4_feed_conc=0.1; 
Cl_feed_conc=2*Ca_feed_conc; 
NH4_feed_conc=3*PO4_feed_conc; 
Total_length=0.06; 
Ca_feed_molecules=500;      %Determines the size of DV in micro-scale 
PO4_feed_molecules=round(Ca_feed_molecules*PO4_feed_conc/Ca_feed_conc); 
Temp=310; 
OH_conc=10^(-6.6); 
I_prod=5e-7;       % Inhibitor production (mol/(L s)) -- 1e-6 
% Difusivities (from CRC) 
DCa=6e-10; %[m^2/s] 
DPO4=3.9e-10; %[m^2/s] 
DCl=20.32e-10; 
DNH4=19.57e-10; 
DI=2e-10;           % Inhibitor diffusivity 
% Steps 
Dx=0.004; 
Dt=10; 
Number_xsteps=Total_length/Dx; 
I_source=round(0.025/Total_length*Number_xsteps);    % Point of Inhibitor production 
% Diffusion & homogeneous reaction Matrices 
Ca_conc=zeros(Number_xsteps,1); 
PO4_conc=zeros(Number_xsteps,1); 
Cl_conc=zeros(Number_xsteps,1); 
NH4_conc=zeros(Number_xsteps,1); 
I_conc=zeros(Number_xsteps,1); 
Ca_square_matrix=zeros(Number_xsteps,Number_xsteps); 
PO4_square_matrix=zeros(Number_xsteps,Number_xsteps); 
Cl_square_matrix=zeros(Number_xsteps,Number_xsteps); 
NH4_square_matrix=zeros(Number_xsteps,Number_xsteps); 
I_square_matrix=zeros(Number_xsteps,Number_xsteps); 
Ca_boundary_matrix=zeros(Number_xsteps,1); 
PO4_boundary_matrix=zeros(Number_xsteps,1); 
Cl_boundary_matrix=zeros(Number_xsteps,1); 
NH4_boundary_matrix=zeros(Number_xsteps,1); 
I_boundary_matrix=zeros(Number_xsteps,1); 
DCa_Dt=zeros(Number_xsteps,1); 
DPO4_Dt=zeros(Number_xsteps,1); 
DCl_Dt=zeros(Number_xsteps,1); 
DNH4_Dt=zeros(Number_xsteps,1); 
DI_Dt=zeros(Number_xsteps,1); 
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%Rate Constants 
c_Ca=0; 
c_PO4=0; 
c_Cl=0; 
c_NH4=0; 
ki=1;             % Rate: Ca + I ===> I-CA  (mol/(L s)) 
% HA Constants 
K=1.364e28;     %  1/L*s    (Nucleation rate constant) 1.364e28 
gamma=0.105;    %  J/m2     (Surface tension water-HA) 
v=2.6324e-28;   %  m3       (HA molecular volume) 
f=0.5;          %           (Contact angle function) 
Ksp=2.35e-59;   %           (Solubity Product) 
Ks=2.59201e22;  %  1/(m2 s) (Crystal growth rate constant) 2.59201e22 
t_max=(60*60*24)*5; %[s] 
% Other Variables 
i=0; 
j=0; 
t=0; 
Break_time=0; 
DV=Ca_feed_molecules/(Ca_feed_conc*6.02e23); %litters 
P=zeros(Number_xsteps,1);    %Nucleation Probability 
I=zeros(Number_xsteps,1);    %Ionic strenght 
Gamma_Ca=zeros(Number_xsteps,1);    % Activity coefficients 
Gamma_PO4=zeros(Number_xsteps,1); 
Gamma_OH=zeros(Number_xsteps,1); 
a_Ca=zeros(Number_xsteps,1);    % Activity 
a_PO4=zeros(Number_xsteps,1); 
a_OH=zeros(Number_xsteps,1); 
S=zeros(Number_xsteps,1);                   %  Supersaturation 
c_nucleation=zeros(Number_xsteps,1);        %  Nucleation Rate 
c_growth=zeros(Number_xsteps,1);            % Crystal growth rate 
n=zeros(Number_xsteps,1);    %  Critical nucleus size (ion number) 
n_Ca=zeros(Number_xsteps,1);    % # Ca ions in critical nucleus 
n_PO4=zeros(Number_xsteps,1);   % # PO4 ions in critical nucleus 
n_HA=zeros(Number_xsteps,1);    % # HA molec in critical nucleus 
n_Ca_total=zeros(Number_xsteps,1);          % Total # of Ca ions/step 
n_PO4_total=zeros(Number_xsteps,1);         % Total # of PO4 ions/step 
n_possible_nucleus=zeros(Number_xsteps,1);  % Total possible nucleus/step  
n_size_HA_nuclei=zeros(Number_xsteps,1);    % Matrix of nuclei size (# HA molec) 
crystal_radii=zeros(Number_xsteps,1);       % Matrix of crystal radii 
Ca_ions=zeros(Number_xsteps,1);         %  Total # Ca ions/step 
PO4_ions=zeros(Number_xsteps,1);        %  Total # PO4 ions/step 
Cl_ions=zeros(Number_xsteps,1);         %  Total # Cl ions/step 
NH4_ions=zeros(Number_xsteps,1);        %  Total # NH4 ions/step 
HA_nuclei=zeros(Number_xsteps,1);       %  Total # HA nuclei/step 
a_Ca_diff=zeros(Number_xsteps,1);       % Propensity Functions: 
a_PO4_diff=zeros(Number_xsteps,1); 
a_Cl_diff=zeros(Number_xsteps,1); 
a_NH4_diff=zeros(Number_xsteps,1); 
a_nucleation=zeros(Number_xsteps,1); 
a_growth=zeros(Number_xsteps,1); 
Sum_a=0; 
n_random=0; 
cumulative_p=0;         % Probabilities: 
diffusion_p=0; 
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nucleation_p=0; 
growth_p=0; 
%========================================================== 
% Macro Scale 
tdraw=0; 
drawstep=3000; 
%Insert a seed specifying size and position (when a seed is considered) 
%HA_nuclei(12)=1; 
%crystal_radii(12)=0.000000001; 
%n_size_HA_nuclei(12)=floor((4*pi*crystal_radii(12)^3/3)/v); 
% Crank-Nicholson method 
% Diffusion matrix (starting values) 
for i=[1:Number_xsteps] 
     
    if i==1 
        Ca_square_matrix(i,i)=-2*DCa/Dx^2; 
        PO4_square_matrix(i,i)=-2*DPO4/Dx^2; 
        Cl_square_matrix(i,i)=-2*DCl/Dx^2; 
        NH4_square_matrix(i,i)=-2*DNH4/Dx^2; 
        I_square_matrix(i,i)=-2*DI/Dx^2; 
        Ca_square_matrix(i,i+1)=DCa/Dx^2; 
        PO4_square_matrix(i,i+1)=DPO4/Dx^2; 
        Cl_square_matrix(i,i+1)=DCl/Dx^2; 
        NH4_square_matrix(i,i+1)=DNH4/Dx^2; 
        I_square_matrix(i,i+1)=DI/Dx^2; 
    end 
    if i>1 && i<Number_xsteps 
        Ca_square_matrix(i,i-1)=DCa/Dx^2; 
        PO4_square_matrix(i,i-1)=DPO4/Dx^2; 
        Cl_square_matrix(i,i-1)=DCl/Dx^2; 
        NH4_square_matrix(i,i-1)=DNH4/Dx^2; 
        I_square_matrix(i,i-1)=DI/Dx^2; 
        Ca_square_matrix(i,i)=-2*DCa/Dx^2; 
        PO4_square_matrix(i,i)=-2*DPO4/Dx^2; 
        Cl_square_matrix(i,i)=-2*DCl/Dx^2; 
        NH4_square_matrix(i,i)=-2*DNH4/Dx^2; 
        I_square_matrix(i,i)=-2*DI/Dx^2; 
        Ca_square_matrix(i,i+1)=DCa/Dx^2; 
        PO4_square_matrix(i,i+1)=DPO4/Dx^2; 
        Cl_square_matrix(i,i+1)=DCl/Dx^2; 
        NH4_square_matrix(i,i+1)=DNH4/Dx^2; 
        I_square_matrix(i,i+1)=DI/Dx^2; 
    end 
    if i==Number_xsteps 
        Ca_square_matrix(i,i-1)=DCa/Dx^2; 
        PO4_square_matrix(i,i-1)=DPO4/Dx^2; 
        Cl_square_matrix(i,i-1)=DCl/Dx^2; 
        NH4_square_matrix(i,i-1)=DNH4/Dx^2; 
        I_square_matrix(i,i-1)=DI/Dx^2; 
        Ca_square_matrix(i,i)=-2*DCa/Dx^2; 
        PO4_square_matrix(i,i)=-2*DPO4/Dx^2; 
        Cl_square_matrix(i,i)=-2*DCl/Dx^2; 
        NH4_square_matrix(i,i)=-2*DNH4/Dx^2; 
        I_square_matrix(i,i)=-2*DI/Dx^2; 
    end 
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end 
Ca_boundary_matrix(1)=(DCa/Dx^2)*Ca_feed_conc; 
PO4_boundary_matrix(Number_xsteps)=(DPO4/Dx^2)*PO4_feed_conc; 
Cl_boundary_matrix(1)=(DCl/Dx^2)*Cl_feed_conc; 
NH4_boundary_matrix(Number_xsteps)=(DNH4/Dx^2)*NH4_feed_conc; 
% Macroscopic Diffusion 
% Main loop 
while t>-1 
    for i=[1:Number_xsteps] 
        if i==1 
            Ca_boundary_matrix(i)=(DCa/Dx^2)*Ca_feed_conc-ki*Ca_conc(i)*I_conc(i); 
            I_boundary_matrix(i)=-ki*Ca_conc(i)*I_conc(i); 
        end 
        if i>1  
            Ca_boundary_matrix(i)=-ki*Ca_conc(i)*I_conc(i); 
            I_boundary_matrix(i)=-ki*Ca_conc(i)*I_conc(i); 
        end 
        if i==I_source 
            Ca_boundary_matrix(i)=-ki*Ca_conc(i)*I_conc(i); 
            I_boundary_matrix(i)=-ki*Ca_conc(i)*I_conc(i)+I_prod; 
        end 
    end 
    DCa_Dt=Ca_square_matrix*Ca_conc+Ca_boundary_matrix; 
    DPO4_Dt=PO4_square_matrix*PO4_conc+PO4_boundary_matrix; 
    DCl_Dt=Cl_square_matrix*Cl_conc+Cl_boundary_matrix; 
    DNH4_Dt=NH4_square_matrix*NH4_conc+NH4_boundary_matrix; 
    DI_Dt=I_square_matrix*I_conc+I_boundary_matrix; 
    Ca_conc=Ca_conc+DCa_Dt*Dt; 
    PO4_conc=PO4_conc+DPO4_Dt*Dt; 
    Cl_conc=Cl_conc+DCl_Dt*Dt; 
    NH4_conc=NH4_conc+DNH4_Dt*Dt; 
    I_conc=I_conc+DI_Dt*Dt; 
    t=t+Dt; 
    if min(round(Ca_conc*DV*6.02e23)+round(PO4_conc*DV*6.02e23))>3 
        break 
    end 
    if t>tdraw      % This shows the free diffusion before change of scale 
        x_position=[1:1:Number_xsteps]; 
plot(x_position,Ca_conc,x_position,PO4_conc,x_position,Cl_conc,x_position,NH4_conc,x_position,I_
conc) 
        xlim([1 Number_xsteps]); 
        ylim([0 Ca_feed_conc]); 
        refreshdata 
        drawnow 
        tdraw=tdraw+drawstep; 
    end 
end 
%======================================================== 
% Micro Scale 
Break_time=t;   % Stores the time of first scale change. 
taccum=0; 
deltat=5000; 
c_Ca=2*DCa/Dx^2;        % Brownian inside length step 
c_PO4=2*DPO4/Dx^2; 
c_Cl=2*DCl/Dx^2; 
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c_NH4=2*DNH4/Dx^2; 
while t<t_max       
    % calculation of rates 
    for i=[1:Number_xsteps] 
        % Nucleation Rate 
P(i)=(504*Ca_conc(i)^5*PO4_conc(i)^3*OH_conc)/(Ca_conc(i)+PO4_conc(i)+OH_conc)^9; 
        I(i)=0.5*(4*Ca_conc(i)+Cl_conc(i)+9*PO4_conc(i)+NH4_conc(i)); 
        Gamma_Ca(i)=10^-(0.5211*4*(I(i)^0.5/(1+I(i)^0.5)-(0.3*I(i)))); 
        Gamma_PO4(i)=10^-(0.5211*9*(I(i)^0.5/(1+I(i)^0.5)-(0.3*I(i)))); 
        Gamma_OH(i)=10^-(0.5211*(I(i)^0.5/(1+I(i)^0.5)-(0.3*I(i)))); 
a_Ca(i)=Gamma_Ca(i)*(Ca_conc(i)/(55.55+OH_conc+Ca_conc(i)+PO4_conc(i)+Cl_conc(i)+NH4_co
nc(i))); 
        
a_PO4(i)=Gamma_PO4(i)*(PO4_conc(i)/(55.55+OH_conc+Ca_conc(i)+PO4_conc(i)+Cl_conc(i)+NH
4_conc(i))); 
a_OH(i)=Gamma_OH(i)*(OH_conc/(55.55+OH_conc+Ca_conc(i)+PO4_conc(i)+Cl_conc(i)+NH4_co
nc(i))); 
        S(i)=a_Ca(i)^5*a_PO4(i)^3*a_OH(i)/Ksp; 
        if S(i)>0 
            c_nucleation(i)=DV*K*P(i)*exp(-(16*pi*v^2*gamma^3*f)/(3*(1.38e-
23)^3*Temp^3*log(S(i))^2)); 
        else 
            c_nucleation(i)=0; 
        end 
        % Critical nucleus size (ion number) 
        if S(i)>0 
            n(i)=round(32*pi*gamma^3*v^2/(3*(1.38e-23)^3*Temp^3*log(S(i))^3)); 
        else 
            n(i)=0; 
        end 
        % Ions number per nucleus 
        n_Ca(i)=ceil(n(i)/9)*5; 
        n_PO4(i)=ceil(n(i)/9)*3; 
        Ca_ions(i)=round(Ca_conc(i)*DV*6.02e23); 
        PO4_ions(i)=round(PO4_conc(i)*DV*6.02e23); 
        Cl_ions(i)=round(Cl_conc(i)*DV*6.02e23); 
        NH4_ions(i)=round(NH4_conc(i)*DV*6.02e23); 
        if n_PO4(i)>0 && n_Ca(i)>0 
             n_possible_nucleus(i)=min([floor(Ca_ions(i)/n_Ca(i)) floor(PO4_ions(i)/n_PO4(i))]); 
             n_HA(i)=ceil(n(i)/9); 
        else 
            n_possible_nucleus(i)=0; 
            n_HA(i)=0; 
        end 
        % Crystal growth rate 
        if Ca_ions(i)>4 && PO4_ions(i)>2 && HA_nuclei(i)>0 
            for j=[1:HA_nuclei(i)] 
                c_growth(i,j)=Ks*4*pi*(crystal_radii(i,j))^2*(S(i)^(1/9)-1)^1.87; 
            end 
        else 
            c_growth(i,:)=0; 
        end 
        a_Ca_diffusion(i)=c_Ca*Ca_ions(i); 
        a_PO4_diffusion(i)=c_PO4*PO4_ions(i); 
        a_Cl_diffusion(i)=c_Cl*Cl_ions(i); 
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        a_NH4_diffusion(i)=c_NH4*NH4_ions(i); 
        a_nucleation(i)=c_nucleation(i)*n_possible_nucleus(i); 
        a_growth=c_growth; 
Sum_a=sum(a_Ca_diffusion)+sum(a_PO4_diffusion)+sum(a_Cl_diffusion)+sum(a_NH4_diffusion)+s
um(a_nucleation)+sum(sum(a_growth)); 
    end 
    Dt=-1/Sum_a*log(rand);      % Random time sampling 
   % Reaction selection 
        n_random=rand; 
        cumulative_p=0; 
diffusion_p=(sum(a_Ca_diffusion)+sum(a_PO4_diffusion)+sum(a_Cl_diffusion)+sum(a_NH4_diffusio
n))/Sum_a; 
        nucleation_p=sum(a_nucleation)/Sum_a; 
        growth_p=sum(sum(a_growth))/Sum_a; 
    %Diffusion 
        if n_random>cumulative_p && n_random<(cumulative_p+diffusion_p) 
            DCa_Dt=Ca_square_matrix*Ca_conc+Ca_boundary_matrix; 
            DPO4_Dt=PO4_square_matrix*PO4_conc+PO4_boundary_matrix; 
            DCl_Dt=Cl_square_matrix*Cl_conc+Cl_boundary_matrix; 
            DNH4_Dt=NH4_square_matrix*NH4_conc+NH4_boundary_matrix; 
            Ca_conc=Ca_conc+DCa_Dt*Dt; 
            PO4_conc=PO4_conc+DPO4_Dt*Dt; 
            Cl_conc=Cl_conc+DCl_Dt*Dt; 
            NH4_conc=NH4_conc+DNH4_Dt*Dt; 
            t=t+Dt; 
        end 
        cumulative_p=cumulative_p+diffusion_p; 
     % Nucleation 
        if n_random>cumulative_p && n_random<(cumulative_p+nucleation_p) 
            [A,I]=max(a_nucleation); 
            HA_nuclei(I)=HA_nuclei(I)+1; 
            Ca_ions(I)=Ca_ions(I)-n_Ca(I); 
            PO4_ions(I)=PO4_ions(I)-n_PO4(I); 
            Ca_conc(I)=Ca_ions(I)/(6.02e23*DV); 
            PO4_conc(I)=PO4_ions(I)/(6.02e23*DV); 
            n_size_HA_nuclei(I,HA_nuclei(I))=n_HA(I); 
            crystal_radii(I,HA_nuclei(I))=((n_HA(I)*v)*3/(4*pi))^(1/3); 
            c_growth(I,HA_nuclei(I))=0; 
            t=t+Dt; 
        end 
        cumulative_p=cumulative_p+nucleation_p; 
     % Growth 
        if n_random>cumulative_p && n_random<(cumulative_p+growth_p) 
            cumulative_p=0; 
            Sum_a=sum(sum(a_growth)); 
            n_random=rand; 
            for j=[1:Number_xsteps] 
                for m=[1:HA_nuclei(j)] 
                    if a_growth(j,m)>0 
                        if n_random>cumulative_p && n_random<(cumulative_p+a_growth(j,m)/Sum_a) 
                            n_size_HA_nuclei(j,m)=n_size_HA_nuclei(j,m)+1; 
                            crystal_radii(j,m)=((n_size_HA_nuclei(j,m)*v)*3/(4*pi))^(1/3); 
                            Ca_ions(j)=Ca_ions(j)-n_Ca(j); 
                            PO4_ions(j)=PO4_ions(j)-n_PO4(j); 
                            Ca_conc(j)=Ca_ions(j)/(6.02e23*DV); 
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                            PO4_conc(j)=PO4_ions(j)/(6.02e23*DV); 
                            cumulative_p=cumulative_p+a_growth(j,m)/Sum_a; 
                        end 
                    end 
                end 
            end 
            t=t+Dt; 
        end 
    if t>taccum     % Shows partial times while code is running 
        t 
        taccum=taccum+deltat; 
    end 
end 
% Shows some final results 
n_HA 
n_size_HA_nuclei 
crystal_radii 
x_position=[1:1:Number_xsteps]; 
plot(x_position,Ca_conc,x_position,PO4_conc,x_position,Cl_conc,x_position,NH4_conc,x_position,I_
conc) 
xlim([1 Number_xsteps]); 
ylim([0 Ca_feed_conc]); 
t 
beep 
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APPENDIX 11 
FINITE ELEMENT MODELS OF MASS TRANSPORT USING COMSOL 
MULTIPHYSICS 
 
 We have used the finite element method (FEM) to model mass transport within 
biomaterials; specifically, 1) the diffusion of a non-reactive solute (Fig. 3.14), and 2) 
the diffusion-reaction of reactive solutes (i.e., calcein-AM (Fig. 3.16) and oxygen 
(Figs. 3.19 and 4.11)).  This appendix briefly describes details of the use of COMSOL 
Multiphysics (Comsol, Inc., Burlington, MA) for the diffusion and diffusion-reaction 
processes. 
 Two-dimensional (2-D) finite element models used in this dissertation 
represent cross-sectional areas of three-dimensional (3-D) scaffolds (Figs. 3.14, 3.16, 
3.19, and 4.11).  We presume that there is no convection in the domains of interest.  
Another important assumption is that individual cells seeded in scaffolds do not serve 
as discrete sinks causing significant concentration gradients of reactive solutes.  We 
have verified this aspect with a 3-D finite element model indicating that the gradient 
of oxygen concentration is negligible across single cells (data not shown).  Therefore, 
an continuum approach using macroscopic parameters would be valid for the 
diffusion-reaction processes; for example, the global consumption rate of oxygen, 
2 2O cell O ,cell
R Rρ= , can be applied to the domains with an assumption that cells are 
uniformly distributed. 
 General steps to run finite element models in COMSOL are as follows: 
1. Non-dimensionalize governing equation(s) and boundary conditions with 
characteristic lengths (e.g., microchannel width) 
2. Open an appropriate module in COMSOL (e.g., transient 2-D diffusion; Fig. 
A11.1A) 
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3. Draw domain(s) (Fig. A11.1B) 
4. Pre-define constants that will be used in a model (e.g., diffusivity, consumption 
rate; Fig. A11.1C) 
5. Set up the domain based on the governing equation(s) (Fig. A11.1D) 
6. Set up the boundary conditions (Fig. A11.1E) 
Steps 1 and 4 are not mandatory, but the steps make it convenient to test a model with 
varying parameters.  If we specify commonly used units of constants when pre-
defining them, COMSOL will automatically convert the constants into the SI unit. 
 As an example, we describe procedure for the transient diffusion-reaction of a 
reactive solute within a microfluidic scaffold.  Figure 3.16A shows the distribution of 
calcein-AM delivered via the embedded microchannels and enzymatically consumed 
by cells in the bulk.  The transient diffusion-reaction of the solute in the 2-D domain 
(i.e., a cross-sectional area of the microfluidic scaffold) is governed by 
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 Non-dimensionalized variables can be defined as 
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 Then, the governing equation and boundary conditions become 
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 where non-dimensionalized rate constant, ,calc g gk −  is 
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 After pre-defining constants as summarized in Table A11.1, Eqs. A11.4 and 5 are 
applied to the domain.  Figure 3.16A is a transient solution to Eq. A11.4 at 120 min.  
Other finite element models presented in this dissertation were fomularized in the 
same way. 
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Table A11.1 Pre-defined input parameters for the 2-D finite element model of the 
enzymatic consumption of calcein-AM 
 
Diffusivity of calcein-AM ,calc g gD −  
6 22.4 10  cm /s−×  
Microchannel width cw  100 µm 
Cell seeding density cellρ  
72.5 10  cell/mL×  
Rate constant for the enzymatic consumption cellk  
111 10  mL/cell s−× ⋅  
Time t 120 min 
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Figure A11.1 General steps to run finite element models in COMSOL 
Multiphysics.  A. Module choice.  B. Draw mode.  C. Pre-definition of input 
parameters.  D. Subdomain settings.  E. Boundary settings. 
 
